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Abstract
Previous studies have demonstrated that rural Gambian children have poor growth, 
delayed puberty and low bone mineral status. Their calcium intake is low (300 - 400 mg/d). 
This study examined the benefit of an increase in calcium intake on growth and bone mineral 
development in Gambian children. 160 subjects, aged 8 - 1 2  years old (80 M, 80 F) were 
recruited into a randomised, double-blind, placebo-controlled study of calcium supplementation.
Bone mineral status was evaluated using single photon absorptiometry of the radius, 
and ultrasound measurements at the calcaneus. Anthropometry was performed and pubertal 
status assessed. Dietary intake was measured, and information on subject characteristics, 
physical activity and lifestyle factors were obtained. Fasting blood and 24h urine were 
collected for measurement of biochemical indices of calcium and bone metabolism. Data was 
collected at baseline, after 12 months of supplementation (714 mg Ca /d) and 12 months after 
withdrawal of the supplement.
Analysis of baseline data showed there were no differences in subject characteristics 
and bone variables between boys and girls, except that girls had significantly greater triceps 
skinfold thickness (p<0.0001). There were no significant differences between the 
supplemented and placebo groups in subject characteristics, anthropometry or bone variables 
at baseline. The Gambian children were smaller by >1 SD for their age compared with British 
reference children and the majority were prepubertal.
At outcome, the supplemented group had significantly higher BMC, BMD and size- 
adjusted BMC at the mid-shaft and distal radius compared with the placebo group. No 
differences were observed in response between boys and girls or at different ages or pubertal 
status. There was no significant effect of the calcium supplement on weight, height or bone 
width. At follow-up, the supplemented group still had significantly higher BMC, BMD and 
size-adjusted BMC at the mid-shaft radius and, although not significant, a similar trend was 
seen at the distal radius. The calcium supplemented group had significantly lower 
concentrations of plasma osteocalcin, parathyroid hormone, phosphate, lower urinary titratable 
acid and phosphate outputs, and had a greater urinary calcium output than the placebo group 
at outcome. At follow-up the only difference remaining was a lower PTH in the calcium 
supplemented group.
The results suggest that Gambian children on a low calcium diet may benefit from a 
higher calcium intake by lowering bone turnover rate. Further studies are needed to determine 
the long-term benefit of calcium supplement on bone mineral acquisition of Gambian children.
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1 An overview
1.1. Situation in The Gambia
1.1.1 Calcium intake
Calcium intakes of both children and adults in the rural areas of The 
Gambia are extremely low and average 300-500 mg/d (Prentice et al., 1993). 
This is about a third to a fourth of the British and American recommendations 
(National Academy of Science, 1989; Department of Health, 1992). The diet in 
rural Gambia is based on cereals, with dark green leafy vegetables, rice, fish and 
groundnuts as the major sources of calcium (Prentice & Bates, 1993). The low 
calcium intake is related in part to limited dairy produce in the Gambian diet, 
which is a rich source of calcium. Although, at present, it is not known how much 
of the calcium from the Gambian diet is absorbed, it is thought that a high 
proportion of the calcium intake may be poorly absorbed due to the high phytate 
and oxalate content of the diet (Allen, 1982, Hongo et al., 1989, Pun et a/., 1991, 
Department of Health, 1992). The calcium intake is low throughout life since 
even in infancy the calcium intake from breast-milk is substantially lower than in 
Western countries (Laskey etal., 1990).
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Table. 1.1 Reference calcium requirements for 8 -10 year old children compared with 
measured calcium intake in rural areas of The Gambia
Calcium intake 
(mg/d) (mmol/d)
World Health Organization (FAO/WHO, 1962; 1991) 700 17.5
USA, RDA (National Academy Science, 1989) 1200 30
USA, Al (National Academy Science,1997) 1300 32.5
UK, RNI (Department of Health COMA, 1992) 1000 25
Rural Gambia (Prentice etal., 1990) 400 10
Conversion factor mg/d to mmol/d: calcium + 40
1.1.2 Poor growth and delayed puberty
The growth rates of Gambian children are poor, and the start and
completion of puberty are delayed compared with British and American children 
(Lo et al., 1990). The pattern resembles the growth of children in other 
developing countries (Waterlow, 1988; Beaton, 1993; Martorell et al., 1994). 
Gambian children, although bom somewhat smaller, grow, on average, at a 
similar rate to those in the West for the first 3 months of life at a time when they 
are exclusively breast-fed (Rowland etal., 1977, Whitehead, 1979; Prentice etal., 
1990). Thereafter, marked growth faltering occurs so that before one year of age 
many children have low weight and height for their age. There is little evidence 
of subsequent accelerated catch-up in weight and height once a deficit has been 
created, so that by the time they reach later childhood, Gambian children are 
lighter and shorter than British children (Rowland etal., 1977; Whitehead, 1979; 
Prentice etal., 1990; Bates etal., 1993, Lo etal, 1990). Poor nutrition and
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infections are believed to be the main causes of growth retardation in Gambian 
children (Rowland etal., 1977; Whitehead, 1979).
There is a seasonal pattern of growth and disease in rural Gambia. 
Growth is particularly poor in the rainy (wet) season and diseases like malaria 
and diarrhoea are also common in the wet season (Figure 1.1).
Fig. 1.1 Weight velocity chart of a typical rural Gambian child compared with National 
Center for Health Statistics reference for US children (NCHS).
seasonal pattern of disease
clinical
survey
endedI  W HO STANDARDS off
breast
2
H
X
o
Hi
£
24
AGE (months)
The data is from MRC Dunn Nutrition Unit’s clinical surveys in rural Gambia from 1978 - 1980. Data set at each 
age group is the mean of all the measurements taken during that period. The child has been seen in a weekly 
infant clinic once a month for a period of two years. The pattern of the graph is typical of how the weight of 
children in rural Gambia behave throughout childhood depending on the season of the year. The fluctuation of 
the graph shows the period between weight faltering in the wet season and catch up in the dry season. 
Diseases such as diarrhoea, pneumonia and other infections are also prevalent in the wet season which also 
affect growth in addition to poor nutrition. The dotted lines represent seasonal boundaries.
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1.1.3 Bone mineral accretion
Previous studies in Keneba, a rural village in The Gambia, have indicated 
that the bone mineral development of children is low compared with British and 
American children of the same age, both before and after size adjustment 
(Prentice etaL, 1990; Lo e ta l, 1990). Differences in bone mineral content (BMC) 
at the mid-shaft radius between the British and Gambian children averaged 11 % 
at birth and increase to 31% at 3 years (Prentice etal., 1990) (see graph below). 
The differential was reduced after allowing for the smaller body size of the 
Gambian children due to their poor growth performance but remained 
considerable (12% comparing children of 15 kg body weight) (Prentice et al., 
1990). It is possible therefore that the low calcium intake of Gambian children 
could limit their bone mineral accretion rate.
Fig. 1.2
0.25 Britain
.p
^  0.15
0
1  0.10
0.20 The Gambia
0.05
0 12 24 36
Age (months)
Bone mineral content (BMC) at mid-shaft radius of Gambian and British infants 
according to age and sex. Continuous line (-) represents boys and dotted line (... ) 
represents girls. Source: Prentice et al., 1990.
4
chapter 1 Possible health implications of a low calcium intake
1.2 Possible health implications of a low calcium intake
1.2.1 Calcium intake and clinical rickets
There is accumulated evidence to suggest that dietary calcium deficiency 
may exist unrecognised in countries where habitual calcium intake is low 
(Pettifor, 1991). A possible association between a low calcium diet and an 
increased incidence of rickets in young children was well documented more than 
two decades ago (Maltz et al., 1970; Kooh et al., 1977; Proesman et al., 1988), 
and was also reported in a more recent study (Pettifor, 1991). These findings 
were supported by a study in South Africa in which the calcium intake of children 
with rickets was estimated at 125 mg/day compared with 337 mg/day in controls 
(Pettifor etal., 1979; Pettifor, 1991). Bone accretion rate in children with rickets 
was enhanced following treatment with calcium (Marie et al., 1982), suggesting 
calcium deficiency was the cause of rickets in these children. This hypothesis 
was further supported by the rapid return to normal of serum calcium 
concentrations in a group of South African children in a high risk area whose diet 
was supplemented with 500 mg calcium/day for 3 months (Pettifor etal., 1981).
1.2.2 Calcium intake and growth
Calcium is a primary bone-forming mineral, and adequate amounts must 
be provided from the diet for bone mass development during growth. Calcium 
accretion rate during childhood is estimated to be around 200 mg/d and is higher 
during periods of rapid growth (Prentice & Bates, 1993). Deficiencies of both 
macro and micro-nutrients may contribute to poor linear growth in early life
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(Tomkins etal., 1986; Keller, 1988). Inadequate intake of bone-forming minerals 
such as calcium have been associated with poor linear growth in children 
(Prentice & Bates, 1993), and the diets of stunted children are thought to be 
deficient in calcium (Keller, 1988).
Linear growth retardation is a major problem in the world’s poorest 
nations. Current estimates of the prevalence of stunting in under 5s in Africa, 
Americas and Asia by the World Health Organization averages around 40% (de 
Onis etal., 1993; Rivera etal., 1998) as defined by a height-for-age more than -2 
SD with regards to the WHO/NCHS reference value (de Onis et al., 1993). 
Although the actual causes of stunting remain controversial, insufficient dietary 
intake, such as an inadequate calcium intake, repeated infections and poor 
standards of living have all been implicated (Keller, 1988, Schurch & Scrimshaw, 
1994).
The impact of calcium supplementation on linear growth has been little 
studied and there are conflicting results on the effect of calcium supplementation. 
Some supplementation studies using growth as the main outcome have 
demonstrated no effect of calcium alone or combined with phosphorus on the 
rate of growth (Pettifor et al., 1981; Aykroyd & Krishnan, 1938). On the other 
hand, studies of Indian children who consumed relatively low amounts of calcium 
had a significantly increased gain in height and weight over 3 - 5  months 
compared with controls (Aykroyd & Krishnan, 1938; Aykroyd & Krishnan, 1939). 
A recent study in Switzerland showed an association between calcium 
supplementation and height gain in a group of 7 year old children with low 
calcium intake (Bonjour etal., 1997).
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1.2.3 Calcium intake and bone mineral accretion
Skeletal growth requires an adequate supply of the building blocks of 
bone of which calcium is the most important mineral. The calcium accretion rate 
during peak growth can be as high as 400 mg/day (Pettifor, 1991; Kanis, 1994). 
Some suggest an adolescent requires an intake of at least 1,500 mg/day in order 
to retain such an amount of calcium (Matkovic & Heaney, 1992). A number of 
studies have indicated a beneficial effect of moderate to high calcium intake on 
bone mineral mass (Matkovic et al, 1990). Similarly, results from 
supplementation studies of children have documented a positive effect of a high 
calcium intake on bone mineral content (Johnston etal., 1992; Lloyd et al., 1993; 
Lee etal., 1994).
1.2.4 Calcium intake and peak bone mass
The importance of dietary calcium in the development of the human 
skeleton has recently received increased attention (Anderson, 1992). A number 
of retrospective studies have reported an association between a high calcium 
intake during childhood and peak bone mass (Fehily et al., 1992; Hu et al., 1993; 
Orwoll, 1991, Slemenda et al., 1991; Metz etal., 1993; Mazess & Barden, 1991; 
Paganini-Hill etal., 1991). A dispute remains as to whether retrospective studies 
can account for all the confounding factors, such as the influence of socio­
economic factors, physical activities and other lifestyle variables. There is 
increasing evidence to suggest that a high calcium intake during growth is 
needed to optimise peak bone mass and reduce risk of fractures later in life 
(Sandler etal., 1985; Halioua & Anderson, 1989). Attainment of high peak bone
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mass has been associated with reduced incidence of fragility fractures (Nordin, 
1996, Adebajo et al., 1991). Therefore prospective studies are needed to 
determine whether consuming high amounts of calcium during adolescence and 
early adult life will result in continuous, incremental gains in bone mass, sufficient 
to increase peak bone mass and reduce fracture incidence in later life.
1.3 Evidence of possible problems in The Gambia
1.3.1 Ethnic differences
There are ethnic variations in the amount of bone mass attained at skeletal 
maturity. Variation in bone mass between ethnic groups is likely to be due to 
both genetic and lifestyle differences between various ethnic groups. Early 
studies in Africa and in other black communities have suggested that 
osteoporosis and related bone fractures are rare in this ethnic group (Adebajo et 
al., 1991; Solomon, 1979; Prentice et al., 1991). The low incidence of fragility 
fracture in blacks compared with Caucasians has largely been attributed to 
blacks having a higher peak bone mass, and lower rates of bone loss in later life 
than Caucasians (Cooper., 1993; Matkovic etal, 1980; Cohn et al., 1977; Ortiz et 
al., 1992; Harris etal., 1995). However, récent studies in The Gambia have 
shown that menopausal bone loss occurs in black African women at a similar 
rate to their European counterparts and that, unlike American blacks, differences 
in bone mass either in young adult life or in old age cannot account for the 
difference in fracture incidence (Prentice et al, 1991; Asp ray et al., 1996). This 
finding is in agreement with earlier work in South Africa that found no
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evidence of higher bone mineral density in African blacks (Walker et al., 1972; 
Solomon, 1979).
At present, clinical osteoporosis is rare in The Gambia despite the low 
habitual calcium intake of the population (Prentice et al., 1991; Aspray et al., 
1996). The reason for the low incidence of osteoporotic fracture in African blacks 
is not fully understood, but it is perceived that this could be due to certain lifestyle 
factors, such as physical activity and muscle strength, rather than a high skeletal 
mass. Migration of African blacks from rural to urban areas with a more 
sedentary lifestyle, in search of better life, could lead to an increased incidence of 
osteoporosis. It is, therefore, important that determinants of bone mass are 
investigated with a view to optimising the bone mineral content of the skeleton.
The incidence of fragility fractures is likely to increase markedly throughout 
the world in the next few decades due to the increasing global population of 
elderly people. The hip fracture incidence is expected to treble to over six million 
cases a year by 2050 (Cooper, 1993).
Promoting the development of bone mass by growing children is regarded 
as a possible strategy in preventing osteoporotic fractures. It is therefore, 
important that the calcium intake of children is optimised to support skeletal 
growth during adolescence. An optimal calcium intake refers to the levels of 
consumption that are necessary for an individual (a) to maximise peak adult 
bone mass (b) to maintain adult bone mass, and (c) to minimise bone loss in later 
years. The dietary calcium intake of children in rural areas of The Gambia is 
similar to countries where low calcium intakes have been linked with bone rickets
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and yet so far there is lack of evidence to suggest that rural Gambian children 
suffer from any abnormalities due to low calcium intake. At present, rickets is not 
a recognised health problem in The Gambia.
Although it is not clear whether the low bone mineral accretion rate of 
Gambian children reflects their low calcium intake, it is plausible that inadequate 
dietary calcium intake could slow the rate of bone development in Gambian 
children and result in poor height attainment and low peak bone mass. Whether 
a high calcium intake would improve growth and bone mineral development of 
Gambian children is a question which warrants further investigation and was the 
subject of the research investigation presented in this thesis.
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1.4. Main aims
The main aims of the research were:
* to determine whether poor growth and low bone mineral status of Gambian 
children could be explained by their low calcium intake, by determining 
whether calcium supplementation has any effect on the growth and bone 
mineral mass development of prepubertal Gambian children,
* if calcium supplementation is associated with an effect on bone mineral 
accretion, to determine whether the increase in bone mineral status is 
sustained after supplement withdrawal,
* to measure biochemical markers of bone metabolism in blood and urine and 
to determine the effect of supplement on these indices in order to investigate 
mechanisms,
* to quantify the calcium intake of rural Gambian children by a direct weighing 
method,
* to examine the growth pattern of prepubertal Gambian boys and girls in the 
age range ( 8 - 1 2  years) including their passage into puberty,
* to evaluate the bone mineral mass development in pre- and peri- pubertal 
Gambian boys and girls,
* to compare bone and anthropometric measures of Gambian children with 
age-matched Cambridge children.
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2.1.1 The skeleton
The skeleton is a complex structure, consisting of a variety of tissues and 
made up of about 200 separate bones (Dequeker, 1988). Bone tissue consists of 
two substances, the fibrous protein collagen, which is strong in tension, and the 
mineral apatite (calcium phosphate), which is strong in compression. Both are 
essential to skeletal function. The adult skeleton is composed of two types of 
bone, cortical bone which has a hard, compact structure and makes up to 75 - 
80% of the skeleton, and trabecular (cancellous or spongy) bone which has a 
looser structure and comprises 20 - 25% of the skeleton (Kanis, 1994; Dequeker, 
1988). Cortical bone is found predominantly in the shafts of long bones and 
forms the outer shell of trabecular regions while trabecular bone is found at the 
ends of long bones and in the axial skeleton, the spine and hip.
Cortical bone is made up of cylindrical structures (osteons) with concentric 
lamellae, which are oriented in the direction of the long axis of the bone 
(Dequeker, 1988). Trabecular bone is a three-dimensional lattice composed of 
plates and columns oriented in the direction of the compressive forces. These 
plates and columns are interconnected by thinner struts (trabeculae) in the non- 
load-bearing plane (Melsen & Mosekilde 1988), which are vital in providing a 
framework of maximum support. The structure of trabecular bone becomes 
disconnected with age, fails to reform, and often disappears, with marked effects 
on bone strength. However, the resultant effect on overall bone mass may not be 
substantial. Although trabecular bone accounts for a minority of the skeletal 
mass, it is metabolically more active and has a higher rate of turnover because its
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surface to volume ratio is much higher than cortical bone (Kanis, 1994). Thus 
bone mineral is lost faster from trabecular bone during periods of bone loss. 
Trabecular bone is more prone to fracture and so the sites in the body at which it 
is found are thought to be more vulnerable, particularly in older people (Kanis, 
1994; Melsen & Mosekilde, 1988). Proportions of the two types of bone vary 
quite considerably between different regions of the skeleton (Riggs etal., 1981, 
Cummings etal., 1985). The bone mineral contributes to the main function of the 
skeleton, the provision of a strong framework for the body and basis of all its 
movements. It also plays a biochemical role in the maintenance of calcium 
homeostasis (Lian & Gundberg, 1988; Ismail etal., 1986).
2.1.2 Skeletal growth
The calcification of the skeleton of the human fetus begins as early as the 
fifth month of life and from then on the demand upon the maternal supply of 
bone-forming substances becomes considerable (Dequeker, 1988; Melsen & 
Mosekilde, 1988). Calcification starts in the clavicle and membranous bones of 
the skull, which follows rapidly in long bones and spine (Riggs etal., 1981). In 
the normal full-term infant, the distal femoral and proximal tibial epiphyses are 
ossified. Calcification of teeth begins by about the seventh month of gestation or 
after delivery. The formation of healthy teeth is promoted by a diet adequate in 
protein, calcium, phosphate and vitamins especially vitamin C and D (Cummings 
etal., 1985; Dequeker, 1988). Hormones such as thyroid hormone and the
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active form of vitamin D (1,25 dihydroxy vitamin D) are also crucial in calcification 
of teeth.
Growth of bone in children takes place at the epiphyseal growth plate of 
long bones by a finely balanced cycle of cartilage growth, matrix formation and 
calcification of cartilage that acts as a platform for bone formation (Price et al.,
1994). This sequence of cellular events constitutes endochondral ossification. 
An increase in bone length is followed by an increase in bone diameter and this 
is achieved by new bone being laid down by the osteogenic layer of the 
periosteum (Price etal., 1994).
The onset of the adolescent growth spurt is an important event in skeletal 
development. The period indicates the start of a prolonged acceleration of bone 
mineralisation in both sexes. During the adolescent growth spurt, the bone 
mineral content increases at a rate of ~ 8.5%/y (Mazess & Cameron, 1972a, 
Christenson et al., 1975, Anderson & Rondano, 1996). Even when puberty 
ceases, adolescents continue to gain bone mass until peak bone mass is 
attained: for girls the figures are approximately 5% in the cortex of the 
metacarpals, 6% in the proximal radius, 15% in the distal radius, 9% in the spine 
(Bonjour et a t, 1991; Matkovic etal., 1990, Anderson & Rondano, 1996; Taylor et 
al., 1997b). This process is known as consolidation (Parsons et al., 1996; British 
Nutrition Foundation, 1989; Prentice & Bates, 1993). Sex hormones such as 
oestrogen and testosterone are important in the initiation of the process of growth 
and bone mineralisation, and probably in the maintenance over many years of 
the accelerated bone mineralisation (Mazess, 1971; Anderson & Rondano,
1996). This view is supported by observations of Krabbe and associates, and
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others which indicated that, in boys with delayed puberty, the maintenance of low 
levels of serum testosterone postpones the onset of the growth and 
mineralisation spurt (Krabbe et al., 1979; Frisancho, 1981; Antoniazzi et al.,
1995).
The start of puberty and the acceleration in bone mineral accumulation are 
later in boys compared to that in girls (Bonjour et al., 1991; Peacock, 1991). 
Some studies found a strong association between bone mineral density and 
height in children (Mazess & Cameron, 1972a; Glastre et al., 1990) while others 
found no direct association (Bonjour etal., 1991).
The process of bone modelling takes place from birth until the cessation of 
longitudinal bone growth (Matkovic, 1996). This is characterised by changes in 
the shape of the bones. Thereafter, the existing bone tissue within the skeleton is 
continuously being formed and resorbed with little change in the volume of bone 
during the remodelling process (Matkovic, 1996). From early life through young 
adulthood, up to about the 30 years of age, bone formation predominates, 
resulting in a continuous accumulation of bone mineral mass (Matkovic, 1996).
Peak bone mass is defined as the maximum amount of bone mineral mass 
achieved during normal growth (Matkovic, 1996; Weaver etal., 1996). The exact 
age at which peak bone mass is reached varies between different studies. Some 
studies have shown that the maximum bone mineral mass is attained in the third 
decade in both sexes and at all skeletal sites (Johnston & Longcope, 1990; Ott,
1990) but others have shown that the attainment of peak bone mass in human 
occurs earlier (Theintz etal., 1992; Matkovic et al., 1990; Gilsanz et al., 1988). 
The amount of peak bone mass attained is a major determinant of the risk of age-
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related osteoporotic fracture (Hui et al., 1989; Wasnich et al., 1989; Matkovic,
1996). Thus identifying the underlying causes responsible for inadequate 
accumulation of bone tissue during modelling and skeletal consolidation is 
important in minimising the later risk of osteoporotic fracture.
2.2 Biology of bone
Three cells are central to bone biology, osteoclasts, osteoblasts and 
osteocytes, these cells are involved in bone modelling and remodelling.
2.2.1 Osteoclasts
Osteoclasts originate from cells of the monocyte lineage and are usually 
multinucleated. Osteoclasts resorb existing bone and are active early in the 
bone remodelling cycle (Parfitt, 1980; Kanis, 1994; Christenson, 1997; Slemenda 
et al., 1997). The osteoclast attaches the outside edge of its membrane to the 
mineral matrix on the surface of bone thus forming a microenvironment termed as 
a sealing zone (Kanis, 1994; Christenson, 1997; Slemenda etal, 1997). It is this 
microenvironment that provides a bone-resorbing compartment at a low pH 
(Christenson, 1997; Slemenda et al, 1997). The function of this 
microenvironment is to erode bone (Christenson, 1997).
2.2.2 Osteoblasts
Osteoblasts are involved in bone formation (Kanis, 1994; Christenson,
1997) Following erosion of bone by the osteoclast, these cells lay down 
replacement bone matrix, called osteoid, at the site of bone metabolism (Kanis, 
1994; Christenson, 1997). The osteoid become mineralised to form new bone
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(Christenson, 1997; Slemenda etal., 1997; Kanis, 1994). The newly formed 
matrix is then mineralised with hydroxyapatite giving the bone tensile strength 
(Christenson, 1997), Osteoblasts have one nucleus with an extensive network of 
rough endoplasmic reticulum, the organelle that is responsible for synthesis of 
bone matrix protein.
2.2.3 Osteocytes
Osteocytes are derived from osteoblasts (Christenson, 1997). These bone-lining 
cells covers and surround much of the surface of bones, particularly of the long 
bones forming a cellular network on bone surface. The calcified bone matrix 
communicates with the bone surface via the network of osteocytes. The bone 
extracellular fluid (ECF) is embedded within the network and is separated from 
the systemic ECF by the lining cells covering the bone surface. In lamellar bone, 
osteocytes are arranged parallel to the axis of the collagen fibres, and in woven 
bone, they are bigger and have a much more haphazard distribution. Although 
these cells are often regarded as metabolically inactive, they are thought to have 
a role in initiating the bone cycle (Bronner, 1994; Christenson, 1997).
2.3 Bone modelling, remodelling and resorption
2.3.1 Bone modelling
The growth process in bone that leads to the attainment of the mature 
skeleton is called modelling (Parfitt, 1980; Kanis, 1994). The growth of the 
human skeleton is thought to take three decades to reach to full adult size and
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density (Trotter & Hixon, 1973; Matkovic etal., 1990; Matkovic, 1991). The rate of 
bone modelling varies in different stages of development (Matkovic, 1991). The 
process is most active during childhood and adolescence, and enables long 
bones to increase in diameter, change shape and develop a marrow cavity 
(Parfitt, 1980; Kanis, 1994).
2.3.2 Bone remodelling in children
Living bone is constantly broken down and reformed as part of the natural 
process of repair and renewal, a process known as remodelling (Frost, 1969; 
Parfitt, 1984). In a normal healthy person, the process of bone formation and 
bone resorption is tightly coupled (Figure 2.1). The imbalance of skeletal 
formation, resorption, and remodelling during rapid growth results in an 
increased cortical porosity which has been associated with fracture of forearm 
(Parfitt, 1994, Kanis, 1994).
Although morphologically well established, the physiological mechanisms 
coupling bone remodelling and resorption are not fully understood. Bone 
remodelling is a dynamic process reflecting the balance between bone formation 
and resorption (Parfitt, 1980; Kanis, 1994). The remodelling cascade is a highly 
ordered sequence of events starting resorption of a discrete cavity on the surface 
of bone followed by recruitment of osteoblasts sometime after resorption, and 
with mineralisation of the newly-formed bone rapidly at first stage of the process 
but more slowly thereafter (Parfitt, 1980; Kanis, 1994; Prentice, 1997). The 
process is important for the maintenance and self-repair of skeletal tissue (Parfitt, 
1980; Kanis, 1994).
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Figure 2.1 Diagram showing the coupling of resorption and formation in bone remodelling starting with a bone 
surface (A), activation of osteoclasts (B), resorption of old bone by osteoclasts (C), attraction and migration 
of osteoblasts to bone surface (D and E) and formation of new bone by osteoblasts (F and G). New bone with 
complete restoration (H). Source: Anderson (1996a). <
Two cells are involved in bone remodelling, the osteoblast and the 
osteoclast. Osteoclasts, the cells responsible for bone resorption are attracted to 
the newly-formed bone remodelling site where they dissolve away a small, 
discrete portion of the surface. The resulting resorption cavity is then refilled with 
pre- mineralised bone tissue by the bone-forming cells, the osteoblasts (Figure 
2.1) (Parfitt, 1980; Kanis, 1994; Slemenda et a/., 1997; Christenson, 1997). 
Osteoclasts resorb bone until the resorption cavity is approximately 100gm in 
diameter and 50p,m deep, resorption is then stopped and osteoblasts, the bone- 
forming cells are attracted and recruited to the remodelling site and refilled the 
resorption cavity (Kanis, 1994; Slemenda etal., 1997; Christenson, 1997). This
results in laying down of bone matrix (osteoid) which become mineralised to form
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new bone (Christenson, 1997; Slemenda et al., 1997;. Kanis, 1994). The newly 
formed matrix is then mineralised with hydroxyapatite (Christenson, 1997). 
Finally, the remodelled area passes into quiescent phase to complete the bone 
cycle (Figure 2.1). The whole process is estimated to take 60 - 120 days to 
complete (Frost, 1969, Kanis, 1991; Kanis, 1994; Christenson, 1997; Slemenda 
et al., 1997). In children, there is imbalance between bone remodelling and 
modelling in favour of increase bone mass until 30 -40 years of life, followed by a 
balanced period where total mass remains constant for a relatively few years 
before bone loss occurs in middle - and old-age (Christenson, 1997).
2.3.3 Bone remodelling in adults
Bone resorption increases with age, and a negative balance between 
formation and resorption has been reported in both cortical and trabecular bone 
after the age of 35- 40 years (Mosekilde etal., 1987; Mosekilde, 1988; Gam etal., 
1967 ). This is thought to be due to a combination of cortical thinning, trabecular 
perforations and negative calcium balance with advancing age (Parfitt, 1984; 
Eriksen etal., 1986).
In a normal adult, approximately 10 -15% of skeletal surfaces are involved 
in the process of remodelling at any one time (Parfitt, 1980; Kanis, 1991 ; 
Prentice, 1997). Thereafter, there is a temporal net decrease in bone mineral 
replacement at the bone remodelling unit and consequently affecting the whole 
body bone mineral (Parfitt, 1980; Kanis, 1991; Christenson, 1997). In healthy 
adults, the reversible calcium deficit is estimated at 14000 mg calcium, 
representing approximately 1.3% of the total calcium in the skeleton (Parfitt, 
1980; Christenson, 1997). In men, this is thought to result in failure of osteoblasts
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to completely fill the eroded areas to their original dimension, leaving a small 
deficit at each remodelling unit (Christenson, 1997; Slemenda et al., 1997). In 
postmenopausal women, the decrease in bone density is thought to be 
osteoclast-mediated, because the cavity eroded by osteoclasts is deeper than 
the standard 50pm depth (Christenson, 1997; Slemenda et al., 1997). The 
oestrogen deficiency that is common in postmenopausal women has been 
associated with an increase in the frequency of bone remodelling unit activation, 
leading to accelerate bone loss (Christenson, 1997; Kanis, 1994). In addition, 
inhibition of bone remodelling has been linked to a spontaneous fracture, which 
is thought to relate to the inability of the skeleton to repair fatigue damage (Frost, 
1960; Parfitt, 1980; Kanis, 1994).
Bone turnover is reduced by high calcium intake due to decreased in 
osteoclast activity, resulting in lower resorption rate, a reduction in the 
remodelling space and increase in bone mineral content (Lee et al., 1994; Lee et 
al., 1995; Slemenda etal., 1993; Prentice, 1997). Conversely, a decrease in 
calcium intake promotes osteoclast activation, increases bone turnover, which 
decreases bone mineral (Kanis, 1991; Kanis, 1994; Slemenda et al., 1993).
The amount of calcium normally removed by bone resorption has been 
estimated to be around 250 mg daily from a total body calcium of 1 kg (Kanis, 
1994). In adults in whom longitudinal growth has ceased, it is estimated that up 
to ninety-five percent or more of the skeletal turnover is accounted for by 
remodelling of bone, with <5% of turnover attributed to the modelling process 
(Parfitt, 1980; Kanis, 1994).
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2.4 Markers of bone turnover
2.4.1. Biochemical markers of bone formation
2.4.1.1 Osteocalcin
The protein and other substances that are produced, modified, released or 
degraded by active osteoclasts and osteoblasts during the different phases of 
cell cycle serves as the biochemical markers for monitoring bone metabolism 
(Christenson, 1997; Slemenda etal., 1997).
Osteocalcin is a bone matrix y-carboxyglutamate protein (bone G la
protein, BGP) synthesised by proliferating osteoblasts (Lian & Gundberg, 1988; 
Karlsson etal., 1992; Christenson, 1997). The osteocalcin produced is released 
into the circulation and is also incorporated into the bone matrix where it is the 
most abundant noncollagenous protein. Its synthesis is dependent on vitamin K 
(Kleerekoper, 1996; Christenson, 1997). Although the exact function of 
osteocalcin is still not fully understood, it is assumed that most of the newly 
synthesised protein is incorporated into the bone matrix where it functions by 
binding to calcium (Christenson, 1997; Slemenda etal., 1997, Fottrell & Power, 
1991). The serum concentration of osteocalcin reflects bone mineral metabolism 
and bone turnover and it is regarded as a specific marker of bone formation (Lian 
& Gundberg, 1988; Ismail etal., 1986). Serum osteocalcin concentrations in 
children have been shown to correlate with growth velocity (Cole et al., 1985; 
Delmas etal., 1986; Johansen etal., 1990; Kanzaki etal., 1992). While most 
osteocalcin is released at time of bone formation, a small amount of osteocalcin 
is degraded, released into the circulation and excreted in the urine during bone
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resorption (Kanis, 1994; Christenson, 1997). This has raised questions about 
whether osteocalcin should be considered a marker of bone metabolism or 
turnover rather than bone formation (Fottrell & Power, 1991; Kleerekoper, 1996), 
but currently is regarded as the most specific bone formation marker available. 
Its concentration in blood correlates well with bone mineral metabolism and bone 
turnover (Lian & Gundberg, 1988; Ismail etal., 1986).
2.4.1.2 Alkaline phosphatase
In bone, alkaline phosphatase is involved in the breakdown of 
pyrophosphate (Christenson, 1997), a potent inhibitor of calcium phosphate 
deposition at the extracellular level. A number of isoenzymes of alkaline 
phosphatase exist, including the bone-specific alkaline phosphatase which is 
produced by the osteoblast and therefore plays an essential role in bone 
formation process. It is produced in high amounts during bone formation and its 
measurement in serum is a measure of bone formation (Canalis et al., 1989, 
Christenson, 1997).
2.4.2 Biochemical markers of bone resorption
Resorption markers, reflect osteoclast activity and/or collagen degradation. 
Type 1 collagen matrix comprises over 90% of the bone matrix (Christenson,
1997). Type 1 collagen has a triple helix structure formed from three chains, one 
of which has a high proportion of the amino acids proline and hydroxyproline. It 
is synthesised as a precursor with large extension peptides on both the 
carboxyterminal and amino terminal ends (Christenson, 1997). These proteins 
are cleaved during the secretion and fibril formation process. Crosslinking
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occurs between lysine or hydroxylysine residues on nonhelical carboxyterminal 
or aminoterminal ends known as telopeptides, and the helical portions of an 
adjacent collagen (Fujimo etaLt 1995, Christenson, 1997). This process forms 
the pyridinoline and deoxypyridinoline crosslinks in the primary structure of type 
1 collagen (Fujimo etal., 1995).
2.4.2.1 Deoxypyridinoline (D-pyr)
Deoxypyridinoline (D-pyr) is one of the most specific markers of bone 
metabolism. D-pyr has only been found in a significant amounts in type I 
collagen of bone and is released into the circulation following bone resorption 
(Delmas, 1992; Seibel etal., 1992). Deoxypyridinoline is a cross-linking amino 
acid of collagen which is excreted in urine both as free amino acid and in 
peptide-bound form (Black et al., 1989; Uebelhart et al., 1990). A good 
agreement between total and free form of deoxypyridinoline measured in urine 
has been reported (Aoshima et al., 1998). However, free D-pyr has the added 
advantage over total D-pyr in that its concentration in the urine does not vary 
between day and night, whereas, urinary concentration of total and bound forms 
of deoxypyridinoline have been shown to have circadian variation (Aoshima et 
al., 1998). Because of this, free D-pyr is thought to be a better marker than total 
or bound form D-pyr which are sensitive to time (Aoshima et al., 1998). 
Measurement of deoxypyridinoline has been used to demonstrate the effect of 
antiresorptive agents in a number of studies (Seibel et al., 1993; Delmas et al.,
1993). The serum concentration of D-pyr has been shown to correlate with 
collagen breakdown and bone resorption (Eriksen et al., 1993). Several studies 
indicate that the excretion of D-pyr in urine as free and peptide-bound form, is
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more specific and sensitive than resorption markers such as urinary 
hydroxyproline or calcium excretion (Eyre et al., 1984; Black et al., 1989; 
Uebelhart et al., 1990; Robins et al., 1991; Garnero et al., ' 1996a), 
Deoxypyridinoline is neither absorbed from the diet nor is it metabolised by the 
liver (Colwell etal., 1993; Fujimoto etal., 1995).
Urinary concentrations of D-pyr in children are higher than those in adults 
(Fujimoto et al., 1983; Beardsworth etal., 1990). However, little is known about 
the age-related changes in urinary D-pyr or in bone resorption in children.
Hydroxyproline is the product of post-translational hydroxylation of proline 
residues of type 1 collagen. Hydroxyproline, pyridinoline, cross-linking amino 
acids of collagen, hydroxylysylpyridinoline, and lysylpyridinoline, are urinary 
metabolites that are excreted in urine both as free amino acids and in peptide- 
bound form and have been widely used in recent years as markers of bone  ^
resorption (Eriksen etal., 1988; Christenson, 1997). Urinary hydroxyproline and 
pyridinoline are not specific for bone and are no longer regarded as markers of 
choice for bone resorption because these markers are degraded in other tissues 
as well as bone, and their concentrations in urine are affected by diet. 
Pyridinoline and deoxypyridinoline are formed via posttranslation of lysine and 
hydroxylysine respectively (Christenson, 1997).
2 4.2.2 Urinary calcium (Ca)
Urinary calcium concentration either in a 24-hour sample, fasting 2 hour 
samples, or in a spot or first morning specimen (corrected for creatinine) has 
been used for assessing skeletal loss in postmenopausal women (Kleerekoper,
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1996; Seibel etal., 1992; Seibel et al., 1993). The problem with urinary calcium
as a marker of bone loss is that the concentration can be substantially affected by
diet, renal function and handling, and excess parathyroid and oestrogen
production (Kleerekoper, 1996).
2.4.2.S Tartrate Resistant Acid Phosphatase (TRAP)
The bone isoenzyme of tartrate resistant acid phosphatase is derived from 
osteoclasts where it is present in high concentrations. It is secreted by 
osteoclasts during resorption between bone matrix and membrane sealing zone 
(Canalis et al., 1989; Christenson, 1997). The enzyme is released into the 
circulation via leakage after detachment of the sealing zone (Canalis et al., 1989; 
Christenson, 1997). Though generally classified as a marker of bone resorption, 
TRAP is not bone specific and changes in serum concentration of TRAP also 
reflect the contribution of extraskeletal sources (Delmas etal., 1993; Pedrazzoni 
etal., 1995). Moreover, TRAP is unique among markers of bone resorption since 
the concentration in serum is thought to depend mainly on the number of 
osteoclasts, whereas the concentration of other markers depends on the 
degradation of bone collagen and reflects osteoclastic activity (Delmas, 1993; 
Pedrazzoni et al., 1995). For this reason and the fact that serum TRAP decreases 
only slightly and transiently during bone resorption, the serum concentration of 
TRAP is not frequently used as a marker of bone turnover.
2.4.2 4 Other markers of bone resorption
N-telopeptides are released into the circulation following type 1 collagen 
degradation by osteoclasts. The fragments readily pass through the kidney into 
the urine (Goulding & Lim, 1983; Need etal., 1991). N-telopeptides are regarded
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by some but not by others as specific for bone tissue breakdown because other 
collagen-derived tissues are not actively metabolised by osteoclasts (Need et al., 
1991). Measurement of urinary concentration of N telopeptide is used for 
monitoring bone resorption (Need etal., 1991; Ginty etal., 1998).
C-telopeptides fragments are also released into circulation as a result of 
the osteoclast mediated degradation of type 1 collagen during the bone 
resorption process (Need etal., 1991; Ginty etal., 1998). For the same reason as 
N-telopeptide, osteoclasts are not active in the degradation of other type 1 
collagen-containing tissues and C-telopeptide fragments are rarely used as 
resorption markers.
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2.5 Growth
2.5.1 Children
Boys are slightly taller than girls during childhood. An exception is in early 
puberty when girls are very slightly taller than boys, and this sex difference 
begins in late fetal life (Eveleth & Tanner, 1990; Paynter & Parkin, 1991). There 
is substantial evidence to suggest that body weight in childhood tracks into adult 
life with overweight children becoming overweight adults (Kelly et al., 1992; Zack 
etal., 1979; Rolland-Cachera etal., 1987; Mossberg, 1989; Must, 1992; Guo, 
1994). Differences in weight gain and height gain between the sexes vary 
between different ethnic groups and are partly influenced by socio-economic 
status (Post & Kemper, 1993). The pubertal growth spurt occurs earlier in girls 
than boys (Amador etal., 1992; Paynter & Parkin, 1991) but the sex difference in 
the onset of pubertal growth spurt varies between different ethnic groups, and in 
different environments. By the time they complete adolescence, the height 
differential between males and females becomes considerable (Eveleth & 
Tanner, 1990; Amador et al., 1996). The sex difference in longitudinal growth 
rate is due to the much longer growth spurt in boys compared with that in girls 
(Eveleth & Tanner, 1990; Paynter & Parkin, 1991). It is not known exactly what 
factors contribute to variation in growth but genetic factors, nutritional and socio­
economic status have all been implicated (Eveleth & Tanner, 1990; Paynter & 
Parkin, 1991).
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2.5.2 Adolescence
Growth
Adolescence refers to physical, psychological and behavioural changes 
occurring around the later stages of childhood. The onset of growth acceleration, 
the so-called “takeoff” varies significantly between individuals and is also sex- 
dependent. On average, age at takeoff is 2 years earlier in girls than boys 
(Abbassi, 1998). The growth spurt during adolescence which varies between 
sexes, contributes about 15% to adult height, 50% to adult weight, and 
approximately 40% to the total body bone mineral content (Abbassi, 1998). In 
boys, adolescent growth spurt is thought to account for a gain in height of 20 cm, 
with peak velocity of height averaging 10 cm per year (Tanner, 1973). The gain in 
weight is estimated around 20 kg (Tanner, 1973). In boys, the adolescent growth 
spurt is thought to account for 17% to 18% of the final adult height (Abbassi, 
1998). In girls, the growth spurt is somewhat smaller in magnitude and the peak 
height velocity averages about 8 cm per year (Tanner, 1973, Abbassi, 1998), and 
contributes to 17% of the final height (Abbassi, 1998). There is some indication 
that adult stature may be influenced by age at peak height velocity (PHV) and 
age at takeoff (Qin etal., 1996). Qin and associates found a negative correlation 
between adult height and age at peak height velocity, suggesting that the older 
the age at PHV, the lower the adult height (Qin et al., 1996). A similar association 
between age at takeoff and adult stature has been reported (Qin et al., 1996). 
This study suggests that children who spurted earlier had a longer duration of 
adolescence, and a larger stature increment during adolescence than those who 
reached the growth spurt later. The observations of Qin and coworkers were 
based on a Japanese population where average growth potential may be 
different from that of Africans and those in the West, and it is now known that in
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humans, physical growth changes over time are influenced both by genetic and 
environmental factors. Secondly, in contrast to the study of Qin et al, a recent 
review on the correlation between adult stature and age at peak height velocity 
found no significant association between adult stature and age at PHV (Bielicki & 
Hauspie, 1994). The physiological maturity in adolescence is best determined 
by radiological examination of the epiphyses, since the closure of the epiphyses 
is more rapid after the growth spurt (Paynter & Parkin, 1991). Racial differences 
in the rates of adolescent growth are highly plausible (Eveleth & Tanner, 1990, 
Paynter & Parkin, 1991).
There are some suggestions that a child’s growth velocity during 
adolescence is pre-determined by his/her growth patterns during early life 
(Abbâssi, 1998; Paynter & Parkin, 1991) but this is highly controversial 
(Satyanarayana etal., 1981; Hussain etal., 1985; Martorell etal., 1990; Amador 
et al., 1996). There are conflicting reports from studies examining the 
relationship between preschool height status to adolescent or adult height 
(Satyanarayana etal., 1981; Hussain etal., 1985; Martorell et al., 1990, Martorell 
e t a l ., 1992; Amador et al., 1996). A positive correlation between final height 
with height at age 5 years was found among Indian adolescents but the height 
increment from age 5 - 18 years was higher in those girls with a height-for-age 
less than -4 z-scores of the National Center for Health Statistics (NCHS) 
reference compared with those with a mean z-score of -2 (Satyanarayana et al., 
1981). This indicates that some degree of catch-up growth had occurred. In 
contrast, a cohort of Nigerian children who were followed from 5 years until 17 
years showed that the growth spurt of previously stunted girls was delayed by
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about 2 years compared with the less stunted (Hussain et a/., 1985). A similar 
observation was reported in Guatemalan children where length at three years of 
age was strongly correlated with height at 18 - 26 years (Martorell et al., 1990, 
Martorell e t a l 1992). In a more recent study in West Africa, girls who were 
stunted at preschool age showed some evidence of catch-up growth between the 
ages of 5 and 17 years (Simondon et al., 1998). From these studies, it seem 
clear that the impact of stunting at early age on the final height is only partly 
known and this is an area that merits further study.
A strong association between skeletal maturation, height, and weight has 
been found in some (Amador et al., 1996; Amador et al., 1992) but not by others 
(Johnston & Mack, 1980). Johnston & Mack reported an association between 
weight and height that was independent of the rate of skeletal maturation 
(Johnston & Mack, 1980).
Puberty is the time of the greatest sex differentiation after the early 
intrauterine months. The event is marked by increases in both total fat mass and 
lean body mass (Goulding et al., 1996). Reproductive maturity is demonstrated 
by the appearance of secondary sex characteristics: breast development and 
onset of menstruation in girls; penis and testis development in boys, pubic and 
axial hair growth and voice change in both sexes (Tanner, 1973). There are 
changes in the reproductive organs, in body size and shape, in the relative 
proportions of muscle, fat and bone, and in a variety of physiological functions 
(Paynter & Parkin, 1991). It refers to the period at which the testes, prostate 
gland and seminal vesicles, or the uterus and vagina enlarge (Paynter & Parkin, 
1991).
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Testicular enlargement is usually the first sign of puberty in boys, 
accompanied by changes in the texture and colour of the skin of the scrotum. A 
little later the penis starts to enlarge and pubic hair appears (Paynter & Parkin,
1991). The first pubertal event for girls is generally the appearance of breast- 
stage 2, often called breast bud (Paynter & Parkin, 1991). This consists of an 
elevation of breast and papilla as a small mound, with slight enlargement of the 
areolar area. Girls who have seen their first period early had a greater growth 
velocity with a shorter growth period during adolescence (Paynter & Parkin, 
1991; Dhuper etal., 1990; Ito et al., 1995). The pubertal growth spurt lasts 
approximately two years after menarche in American girls, with a maximum 
velocity at 12.5 years, and for about two years in American boys, with a peak 
velocity at almost 14 years (Underwood, 1991; Abbassi, 1998). During this two 
year-growth spurt, calcium accumulates in the skeleton of girls at a rate of 
approximately 200 mg/day, and in boys at a rates of roughly 400 mg/day 
(Abbassi, 1998; Underwood, 1991; Matkovic & llich, 1993). In the last thirty 
years, the mean age of menarche is one year earlier in Western Countries 
compared with the turn of the century (Underwood, 1991; Abbassi, 1998). The 
start and duration of pubertal growth differs between children in affluent societies 
and those in developing countries (Underwood, 1991, Lo et al., 1990).
Evidence from epidemiological studies suggests that the timing of the 
onset of puberty can be influenced by the level of nutrient intake (Cameron, 
1996), with well-nourished children progressing through puberty earlier than 
undernourished children (Frisch, 1972; Bhalla & Shrivastava, 1976; Cameron, 
1996).
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Positive correlations between a number of indices of body growth, such as 
weight, percent body fat and metabolic rate, and the timing of the onset of puberty 
have been reported in a number of studies (Frisch, 1972; Tanner, 1968; 
Chowdhury et al., 1977; Frisch & McArthur, 1974; Zacharias et al., 1976). In 
Western Countries, where reliable written records are available, there is 
evidence to suggest that the decrease in the age of the onset of puberty over the 
last 200 years may be related to improvements in socio-economic conditions and 
nutrition (Roche et al., 1995; Freeman et al., 1995; Rona & Chinn, 1995). The 
reported negative correlation between socio-economic status and the age of 
menarche tends to suggest that puberty occurs earlier in better-nourished 
individuals (Burrell et al., 1961; Laska-Mierzejewska, 1970; Madhavan, 1965; 
Gopalan et al., 1973). However, it is likely that poor health status and 
psychological stress, in addition to poor nutrition, contribute to a later onset of 
puberty in individuals of low socio-economic status. Severe undernutrition has 
been shown to retard the development of sexual organs and to delay the onset of 
sexual activity (Biederman eta!., 1986).
2.5.3 Difference between boys and girls
There is considerable individual variation in the time of onset and rate of 
adolescent changes in both boys and girls. On average, boys are of similar 
weight and height as girls at birth, but boys becomes significantly larger than girls 
at puberty (Kelly etal., 1992; Paynter & Parkin, 1991). Once longitudinal growth 
is completed towards the end of adolescent years, men are significantly taller 
and heavier than women (Hamill efal, 1979; Roche & Himes, 1980). There are 
gender differences in body fat content and these differences begins in
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adolescence. Average heights and weight of boys and girls are similar shortly 
before puberty (Kelly etal., 1992). The sex differences in body composition and 
the distribution of body fat are less evident in early childhood (Ley et al., 1992) 
but occur around puberty (Rico etal., 1993; Ogle et al., 1995). Measurements of 
total body fat, lean and bone mineral content using dual energy x-ray 
absorptiometry have indicated differences between boys and girls (Ogle et al., 
1995; Lazarus et al., 1996; Taylor et al., 1996; Traver et al., 1995). Boys have 
been shown to have lower body fat than girls of similar age, weight and height 
(Faulkner et al., 1993; Nelson etal., 1997; Taylor etal., 1997a). Lean tissue 
mass has also been shown to be higher in girls than boys (Taylor etal., 1997a).
The sex differences in lean and fat mass are largely attributed to 
differences in sex steroids and the hormonal factors including oestrogen, 
androgens, cortisol, growth hormone and insulin-like growth factor - 1 (IGF-1). 
Testosterone concentrations has been shown to correlates with body fat mass in 
girls during early puberty (de Bidder et al., 1990). Androgen concentration also 
increases in girls during puberty and this may be responsible for fat distribution 
(Mueller, 1982; Ogle etal., 1995).
2.5.4 Ethnic differences
Variation in growth performance, body size and composition between
different ethnic groups has been recognised for many years (Ulijaszek, 1994).
The mean height for 7 year-old boys of 28 European and European-origin
populations ranged from 119.1 to 126.5 cm (Ulijaszek, 1994). This is similar to
those for African and African descendant populations (119.6 to 126.0 cm) and
Indo-Mediterranean populations, but higher than that for Asiatic populations
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(118.1 to 122.6 cm) (Ulijaszek, 1994). While in African children, weight-for- 
height differences reflect to a greater extent environmental influences, the size 
differences amongst European populations are thought to be predominantly 
genetically rather than environmentally controlled (Eveleth & Tanner, 1990). 
American blacks have been shown to have greater muscle mass than age- 
matched American whites (Cohn etal., 1977).
Ethnic variations in bone mineral mass and hip axis length have been 
reported by a number of studies (Cohn etal., 1977; Harris etal., 1995; Ortiz et al„ 
1992; Cummings etal., 1994; Mikhail etal., 1996). Total body bone mineral 
mass of African-Americans is known to be greater than Caucasians (Cohn et al., 
1977; Ortiz et al, 1992). Black women have shorter hip axis length than their 
white counterparts (Cummings ef al., 1994; Mikhail etal., 1996).
2.5.5 Factors influencing growth
2.5.5.1 Environmental factors
A child’s growth pattern reflects his state of health and nutrition. There are 
large differences between populations, in height and weight and the age of 
puberty (Eveleth & Tanner, 1990). Considerable world-wide variation in human 
growth exists, and within a country, marked differences exist between the well-off 
and the poor, with the rich growing better than the poor (Eveleth & Tanner, 1990)
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2.5.5 2 Genetic factors
The pattern of human growth reflects both environmental and genetic 
components and it is not always easy to separate genetic from environmental 
influences (Post & Kemper, 1993; Paynter & Parkin, 1991; Amador etal., 1996). 
Within a population, there is a wide range of normal growth which is influenced 
partly by genetic factors (Paynter & Parkin, 1991, Amador et a/., 1996). A wide 
variation in adult height exists between different people and this has been 
assumed to result from genetic differences. For example, New Guinea 
Highlander, Japanese, South Indians and the Pygmies of Central Africa are 
small (Paynter Parkin, 1991). In contrast, American Indians and Polynesians are 
tall and big (Paynter & parkin, 1991).
2.5 5.3 Diet and poor growth
Growth is at its greatest rate in early infancy and adolescence, and 
therefore, children need to consume more nutrients at these periods. One 
obvious reason for poor growth and stunting in poorer countries is the restriction 
of food. Approximately two-thirds of the population in developing countries do 
not meet their nutritional needs (Benefice & Malina, 1996). In addition, 
consumption of animal products is very low in most developing countries 
(Prentice etal., 1993). Low consumption of calories and animal protein could 
result in poor growth and delay in puberty (Prentice et al., 1990, Lo et al., 1990). 
Malnutrition, high morbidity, gastrointestinal dysfunction, poverty and other 
related environmental factors are known causes of poor growth and delayed 
maturation of children in developing countries and contribute to the prevention of
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complete catch-up growth once malnutrition has occurred (Keller, 1988; Prentice 
et al., 1990). Inadequate intake and poor bioavailability of the major bone 
forming minerals, such as calcium, phosphorus, magnesium and zinc could also 
contribute to the growth retardation of children in developing countries (Bates et 
al., 1993; Prentice etal., 1990; Burr & Sweetnam, 1980; Elo & Preston, 1992).
Protein energy malnutrition (PEM) which ranges from marasmus to 
kwashiorkor is common among children of Third World rural communities. 
Although commonly seen in children aged under three years, PEM predisposes 
African children to poor growth and is thought to be responsible for delayed 
maturation of these children (Burr & Sweetnam, 1980; Lo et al., 1990; Elo & 
Preston, 1992). Protein intake has been positively associated with bone mineral 
density in children (Chan etal., 1987). Similarly, protein deprivation has also 
been reported to have an adverse effect on bone (Orwoll et al., 1992). Protein- 
energy malnutrition in children leads to stunting and has been shown to reduce 
bone mineral content (Adams & Berridge, 1969; Prentice & Bates, 1993) and 
delayed skeletal maturation (Adams & Berridge, 1969).
2.5.5 4 Exercise
The underlying mechanism by which exercise enhances linear growth is 
not clear, but is thought to be mediated by hormonal factors such as growth 
hormone and somatomedins, that promote growth of long bones. Torun and 
Viteri (1994) compared 2 - 4 year old Panamanian children recovering from 
protein-energy malnutrition in a rehabilitation centre, who participated in exercise 
such as walking on a slope, running, tumbling and climbing stairs, with controls
37
Chapter 2 Growth
and found that the active group had a greater linear growth (active, 22± 8 mm, 
inactive 14± 6 mm, p<0.0001). Creatinine-height index was also higher in the 
exercise group than the control (0.97 ±0.12, vs 0.89 ± 0.09, P < 0.05), suggesting
a greater muscle mass and protein repletion. Dietary intake did not differ 
between groups, thus further supporting the evidence that the difference in height 
gain between the exercise and control groups could be attributed to physical 
activity. Bone mass during adolescence and early adulthood is greatly 
influenced by environmental factors, such as dietary calcium intake and physical 
activity (Charles et al., 1991; Matkovic, 1996). Physical activity is thought to act 
as a stimulus for bone growth through the pull of muscle on the ends of the long 
bones (Goulding, 1994, Rizzoli etal., 1998). Bone turnover and weight gain 
have been shown to relate to muscle mass even in malnourished children 
(Goulding, 1994). The strong relationship between growth and muscle mass in 
children could partly be explained by physical activity. The hypothesis is, as 
children gain weight and put on muscle, they become more active. The 
mechanism is thought to stress the bone and stimulate linear growth (Goulding,
1994).
There is evidence to suggest that exercise training can delay the onset of 
puberty and suppress adult reproductive function (Malina et al., 1978; Warren, 
1980; Frisch, 1980; Loucks etal., 1992).
2.5.5 5 Hormones
There is a wide variation in growth and sexual maturation between 
individuals of the same age (Marshall & Tanner, 1970; Eveleth & Tanner, 1990;
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Krabbe et al., 1979). This suggests that the use of chronological age as an 
indicator of physical development may be inappropriate in puberty. Serum levels 
of testosterone appear to correlate well with pubertal stage in males (Knorr et al., 
1974) and this is thought to be a better measure of physical development than 
chronological age during adolescence (Krabbe etal., 1979). Although the level 
of serum testosterone has been used as an indicator of physical development in 
boys, there have been limited studies on the influence of serum testosterone on 
bone mineral content (Tanner & O'keefe, 1970; Krabbe et al., 1979). A positive 
association between growth velocity and a number of hormones have been 
reported (Lanes etal., 1995; Ross etal., 1986; Kollman etal., 1991; Dhuper etal., 
1990). Oestrogens, anabolic steroids and, more recently, growth hormone have 
been shown to promote bone mineralisation in humans (Krabbe et al., 1979; 
Riggs & Melton, 1988; Dhuper etal., 1990).
Oestrogen and growth hormone are known to play an important role in 
bone metabolism and mineralisation (Riggs & Melton, 1988). An association 
between early menarche and high bone mineral density have been reported by a 
number of studies and is thought to relate to oestrogen exposure (Fox et al., 
1993, Dhuper eta l., 1990; Ito et al., 1995). Early exposure to oestrogen has 
resulted in a high bone mineral density at the spine in adolescent girls (Dhuper 
et al., 1990). Similarly, low spinal bone mineral density has been linked with a 
low oestrogen exposure in the same study (Dhuper et al., 1990). Girls in whom 
menarche had occurred at age 12 years have been shown to have 6% higher 
bone mineral density than those in whom it occurred at age 16 years (Fox et al., 
1993). Age at menarche is thought to be related to the peak bone mass perhaps
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because of the positive correlation of early menarche with high bone mineral 
density (Ito et al., 1995). Oestrogen, anabolic steroids and, more recently, 
growth hormone have been shown to improve growth velocity of patients with 
Turner’s syndrome (Joss, 1988; Ross etal., 1986; Sadeghi-Nejad etal., 1985, 
Lanes etal., 1995).
2.5.5 6 Other factors
Large family size has also been associated with poor growth, since 
malnutrition and infection are common because less food is available to nourish 
the child (Kuh & Smith, 1993; Billewicz & McGregor, 1981). Short birth intervals 
mean children receive inadequate child-care and increased exposure to 
infection. All these are factors that have been implicated with poor growth (Burr & 
Sweetnam, 1980; Elo & Preston, 1992).
2.6. Calcium in the body
Calcium is a major component of mineralised tissues. There is about 
32,500 mmol (1,300,000 mg) of calcium in the body of average healthy adult, of 
which 99% is within the skeleton and teeth (British Nutrition Foundation, 1989; 
Willatts, 1987, Hughes et al., 1994). The remainder is present in muscle and 
throughout the extracellular fluid, where the concentration of ionised calcium is 
maintained within very narrow limits. Maintenance of ionised calcium is critically 
important for endocrine and nervous function and muscle activity (British Nutrition 
Foundation, 1989; Willatts, 1987; Zilva etal., 1991; Charles et al., 1991; Matkovic 
etal., 1995; Hughes etal., 1994; Ritchie etal., 1998).
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2.6.1 Function
Calcium is required for normal growth and development of the skeleton 
and teeth. Other functions of calcium include control of excitability, release of 
neurotransmitters, initiation of muscle contractions and as a coenzyme for 
coagulation factors. Calcium is also an intracellular second messenger (Willatts, 
1987, Marshall, 1988, Hughes etal., 1994; Ritchie etal., 1998).
2.7. Calcium homeostasis
Regulation of calcium metabolism is extremely complex and aimed at 
maintaining plasma calcium at a concentration of about 2.2 - 2.6 mmol/l (88 - 104 
mg/l) (Willatts, 1987; Brune & Ullrich, 1992; Cross et al., 1995b; Ritchie et al.,
1998). It is this concentration which is critically important for muscle activity, 
endocrine secretion and nervous system function and in the long term depends 
on maintenance of extracellular fluid (ECF) calcium by hormonal activity (Cross 
etal., 1995b).
Bone is metabolically active, and some of its calcium is rapidly 
exchangeable with the extracellular fluid. The turnover between bone and 
extracellular fluid is approximately 12.5 mmol/day (500 mg/d). In the kidney, up 
to 240 mmol/d (9,600 mg/d) of ionised calcium is filtered by the glomeruli. Most 
of the filtered calcium is reabsorbed in the tubules and normal renal calcium 
excretion is 2.5 - 7.5 mmol/d (100 - 300 mg/d) (Schaafsma, 1988; Marshall, 1988; 
Hughes etal., 1994; Cross etal., 1995b; Ritchie etal., 1998). Dietary calcium is 
ingested into the body, and absorbed, depending on absorbability, from digested 
food in the intestine.
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Plasma calcium is maintained at a constant concentration by a complex 
homeostatic mechanism that is poorly understood and is closely linked to bone 
metabolism (Schaafsma, 1988; Cross etal., 1995b). The postulated mechanism 
for the regulation of plasma calcium is that hypocalcaemia stimulates parathyroid 
hormone (PTH) production which in turn increases production of 1, 25 dihydroxy 
vitamin D. 1,25-dihydroxy vitamin D stimulates the absorption of calcium and 
phosphorus in the intestine and mobilisation from bone (Schaafsma, 1988; 
Polley et al., 1987; Marshall, 1988; Hughes et al., 1994; Cross et al., 1995b; 
Ritchie etal., 1998, Peacock, 1998). As the plasma ionised calcium is restored, 
the concentration of 1,25-dihydroxy vitamin D returns to normal. Raised ionised 
calcium has the opposite effect, PTH and 1,25-dihydroxy vitamin D production 
are inhibited, and calcitonin is secreted from the thyroid gland. The main function 
of calcitonin is inhibition of bone resorption and promotion of calcium and 
phosphate excretion by the kidney, thus returning extracellular ionised calcium to 
its normal level (Cross etal., 1995b; Peacock, 1998).
Vitamin D is synthesised primarily in the skin by the action of sunlight 
(ultraviolet) on the provitamin (Cross etal., 1995b, Hughes et al., 1994; Peacock,
1998). Vitamin D can also be obtained from the diet. There are two forms of 
vitamin D, cholecalciferol (D3) is made in the skin by the action of ultraviolet light 
and is present in animal products, and ergocalciferol (D2) derived from a 
provitamin is found in some plants and fungi. Vitamin D itself however, is almost 
inactive. Both cholecalciferol and ergocalciferol are hydroxylated in the liver and 
perhaps other organs to produce 25-hydroxy vitamin D, and have similar activity 
(Willatts, 1987; Cross etal., 1995b). 25-hydroxy vitamin D, however, is still
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relatively inactive although it is the major circulating form of the vitamin (Hughes 
et al., 1994; Cross et al., 1995b; Peacock, 1998). It is transported on a specific 
globulin binding protein to the kidney, where further hydroxylation occurs to 
produce several metabolites, the most important of which is 1,25-dihydroxy 
vitamin D ( Cross etal., 1995b; Cross etal., 1995a).
1,25-dihydroxy vitamin D stimulates the absorption of calcium and 
phosphate from the gut, resorption of calcium and phosphate from bone and of 
calcium and phosphate from renal tubules. The healing action of vitamin D in 
rickets seems to be due to its action in raising plasma calcium and phosphate 
levels (Sower etal., 1990; Hughes etal., 1994; Cross etal., 1995b; Ritchie et al., 
1998, Peacock, 1998). 1,25-dihydroxy vitamin D levels are high in conditions of 
increased demand such as rapid growth (Sower etal., 1990, Cross et al., 1995b; 
Schaafsma, 1988). The precise action of 1,25-dihydroxy vitamin D in the 
intestine is not known but it is thought to involve increased production of a 
calcium binding protein which is raised during periods of active growth and in 
conditions of low calcium intake (Willatts, 1987; Hughes etal., 1994; Ritchie etal., 
1998).
The vitamin D metabolite commonly measured in blood is the 25-hydroxy 
vitamin D and is regarded as a good marker of vitamin D status (Krall et al., 1989; 
McKenna, 1992; Dawson-Hughes, 1998). However, its concentration in blood 
must be interpreted in the light of the marked seasonal variation in circulating 
levels of this metabolite which may result in several fold differences between 
winter and summer (Krall et al., 1989; McKenna, 1992; Byrne et al., 1995; 
Dawson-Hughes, 1998). The concentration of 1,25-dihydroxy vitamin D is
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largely independent of the amount of the circulating level of 25-hydroxy vitamin D 
and is dependent on the plasma calcium concentration (Byrne et a i, 1995).
2.7.1 Parathyroid hormone
PTH is secreted by the parathyroid glands and secretion is controlled by
two intracellular messengers, calcium and cyclic-AMP (Byrne et ai, 1995). PTH 
increases plasma calcium concentration by activating mechanisms that transfer 
calcium from bone, glomerular filtrate and the gut to the extracellular fluid. The 
concentration of ionised calcium in serum is tightly regulated through negative 
feed back of calcium on the secretion of PTH from the parathyroid glands (Byrne 
et ai, 1995; Peacock, 1998). The reduction of PTH secretion in response to a 
rise in serum calcium is dependent on the network of a calcium-sensing receptor 
(Peacock, 1998). Renal regulation of 1,25-dihydroxyvitamin D is partly 
dependent on PTH secretion (Byrne et ai, 1995; Peacock, 1998). PTH acts 
primarily at kidney by enhancing the tubular reabsorption of calcium and 
stimulating the formation of calcitriol, but also at the skeletal level by storing 
calcium (Peacock, 1998; Fassler & Bonjour, 1995). The 1,25-dihydroxyvitamin D 
produced stimulates intestinal calcium absorption, and down-regulates the 
synthesis of PTH (Peacock, 1998; Fassler & Bonjour, 1995). Measurement of 
the blood level of parathyroid hormone which rises in response to low calcium 
intake is a marker of calcium nutritional status (Fassler & Bonjour, 1995; Prince, 
1997). Equally, high calcium consumption leads to decrease secretion of PTH 
(Fassler & Bonjour, 1995; Prince, 1997).
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2.7.2 Calcitonin
The secretion of calcitonin, mostly from the thyroid, is also controlled by 
intracellular calcium and cyclic AMP. Calcitonin decreases the circulating level 
of calcium phosphate by direct action on the osteoclasts to inhibit collagen 
breakdown and to promote phosphate uptake into bone (Aurbach, 1988, Cross et 
a/., 1995b). Calcitonin secretion in young adults is increased by oestrogen and 
recent studies of the effects of oestrogen in post-menopausal women showed 
sharp increases in plasma calcitonin (Stevenson etal., 1984; Aurbach, 1988; 
Cross et ai, 1995b). Oestrogen has been shown to prevent menopausal bone 
loss and this effect could be mediated at least in part by control of calcitonin 
secretion (Stevenson et ai, 1984; Aurbach, 1988). There appears to be a strong 
association between low circulating level of calcitonin and osteoporosis 
(Aurbach, 1988, Cross et a i, 1995b). Circulating calcitonin levels are lowest in 
the white women compared to age-matched black women (Stevenson et ai, 
1984; Hughes et ai, 1994; Ritchie et a i, 1998). The incidence of fragility 
fractures due to osteoporosis are lower in Blacks than White Caucasians 
(Adebajo et ai, 1991; Solomon, 1979; Prentice et ai, 1991). Low circulating 
calcitonin concentration has been associated with loss of bone (Hughes et ai, 
1994; Ritchie et a/., 1998) and so this may partly account for the low incidence of 
osteoporosis in blacks compared with Caucasians.
2.8. Calcium requirement for bone growth
During skeletal growth there is a positive input of calcium into the skeleton. 
This means that dietary intake of calcium must be sufficient to balance obligatory 
calcium loss and the amount of calcium needed for positive skeletal calcium
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balance. In early infancy calcium accretion into bone is estimated to be around 
130 - 155 mg/d (3.25 - 3.88 mml/d) (Fomon, 1974; Krebs & Hambidge, 1986). 
Calcium accretion rates drop rapidly in the first three years of life to reach a nadir 
of between 7 0 - 100 mg/d (Pettifor, 1991; Kanis, 1994). Values rise thereafter to 
peak during the adolescent growth spurt with estimates ranging between 200 
and 400 mg/d depending on sex. Boys peak later than girls and have higher 
peak values (Garn etal., 1972; Prentice & Bates, 1993). The average daily 
accumulation of calcium for ages 10 to 20 years is 180 to 210 mg in boys and 90 
to 110 mg in girls (Committee on Nutrition, 1978).
Calcium needs vary with the stage of skeletal development (Matkovic et 
al., 1990). The calcium requirements during periods of skeletal modelling and 
consolidation are high (Nordin etal., 1987; Nordin & Marshall, 1988; Heaney & 
Recker, 1982; Matkovic, 1991).
Table 2.1 Estimated calcium accretion rates (mg/day) for boys and girlst
Age (years) 2 4 6 8 10 12 14 16 18 20
Boys (mg/d) 89 70 70 105 125 173 269 394 166 60
Girls (mg/d) 93 71 83 105 147 217 330 240 101 40
f Accretion rates as calculated by Leitch & Aitken, (1959). Source: Pettifor, 1991
Conversion factor mg/d to mmol/d Calcium, + 40
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In addition to requirements for growth, part of the calcium consumed is 
excreted in urine, sweat, faeces, skin and hair. Consequently, growing 
individuals must be in sufficient positive calcium balance to increase skeletal 
mass (Kanis, 1994; Charles etal., 1991; Matkovic etal., 1995). Although data on 
mineral losses in children are scarce, there is evidence that mineral losses are 
greatly reduced in people accustomed to a very low intake (Widdowson & 
Dickerson, 1964; Begum & Pereira, 1969, Taylor et al., 1991). It has been 
argued that assignment of reference values for calcium losses in children is 
inappropriate, since there appear to be no obligatory calcium losses for children 
(Department of Health COMA, 1992). However, this hypothesis has been 
challenged by recent balance studies which reported an obligatory calcium 
losses in urine, faeces, and sweat for children (Charles et al., 1991; Matkovic et 
al., 1995).
Calcium balance in the skeleton varies throughout life (Charles et al., 
1991). After cessation of rapid growth, bone mineral accretion, the so called 
skeletal consolidation is thought to continue through late adolescence (Charles 
etal., 1991; Matkovic etal., 1995).
2.9. Calcium requirements
Calcium needs are greater during adolescence ( 9 - 1 7  years) than in 
either childhood or young adulthood when comparing the maximal calcium 
retention in the body. This is due to the high velocity of growth during puberty as 
well as skeletal consolidation towards end of adolescence. All these together 
exert a major influence on calcium requirements during adolescence. Since up 
to sixty percent of the weight of mature bone is mineral (Boskey, 1988), mainly in
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the form of calcium phosphate, and because bone mineralisation is achieved 
after the laying down of bone matrix, an important requirement for healthy bone 
development both during childhood and adolescence is a continuous supply of 
calcium and phosphate at a level required by the changing needs of growth. 
Thus calcium requirements during adolescence need to be considered in light of 
the following features of growth: the intensity and the extent of the pubertal 
growth spurt, sexual differences in the timing of peak growth (boys develop later), 
and individual variations in the timing of the pubertal growth spurt (Avioli, 1988). 
It is likely that all these aspects of growth have a profound effect on calcium and 
bone metabolism.
The issue of dietary calcium requirements remains unresolved and the 
question of whether people are eating a diet that is adequate in calcium has 
been an ongoing debate for over half a century. As early as the beginning of the 
century, Lusk reported that calcium deficiency was common (Lusk, 1917). 
However, despite the great attention calcium has received little progress has 
been made in resolving calcium requirements for bone health. This is reflected 
in the wide differences in recommendations for calcium from various 
communities of the world which range from 400 - 1500 mg/day (10 - 37.5 mmo/d) 
for adults (Department of Health, Committee on Medical Aspects of Food Policy 
and Nutrition (COMA), 1992; National Academy of Sciences, 1989).
Similar differences are seen in the recommendations for children and 
adolescents. The World Health Organization (WHO) and the Committee on 
Medical Aspects of Food Policy and Nutrition (COMA) recommends a daily intake 
of 700 mg/day and 1000 mg/day respectively for 8 - 10 year olds (FAO and WHO, 
1962; Committee on Medical Aspects of Food Policy (COMA), 1992). The World
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Health Organization also recommends intakes of 600 - 700 mg/day for 11 - 15 
year-old adolescents and 500 - 600 mg/day for those 16 - 19 years old (WHO,
1991). National Research Council recommends 1200 mg/day for these age 
groups (National Academy of Sciences, 1989) but more recently set Al (adequate 
intake) of 1,300 mg/day for 9 - 18 year old (National Academy of Sciences, 
1997). In a recent review by the Committee on Medical Aspects of Food and 
Nutrition Policy Subgroup on Bone Health, it was felt that there is insufficient 
evidence to relate the current UK Reference Nutrient Intake (UKRNI) to bone 
health, in terms of measures of bone mineral content, bone mineral density, 
fracture, and biochemical markers and therefore, the factorial method was 
retained. It was therefore concluded that the available data were insufficient to 
warrant revising the current Dietary Reference Value for calcium for children and 
adolescents and other age groups.
Table 2.2 Recommendations for calcium intakef
Sex
Calcium (mg/dy 
8 - 1 0  years 11-15  years 16 -19  years
WHO (WHO, 1962; 1980, 1991) M + F 700 600 - 700 500-600
USA, PDA (National Academy Science, 1989) M + F 1200 1200 1000-1300
USA, Al (National Academy Science, 1997) M + F 1300 1300 1300
NIH (National Institute of Health, 1994) M + F 800-1200 1200-1500 1200-1500
UK, RNI (Department of Health, 1992, 
Bone Health Report, 1998) M 550 1000 1000
F 550 800 800
f Figures are for both males and females. Conversion factor from mg/d to mmol/d: calcium + 40
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Judging by these differences, it is certain that the amount of dietary 
calcium needed to sustain growth, as well as to provide maintenance, requires 
much more study, particularly with respect to different populations.
The fact that all these recommendations for calcium intake are based on 
different criteria further complicates the issue of dietary calcium requirements. 
For example, the UK Reference Nutrient Intake (RNI) for adolescents is based on 
a mean retention of 250 mg (6.3 mmol)/d for girls and 300 mg (7.5 mmol)d for 
boys, and a net absorption of 40 per cent (Department of Health, 1992). In 
contrast, National Institute of Health Consensus Statements optimal calcium 
requirements are figures adopted by a panel of experts and not based on any 
real experimental data (National Institutes of Health, 1994). The Adequate Intake 
(Al) recently, set by the US Food and Nutrition Board is based on the amount of 
calcium required to support maximal calcium retention (National Academy of 
Sciences., 1997). Al is intended to replace the more conventional 
Recommended Dietary Allowance (RDA) which was based on a calcium intake 
sufficient to minimise the risk of developing a condition or sign that is associated 
with calcium deficiency (National Academy Science, 1989).
There are some suggestions that up to twice the WHO recommendation is 
necessary to maintain the skeletal balance for calcium in young healthy 
populations (Nordin & Heaney, 1990). However, many researchers have argued 
that more than half of the world’s population are accustomed to low dietary 
calcium intake (< 500 mg/day) and that at present there is little evidence that
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such countries are disadvantaged with respect to osteoporosis (Kanis & 
Passmore, 1989). In early studies from India, children consuming a relatively low 
calcium intake ( ~ 300 mg/d ) were still able to maintain a sufficiently positive 
calcium balance to assure skeletal development (Begum & Pereira, 1969; 
Aykroyd & Krishnan, 1938; Aykroyd & Krishnan, 1939).
It is plausible that populations exposed to more sunlight and with better 
vitamin D status, like most Africans, may maintain calcium balance more readily 
on low calcium intake. Therefore, it has been argued by some that current 
recommendations should be specific to the individual populations and not to be 
regarded as universal as the FAO/WHO report suggested (WHO, 1991).
There is some evidence however that the dietary calcium intake of a large 
proportion of the World’s children may be insufficient to support optimal linear 
growth and maximal bone mineralisation (Miller etal., 1988; Lee etal., 1994).
2.9.1 Calcium intakes in different populations
Dietary calcium intakes vary considerably between countries. Much of 
between country variation in calcium intake can be ascribed to differences in milk 
consumption. Currently, Finland has the highest mean daily calcium intake in the 
world at 1300 mg/d (32.5 mmol/d) with approximately ninety percent of the intake 
from milk and dairy products (Nordin & Marshall, 1988; Nordin 1997). In Britain, 
the current national average intake of calcium is estimated around 820 mg/day 
(20.5 mmol/day) and the major dietary sources of calcium are milk and milk 
products (approx 56%; Department of Health, Committee on Medical Aspects of 
Food Policy (COMA), Report of the Subgroup on Bone Health, 1998). This is
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much lower than the percentage of milk and dairy products in Finland because 
an extra 14 percent of calcium intake in Britain comes from bread due to 
fortification of white flour with calcium, In the United States, the current mean 
calcium intake of the population is calculated around 970 mg/d (24.3 mmol/d) 
(Nordin & Marshall, 1988; Park et al., 1997), fifty-two-percent of which comes 
from milk and milk products. In countries where milk consumption is low, such as 
in China and The Gambia, the calcium intake of the population is extremely low 
compared with British and America, and averages 300 - 500 mg/d (7.5 - 12.5 
mmol/day) (Prentice etal., 1993; Lee etal., 1994).
2.10. Peak Bone Mass (PBM)
Maximising peak bone mass has been associated with reduced incidence 
of osteoporosis (Cummings etal., 1993; Eisman etal., 1993). The low fracture 
incidence of osteoporosis in African - American blacks has partly been ascribed 
to a higher peak bone mass (Cohn et al., 1977; Ortiz et al., 1992; Harris et al.,
1995).
2.10.1 Genetic factors influencing bone mass
Genetic factors are estimated to contribute around 80% of the total 
variance in bone density (Kelly & Eisman, 1993; Eisman, 1995; Peacock, 1995, 
Rizzoli et al., 1998). However, the relative importance of genetic and 
environmental factors in determining the variability in bone density is not fully 
understood. Both genetic and environmental factors influence the amount of 
peak bone mass attained in early adulthood (Kelly & Eisman, 1993). Physical
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fitness, muscle mass and bone mineral density are thought to have genetic 
determinants (Lortie etal., 1982; Bouchard etal, 1986).
Allelic variants have recently been isolated in a number of candidate 
genes that may be associated with bone health, such as the vitamin D-receptor 
(VDR) gene, parathyroid-hormone-receptor gene, collagen genes, oestrogen- 
receptor gene, interleukin-6 gene and apolipoprotein E (ApoE) gene (Sainz et 
al., 1997, Rizzoli et al., 1998). At present it is not clear to what extent 
polymorphism in any of these genes influences bone mineral status, bone 
turnover, or fracture risk (Eisman, 1995; Peacock, 1995). In adolescents, alleles 
of vitamin D-receptor gene have been shown to be a good predictor of femoral 
and vertebral bone density in some studies (Sainz et al., 1997) but not others 
(Peacock, 1995). In the Sainz study, girls with the aa and bb genotypes as 
indicated by the Apal and Bsml endonucleases had 2 to 3 percent higher femoral 
bone density and 8 to 10 percent more vertebral bone density than girls with the 
AA and BB genotypes. The variation in bone density between the variants in the 
Sainz study could not be accounted for by differences in bone size or in 
biochemical indices.
Studies of the relationship of vitamin D-receptor alleles and bone density 
are far from conclusive. Of the 50 or more studies reported to date only half 
found a significant association between vitamin D-receptor genotypes and bone 
density and others found no association (Eisman, 1995; Peacock, 1995). There 
is some evidence to suggest that nutrient-gene interactions may influence the 
importance of nutrition to bone health (Ferrari et al., 1995). For example the 
effect of calcium supplements on lumbar spine bone mineral mass and
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analogues of vitamin D in older people differs according to VDR genotype 
(Ferrari etal, 1995; Matsuyama et al., 1995) and the transport of vitamin K by 
lipoproteins is thought to be affected by ApoE genotype (Saupe etal., 1993).
2.10.2 Calcium intake and peak bone mass
Increasing evidence suggests that adequate calcium intake during growth 
is needed to optimise peak bone mass and reduce risk of fractures later in life 
(Sandler et al., 1985; Halioua & Anderson, 1989; Matkovic, 1996; Kelly et al., 
1994; Theintz et al., 1992; Anderson & Rondano, 1996; Valimaki et al., 1994). 
Low calcium intake could lead to reduced calcium accretion into bone and this 
may have a negative impact on skeletal development and ultimately on peak 
bone mass (Theintz etal., 1992, Anderson & Rondano, 1996; Adami etal., 1994).
2.10.3 Calcium intake, physical activity and peak bone mass
Physical activity in childhood is perceived to be important in maximising 
peak bone mass (McCloskey et al., 1990; Slemenda et al., 1991; Metz et al., 
1993; Ulrich etal., 1996) and is important in the maintenance of bone mass later 
in life (Halioua & Anderson, 1989; Kriska et al., 1989; Snow-Harter & Marcus, 
1991, Ulrich et al., 1996). The association between usual calcium intake and 
bone mass is thought to be influenced by the level of physical activity (Kanders et 
al., 1988; Halioua & Anderson, 1989). Both physical activity and adequate 
calcium intake have been shown to have some effect on the accumulation of 
radial peak bone mass (Kanders et al., 1988; Halioua & Anderson, 1989). 
However, the influence of activity on bone mass is a controversial issue. Some 
studies have indicated that the influence of exercise on bone mass depends not
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only on the type and intensity of exercise, but also on the duration of the exercise 
and the age at which it is practised (Steinberg & Trueta 1981). In addition, some 
studies have shown that exercise affects both trabecular and cortical bone 
(Pocock et al, 1986), only trabecular bone (Colleti et al., 1989; Krolner et al., 
1982), or neither component (Frisancho etal., 1970; Puustjarvi etal., 1991).
Low calcium intake and being inactive during early adolescence are 
thought to be detrimental to optimising peak bone mass (Tylavsky et al., 1992; 
Anderson, 1996a). However, the effect of regular physical activity and adequate 
calcium intake during early life on bone mass in later life is uncertain (Vuori, 
1996; Theintz etal., 1992). There are some indications that the effect of physical 
activity and high calcium intake is not confined to radial bone mass alone, but 
would be found at other sites in the skeleton (Gleeson et al., 1990; Rockwell et 
a/., 1990; Bassey & Ramsdale, 1994).
2.10.4 Sex differences
There are sex differences in the amount of peak bone mass achieved. 
Peak bone mass is reported to be -25%  higher for males than females, and is 
believe to be attained around the age of 30- 40 years, and is somewhat earlier in
trabecular than cortical bone (Charles etal., 1991; Ito etal., 1995).
2.10.5 Menarche and peak bone mass
Early menarche has been shown to be associated with higher bone 
mineral density in adulthood (Ito et al., 1995). Using single photon 
absorptiometry, Fox et al. showed that premenopausal women in whom 
menarche had occurred at age nine years had six percent high bone density 
than those in whom menarche
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occurred at age sixteen (Fox et al., 1993). Similarly techniques such as dual 
energy x-ray absorptiometry (DXA) and quantitative computer tomography (QCT) 
have indicated a positive association between early menarche and higher adult 
bone mineral density (Ito etal., 1995). Similarly, early exposure to oestrogen has 
resulted in a high bone mineral density at the spine in adolescent girls (Dhuper 
et al., 1990). Because of the positive correlation of early menarche with high 
bone mineral density, age at menarche has been linked to peak bone mass (Ito 
etal., 1995). Since bone mineral is maintained in part by oestrogen exposure 
(Ito et al., 1995), it is reasonable to speculate that women with a longer 
reproductive periods will attain a higher bone mineral content than their 
counterparts with a shorter reproductive period. For the same reason early 
menopause is associated with a low bone mineral content in postmenopausal 
women. Conditions such as anorexia nervosa and certain lifestyle factors, such 
as early physical training, which induce amenorrhoea or delay menarche can be 
regarded as risk factors affecting the normal development of peak bone mass in 
young adolescents.
2.10.6 Physical activity and bone mass in adults
There is some evidence to suggest that women with both adequate 
calcium intake and high physical activity may be able to maintain their peak bone 
mass as they progress in adult premenopausal age (Anderson & Metz, 1993). In 
contrast, Ulrich et al. showed physical activity and not calcium intake to be a 
more powerful enhancer of premenopausal bone mass (Ulrich etal., 1996). This 
study demonstrated a strong correlation between lifetime weight-bearing 
exercise and lean body mass, and supported the hypothesis that low muscle
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mass, as a result of low levels of physical activity, may be a risk factor for low 
bone mineral density.
2.10.7 Muscle strength and bone mineral mass
Boys grow more rapidly in muscle strength and co-ordination than girls after the 
age of thirteen years (Eveleth & Tanner, 1990; Paynter & Parkin, 1991). From the 
age of 70 and above, it is estimated that muscle strength is approximately 35 - 
45% lower than the peak value in younger life (Grimby & Saltin, 1983; Paynter & 
Parkin, 1991). The decline is sex dependent and varies according to muscle 
group (Grimby & Saltin, 1983).
One of the tools for testing physical performance is handgrip which 
correlates with muscle mass in young Caucasian adult males (Bassey, 1990). 
The hand grip requires the combined action of a number of muscles in both the 
hand and forearm, and represent a familiar action of functional importance for 
many activities of daily life. Such as holding onto support, opening containers, 
using tools, pulling and pumping water out of well. Low handgrip strength in 
elderly implies considerable functional impairment (Kallman ef a/., 1990; Bassey 
& Harries, 1993). Handgrip strength is shown to be more sensitive than body 
composition measurements in predicting post-operative complications (Klidjian 
etal., 1980; Webb etal., 1989). To what extent handgrip strength correlates with 
disease in young adults is not known. It is plausible that grip strength in young 
adulthood may correlate positively with forearm bone mineral content which may 
protect fracture of the forearm in later life. A positive correlation between muscle 
strength and bone mineral mass in children has been reported in a number of
studies (Schiessl etal., 1996; Schonau etal., 1996), and this is thought to be due
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to the positive effect of muscle strength on bone strength. Increase bone strength 
has been shown to increase bone mass in children (Schiessl et al., 1998). 
Similarly, it has been shown that the rate of bone mass formation in girls was 
reduced following a decline in muscle strength (Schiessl et al., 1998). A high 
grip strength indicates a high level of activity which could result in high bone 
mineral mass and lower incidence of fracture (Lau et a i, 1993).
2,11 Calcium deficiency
The first evidence that calcium deficiency causes rickets in infants came 
from two studies in late seventies (Kooh et a i, 1977, Maltz et a i, 1970). Studies 
of children with rickets have shown that their calcium intakes were remarkably 
lower than the recommendations (FAO/WHO, 1962) and this is thought to be 
responsible for the bone deformities in these children in spite of normal vitamin D 
status (Pettifor ef a/., 1981 ).
Low calcium intake of children in rural South Africa has also been 
associated with hypocalcaemia, elevated alkaline phosphatase, decreased 
urinary calcium excretion and a significant decrease in bone mineral content of 
the radius compared with those children on a high calcium diet (Eyberg et a i, 
1986; Pettifor & Moodley, 1997).
Children living in rural areas in South Africa where calcium intakes are 
low have been shown to have low bone mineral density, and significantly higher 
prevalence of biochemical abnormalities than urban children on high calcium
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diet (Pettifor etal., 1981; Eyberg etal., 1986). However, two groups had different 
biochemical profiles prior to the study, as the criterion for the study. The study 
children had elevated serum calcium and alkaline phosphatase while these 
indices were normal in the controls.
2.11.1 Interaction between calcium and fluoride
A high incidence of childhood rickets has been reported in areas of India 
with high water fluoride concentrations (Teotia et al., 1979). Bone deformities 
due to endemic fluorosis have also been documented in children (Jackson, 
1962; Pettifor, 1991). The biochemical abnormalities of fluoride-related bone 
deformities are elevated alkaline phosphatase, low urinary calcium excretion and 
decreased tubular reabsorption of phosphate (Pettifor, 1991). The condition 
resulted in secondary hyperparathyroidism, elevated 1,25-dihydroxyvitamin D 
concentrations and osteomalacia (Pettifor, 1991; Pettifor & Moodley, 1997; 
Eyberg etal., 1986).
In all these studies, the onset of fluoride-related bone disease in children 
have been associated with low dietary calcium intake. Although the mechanisms 
that underline the cellular actions of fluoride on bone are poorly understood, it is 
thought fluoride excess stimulates osteoblast formation and impairs mineral 
resorption (Pettifor et al., 1981; Pettifor & Moodley, 1997; Eyberg et al., 1986; 
Dure-Smith et al., 1996). The excess fluoride has also been associated with 
severe bone deformities which resemble clinical rickets (Pettifor et al., 1981 ; 
Pettifor & Moodley, 1997).
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2.12. Osteoporosis
Public interest in calcium nutrition and bone disease prevention has 
greatly increased in recent years because of raised awareness of osteoporosis. 
Osteoporosis is characterised by low bone mass and microarchitectural 
deterioration of bone tissue leading to increased incidence of fragility fractures 
(Food and Agricultural Organization/World Health Organization, 1994). In 
osteoporosis, both protein and bone mineral are lost but the composition of the 
remaining bone is normal. The criteria for the diagnosis of osteoporosis rest on 
bone density measurement. Within 1 standard deviation (SD) of young adult 
mean is defined by the World Health Organization (WHO) as normal bone 
mineral mass and bone mineral density while osteoporosis is defined as bone 
mineral mass and bone mineral density >2.5 SD below the young adult mean 
(Consensus Development Conference, 1993, Food And Agricultural 
Organization/World Health Organization, 1994; Christenson, 1997).
Osteoporosis constitutes a major burden of morbidity and mortality in 
many affluent societies. In the United States, for example, fractures due to 
osteoporosis are estimated to affect well over 20 million Americans over the age 
of 45 years (Matkovic etal., 1980; Peck etal., 1987; NIH Consensus Conference,
1994) with more than 200,000 hip fractures occurring each year and with 50% of 
those affected dying within a year of the fracture (Evans et al., 1979; Beals, 1972; 
Jensen & Tonderold, 1979). Recent estimates of the cost of fracture on the health 
care system in the United States is around $10 billion per year (NIH Consensus 
Conference, 1994). It is estimated that one in four European women suffers from 
osteoporosis by the age of seventy years, and the cost of hip fracture to the
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National Health Service in England and Wales is approaching three-quarter 
billion pounds a year (Compston, 1992). The incidence of osteoporosis is 2 - 3 
times higher in women than men in Western Countries (Cooper, 1992), although 
in countries where overall incidence is lower, the sex ratio is closer to one (Xu et 
al., 1995; Xu etal., 1996).
Two types of age-related osteoporosis have been identified. Post 
menopausal (Type 1) osteoporosis occurs within 1 5 - 2 0  years of the 
menopause, affects primarily trabecular bone, and is clinically associated with 
vertebral crush fractures and wrist fractures (Riggs & Melton, 1986). Senile 
osteoporosis (Type II), affects both trabecular and cortical bone, and is 
associated with femoral neck (hip) fractures after the age of 70 (Riggs et al.,
1986).
While there is general consensus that high calcium intake will slow bone 
mineral loss (National Institutes of Health, 1994), there is insufficient evidence to 
be certain of a direct relationship between dietary calcium intake and bone 
mineral content. Some investigators (Albanese et al., 1981; Albanese et al., 
1983; Matkovic et al., 1990; Matkovic et al., 1979) have shown significant 
associations while others (Gam et al., 1967; Smith et al., 1989; Sowers et al., 
1985) have failed to show any relationship between dietary calcium intake and 
bone density. Furthermore, calcium intake is known to differ between countries 
with similar incidence of osteoporotic fractures. For example, the incidence of 
fragility fractures in Denmark is similar to Great Britain despite the high calcium 
intake of the Danes (Anonymous, 1984; Jensen & Tonderold, 1979). The lack of 
an association between dietary calcium intake and bone mineral content may 
reflect confounding, for example, by body size (Prentice etal., 1994). Studies on
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the relationship of dietary factors and bone loss leading to osteoporosis have 
focused primarily on calcium. However, intakes of other nutrients such as 
phosphorus, vitamin D and protein have also been studied (Abelow et al., 1992; 
Harris & Dawson-Hughes, 1994; Hernandez-Avila etal., 1993).
The major cause of postmenopausal bone loss appears to be oestrogen 
deficiency and the administration of oestrogens can be successful in preventing 
bone loss (Kanis, 1994). Oestrogen deficiency not only causes an increase in 
remodelling rate of bone, but also induces an imbalance at remodelling sites 
(Stepan etal., 1987; Heaney etal., 1978). The role of calcium in the treatment of 
osteoporosis appears to be via its ability to reduce bone turnover (Nordin & Need 
1989), resulting in a decrease in rate of skeletal loss. However, the imbalance 
between bone resorption and formation caused by oestrogen deficiency in 
postmenopausal individuals has been shown to be resistant to calcium therapy 
(Hillyard etal., 1978, Riis etal., 1987; Dawson-Hughes et al., 1990; Elders et al.,
1994).
In healthy adults, the deposition of calcium in bone is closely linked with 
the deposition of bone matrix (Charles etal., 1991; Kanis, 1994; Parfitt, 1980). 
However, in osteoporosis, the coupling process appears intact but there is an 
imbalance between the amount of mineral and matrix removed and that 
incorporated into each resorption cavity which results an increased reduction of 
skeletal mass (Christenson, 1997; Kanis, 1994, Parfitt, 1980), In 
postmenopausal osteoporosis, there is evidence to suggest that the imbalance 
between bone resorption and bone formation at each remodelling site is due to a
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decrease in the functional capacity of osteoblasts and their recruitment to 
previous resorption sites (Charles etal., 1991; Kanis, 1994).
2.13. Calcium absorption
Calcium is absorbed via two routes; a saturable regulated vitamin in­
dependent transcellular path, and a nonsaturable path that is paracellular and 
not acutely regulated (Nellans & Kimberg, 1977; Bringhurst & Potts, 1979; 
Bronner, 1995; Ganong, 1993). The rate of production of 1,25-dihydroxy vitamin 
D is increased when the plasma calcium level is decreased and reduced when 
the plasma calcium level is elevated. The 1,25-dihydroxy vitamin D is 
concentrated in the nuclear chromatin of the intestinal absorptive cell where it, 
may interact with DNA to code a specific m-RNA which, interacting with the 
polysomes, leads to the synthesis of calcium binding protein (CaBP) (Nellans & r 
Kimberg, 1977; Bringhurst & Potts, 1979; Bronner, 1995).
The amount of calcium absorbed is thought to depend both on the body 
requirements and intake until a threshold is reached (Spencer et al., 1984; 
Matkovic etal., 1995). Absorption increases at low calcium intake and decreases 
at higher intake (Matkovic etal., 1995; Bronner, 1995). About 40-50% of calcium 
in the diet is absorbed in the small intestine, (Bronner, 1995; Ganong, 1993) and 
there is significant absorption in the lower intestine. Some of the endogenous 
calcium secreted into the gut is reabsorbed, and only a small amount of the 
filtered calcium is excreted into the kidneys each day (Schaafsma, 1988). At a 
very high calcium intake, the absorption efficiency may range from 20-80%
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(Ganong, 1993). It is estimated that up to about 40% of dietary calcium is 
absorbed from typical Western diets (Schwartz, 1990; Department of Health 
COMA, 1992). The extent to which dietary calcium is absorbed and excreted 
depends on the calcium vehicle and the presence of protein, phosphate, oxalate, 
etc, in the diet. Calcium absorption is increased during growth and during 
pregnancy (Matkovic, 1991, Schwartz, 1990). Absorption of calcium is thought to 
be greater in adolescence than any other stage of life (Matkovic, 1991). Calcium 
absorption efficiency is high in children and adolescents (Matkovic, 1991, 
Schwartz, 1990). It has been shown that children on a low dietary calcium intake 
absorb a great proportion of their calcium intake compared with those on higher 
intake (Ireland & Fordtran, 1973; Heaney et al, 1975; Gallagher et al., 1979; 
Abrams, 1993; Abrams & Stuff, 1994). This is consistent with the report that 
fractional calcium varies inversely with calcium intake (Spencer etal., 1969; 
Ireland & Fordtran, 1973; Heaney etal., 1975; Gallagher etal., 1979).
Absorption of calcium is higher in boys than in girls of all races (Bell et al., 
1993). High rates of calcium absorption have been demonstrated in prepubertal 
black girls compared with prepubertal white girls and are thought to be 
responsible for the greater increase in bone mineralisation in American black 
girls during puberty (Abrams, 1993), although, this remains controversial.
Calcium absorption is higher during prepuberty and the early pubertal 
period and reduced at late puberty (Matkovic et al., 1990; Abrams & Stuff, 1994). 
Because nearly all the calcium retained from the diet is used for bone 
mineralisation and remodelling, the current calcium intake of children during the 
pubertal growth period may be inadequate to ensure maximal bone mineral
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retention. Furthermore the diets of most of the world’s population vary in the 
proportions of other nutrients such as protein, sodium and phosphorus, which 
may affect both mineral absorption and excretion. Fractional absorption in 
neonates is estimated to be eighty percent from human milk and addition of 
mineral supplement has been shown to increase the absorption efficiency to 
eighty-two percent (Liu etal., 1989). However, not all studies have shown such a 
high absorption (Barltop etal., 1977). In some studies, calcium absorption failed 
to correlate with age in children (Peacock, 1991).
2.13.1 Dietary factors affecting calcium absorption
2.13.1.1 Chelating agents
Calcium absorption is inhibited by phosphate and oxalate because these 
anions form insoluble salts with ionised calcium in the intestine (Allen, 1982; 
Department of Health COMA, 1992). Vegetarian diets are thought to be poorly 
absorbed due to chelation properties of compounds such as inositol 
hexaphosphates and oxalate (Allen, 1982; Department of Health COMA, 1992). 
However, there is controversy over the effect of phytate on calcium absorption 
and how much calcium is absorbed from a phytate-containing diet is likely to 
depend on methods of food preparation (Walker, 1985; Murphy et a!., 1992). 
There is some evidence to suggest that baking, fermentation and germination 
reduce the effect of phytate (Walker, 1985; Golden, 1988; Murphy et al., 1992). 
The Ca : P ratio is low in the diets of most developing countries and is thought to 
imply a high phytate intake and a poor calcium absorption (Prentice & Bates,
1993).
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2.13.1.2 Protein
There are conflicting reports on the association between protein intakes and 
bone health. Increased risk of fracture and low bone mineral density have been 
related to high intake of protein in women (Abelow et al., 1992; Feskanich et al.,
1996). This contrasts with studies which either found the reverse effect (Fehily et 
al., 1992) or found no effect at all (Hernandez-Avila etal., 1993). Elderly patients 
who were treated with protein-rich supplements showed some clinical 
improvement (Delmi et al., 1990). A high animal protein intake has been 
associated with a modest increase in urinary calcium excretion (Lennon et al., 
1962), this is presumably because these factors increase the urinary titratable 
acid excretion and because of increased absorption which leads to calciuria.
2.13.1.3 Fibre
There is some evidence to suggest that dietary fibre alone or mixed with 
constituents such as phytate and oxalate affects calcium absorption (Southgate, 
1987; Heaney, 1996a; Heaney, 1996b). However, the results of the effect of fibre 
on calcium absorption are inconclusive as others reported a long-term 
adaptation to variation in nutrient availability (Walker, 1985). Studies of Eaton & 
Nelson have shown that the potential adverse effects of life-long high fibre 
consumption on calcium bioavailability are negligible provided that other aspects 
of the diet are adequate (Eaton and Nelson, 1991). Recent studies have shown 
that many forms of fibre such as those found in dark green vegetables fail to 
influence calcium absorption (Heaney, 1993; Heaney, 1996a).
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2.13.1.4 Vitamin C
A positive association between vitamin C intake and high bone mineral 
density have been documented in adolescents (Gunnes & Lehmann, 1995), 
middle-age women (New et a/., 1997) and postmenopausal women (Hall & 
Greedale, 1998). Vitamin C is a cofactor for the hydroxylations of lysine and 
proline residues required for the formation of collagen (Bunker, 1994; Gunnes & 
Lehmann, 1995). Pyridinoline is formed from two hydroxylysyl residues, while 
deoxypyridinoline is synthesised from hydroxylation of lysyl and hydroxylysyl 
residue. Deficiency of vitamin C has been linked to impairment of bone formation 
in infants (Franceschi, 1992), and osteoporosis in adults (Lynch et al., 1967; 
Bunker, 1994).
2.13.1.5 Caffeine
High caffeine intake promotes urinary calcium excretion (Heaney & Pecker,
1982; Massey & Wise, 1984; Morgan etal., 1994). Recent longitudinal studies 
have shown that caffeine promotes bone loss in postmenopausal women with 
low calcium intake (Harris & Dawson-Hughes, 1994). An association between 
high caffeine intake and low bone mineral density have been shown in pre- and 
perimenopausal women (Hernandez-Avila etal., 1993) and in postmenopausal 
women (Lloyd etal., 1997). However, in a recent review on the effects of dietary 
factors on calcium absorption, caffeine was thought to have a minimal effect on 
intestinal absorption of calcium compared with other nutrients (Heaney, 1996b).
2.13.2. Adaptation to low calcium intake
It is possible that individuals accustomed to a low calcium intake absorb 
more and excrete less calcium to compensate for the low calcium supply.
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However, the extent to which such populations can adapt to a low calcium intake 
is unknown. There are conflicting reports regarding the importance of intestinal 
absorption of calcium in increasing the risk of osteoporosis, with some literature 
suggesting decreased absorption in older women with the disease (O’Brien et 
al., 1998; Dawson-Hughes etal., 1997; Lips et al., 1996; Ott, 1994), while others 
have shown increased absorption (Hasling etal., 1990; Parsons etal., 1964), 
and a few studies have demonstrated normal absorption in osteoporotic 
individuals ((Kung etal., 1998; Bronner etal., 1963).
2.14. Calcium excretion
The excretory routes for calcium are through the intestine (the 
endogenous faecal calcium), the kidneys (urinary calcium excretion), and the 
skin (dermal calcium loss) (Peacock 1987; Charles et al., 1991; Matkovic et al.,
1995).
The relationship between calcium intake and urinary calcium excretion in 
adults has been well documented (Nordin & Marshall, 1988; Lemann et al., 
1979) with about 5 - 7% of oral load being excreted in urine (Prentice et al.,
1995). However, the association between calcium intake and excretion is poor, 
since the control of calcium balance is via the gut and not by the kidney, and this 
is supported by the fact that increases in calcium intake is matched by only a 
moderate excretion of calcium in urine (3% of the dose, Prince etal., 1991).
2.14.1 Ethnic differences in calcium excretion
There are ethnic differences in urinary calcium excretion. The excretion 
rate is lower in Black than in Caucasian boys and girls and in prepubertal 
American girls with the same calcium intake (Bell etal., 1993; Abrams, 1993). A
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comparative study of Gambian and British adults has also demonstrated a higher 
urinary calcium excretion in the British compared with the Gambians (Dibba et 
al., in press). Low calcium and phosphate excretion, higher parathyroid hormone 
levels and lower 25-(OH)D was reported in a group of young Zairean men living 
in Belgium compared to Zairean living in Zaire (M’buyamba-Kabanga et al.,
1987). A similar low urinary output of calcium has been demonstrated in young 
Black adult men and women compared with White adults (Bell et al., 1993). It is 
therefore plausible that ethnic differences in renal excretion of calcium may begin 
in childhood. This may partly explain the slow rate of bone loss observed in 
older black Americans (Bell et al., 1993; Abrams, 1993). This observation 
indicates that differences in renal excretion of calcium may allow for a more 
positive calcium balance and account for the higher bone mass in American 
Blacks than in White children (Bell etal., 1991).
2.14.2 Calcium excretion and bone mass
A negative association between urinary calcium excretion and whole body 
bone mineral content and density have been indicated in a number of studies 
(Matkovic etal., 1990; Matkovic, 1992; Matkovic et al., 1995). Urinary calcium 
excretion is one of the important determinants of calcium retention in the body 
(Weaver etal., 1995). However, the nature of the relationship between dietary 
calcium and urinary calcium in children is not clear (Matkovic, 1992; Weaver et 
al., 1995). A number of studies reported a decrease in bone mineral density at 
range of skeletal sites in adult patients with hypercalciuric syndrome (Barkin et 
al., 1985; Pacifici etal., 1990; Bataille etal., 1991; Pietschmann et al., 1992; 
Jaeger et al., 1994). Since calcium intake is an important determinant of bone 
formation and possibly peak bone mass, it is plausible that high obligatory
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calcium loss in the urine may reduce the degree of calcium retention in the body, 
with a consequent of low bone mineral content and increased risk of osteoporotic 
fracture.
2.14.3 Dietary factors affecting calcium excretion
2.14.3.1 Sodium
Dietary sodium increases calcium loss in the urine due to a close 
association between renal tubular mechanisms involved in the reabsorption of 
these ions (Goulding & Lim, 1983; Sabto etal., 1984; Need ef al., 1991; Nordin et 
al., 1993; Devine et al., 1995; Matkovic et al., 1995; Ginty et al., 1998). This 
suggests that a high sodium intake could be a risk factor for osteoporosis through 
its influence on calcium retention and hence on peak bone mass. It has been 
shown that salt intake influences over night bone loss in postmenopausal women 
(Goulding & Lim, 1983). Thus it is possible that high salt intake may promote 
higher calcium excretion leading to loss of bone whereas a low salt intake should 
help to conserve bone mass by reducing calcium loss in urine. The direct effects 
of sodium on bone mass of human are equivocal and the magnitude of the 
changes in urinary calcium excretion attributable to changes in sodium excretion 
have been disputed (Ginty etal., 1998; Sabto etal., 1984).
2.14.3.2 Potassium
Potassium bicarbonate reduces urinary calcium excretion and enhances 
calcium retention in healthy adults without altering calcium absorption (Lemann 
et al., 1989; Lemann et al., 1991). Potassium bicarbonate has also been 
associated with reduced bone resorption and increased bone formation in 
postmenopausal women (Sebastian et al., 1994).
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A positive association between the dietary intake of potassium and bone 
mineral density has been found in postmenopausal women (Miehaelsson etal., 
1995, New et al., 1997) but this association may be confounded by 
environmental factors and body size considerations.
2.14.4 Calcium balance studies
There is a great controversy surrounding calcium threshold above which 
the amount of calcium consumed is not related to calcium retention in the body 
but with faecal and urinary calcium excretion (Matkovic & Heaney, 1992; Weaver 
etal., 1995) and this is thought to differ between different age groups (Matkovic & 
Heaney, 1992). In general, higher calcium intake has been associated with a 
greater calcium retention in adolescents (Matkovic & Heaney, 1992; Weaver et 
al., 1995; Weaver etal., 1996). In a review of balance studies from 1922 until 
1991, Matkovic & Heaney estimated that the threshold intakes of calcium where 
calcium accretion increase no further (plateaus) were 1480 mg/d (37 mmol/d) for 
adolescents and 957 mg/d (23.9 mmol/d) for young adults (Matkovic & Heaney,
1992). It was on the basis of these estimates and the results of calcium 
supplementation studies (Johnston et al., 1992; Lloyd et al., 1993), that a 
recommendation of 1500 mg/d (37.5 mmol/d) for optimal calcium intake in 
adolescents was proposed by the National Institutes of Health Consensus 
Conference on Optimal Calcium intakes in 1994 (National Institute of Health,
1994). Using more sophisticated modelling procedure Jackman et al have more 
recently estimated the calcium threshold at < 1300 mg/d (32.5 mmol/d) for the 
same age group (Jackman etal., 1997).
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Calcium balance is defined as the difference between intake and output 
(Matkovic & Heaney, 1992). However, it is difficult to quantify the balance 
between absorption and excretion, because present methods for measuring 
intake and output are subjected to large measurement errors (Weaver et al., 
1995; Matkovic & Heaney, 1992; Matkovic et al., 1995). It has been argued that 
most balance studies do not take into account the calcium excreted in the sweat 
(Dawson-Hughes, 1998). Calcium loss from sweat is estimated to be as high as 
65 mg/d (1.63 mmol/d) (Charles et al., 1983). Very little is known about calcium 
excretion in children. There is some suggestion that adolescents may have 
lower urinary and faecal calcium excretion and greater net calcium absorption 
than adults (Matkovic & Heaney, 1992; Weaver etal., 1995).
2.15 Calcium supplementation studies
2.15.1 Calcium supplementation studies in children
A number of retrospective studies have shown an association between
high calcium intake in early life and attainment of a greater peak bone mass 
(Chan, 1991; Fehily et al., 1992; Hu et al., 1993). Hu et al. found a strong 
association between high milk intake during childhood and bone mineral density 
in adults and further speculated that a high calcium intake may optimise peak 
bone mass (Hu etal., 1993). However, the long-term benefits of a high calcium 
intake for increasing bone mineral status or for reducing fractures have not yet 
been validated experimentally.
At the start of this study, there were only three published calcium 
supplementation trials (Johnston etal., 1992; Lloyd etal., 1993; Lee et al., 1994), 
and all had shown a significant effect of a calcium supplement on bone mineral
acquisition. The timing of the responsiveness to the calcium supplement relative
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to the pubertal growth spurt, and the relationship between the dose of calcium 
supplement and habitual calcium intake are controversial. A supplementation 
trial of identical twins demonstrated a significant effect of calcium supplement on 
bone mineral accretion in prepubertal children but not in twins who were 
postpubertal or went through puberty during the study (Johnston et al., 1992). In 
contrast, 2 other supplementation studies showed an effect of calcium 
supplement on bone mineral content and bone density of children who were 
either postpubertal or went through puberty during the study (Lloyd et al., 1993; 
Nowson etal., 1997). Since that time several other calcium supplementation 
studies have shown an effect of a calcium supplement or milk on bone mineral 
status, mostly in prepubertal children (Lloyd et al., 1996; Lee et al., 1995; Lee et 
al., 1996; Chan etal., 1995, Cadogan etal., 1997).
2.15.2 Calcium supplementation and follow-up studies
To date there have been three supplementation studies in children in 
which follow-up data have been collected and all these studies indicated that the 
gain in bone mineral acquired as a result of calcium supplementation is not 
sustained after cessation of calcium supplement (Lee et al., 1996; Lee et al., 
1997; Slemenda et al., 1993). This raises questions about the mechanisms 
involved. One possibility is that calcium supplement may exerts its effect by 
slowing down bone remodelling rate rather than by promoting skeletal growth. 
The process of skeletal remodelling continues throughout life. Serum 
concentrations of bone formation and resorption markers are at their highest 
during rapid growth period, to allow greater bone mass accretion. The 
mechanism of the effect of calcium supplementation on bone mineral is unknown
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but one report suggests that calcium supplementation acts by reducing bone 
formation as shown by reduction in osteocalcin concentration (Slemenda et al., 
1993; Johnston etal., 1992). The reduction in osteocalcin concentration possibly 
reflected a decrease in osteoblast activity.
The disappearance of the supplement effect in follow-up studies also 
supports the possibility that the calcium supplement may have acted by altering 
bone remodelling process. A reduction in remodelling space has been shown to 
result in apparent increase in bone mass (Heaney, 1994) through a process 
called bone remodelling transient (see section 2.2). Based on the same concept, 
the low concentration of biochemical markers of bone remodelling in Blacks 
compared with Caucasians is associated with a superior bone- mass 
(Kleerekoper etal., 1994, Slemenda etal., 1997). There is also a suggestion that 
decreased remodelling in calcium supplemented children could be a reflection of 
calcium-mediated suppression of parathyroid hormone secretion (Slemenda et 
al., 1997) but this has not been proved.
Whether reduced rates of skeletal remodelling during growth have any 
long term benefit in children accustomed to a low calcium intake is unknown. 
Therefore, studies are needed to examine the possible mechanism of action of 
calcium supplements on bone.
2.15.3 Calcium supplementation studies in adults
The effect of calcium supplementation on bone health in adults is an area 
of great debate and controversy. A number of calcium supplementation studies 
have found an association between calcium intake and bone mineral density in
74
chapter 2 Calcium supplementation studies and bone remodelling transient
adults (Dawson-Hughes, 1991; Elders etal., 1989a; Elders etal., 1989b, Elders 
etal., 1991) while others failed to show any association (Dawson-Hughes et al., 
1989; Recker et al., 1977). An effect of calcium supplement on the reduction of 
cortical bone loss has been observed in some studies (Polley et al., 1987; Smith 
etal., 1989; Elders etal., 1994). Similarly, calcium supplementation in elderly 
women has been shown to reduce bone loss at the hip (Dawson-Hughes et al., 
1990; Nelson etal., 1991; Reid et al., 1993; Chevalley etal., 1994; Prince etal.,
1995) and distal forearm (Prince et al, 1991). Conversely, calcium 
supplementation during the early menopause has been shown to be ineffective 
in reducing trabecular bone loss (Riis et al., 1987; Dawson-Hughes et al., 1990; 
Elders et al., 1994). In postmenopausal women, the response to calcium 
supplementation appears to depend on menopausal age (Dawson-Hughes, 
1991). An association between calcium intake and fracture incidence has been 
reported (Matkovic et al., 1979). Supplementation with vitamin D and calcium 
had resulted in a significant reduction in fracture incidence in a large cohort of 
elderly women (Chapuy etal., 1992).
2.16. Bone remodelling transient
A bone remodelling transient is a complex series of events occurring 
within the remodelling apparatus of bone that occurs in response to a change in 
remodelling rate (Heaney, 1994). These events produce a change in the amount 
of mineralised bone tissue as well as in calcium balance. The process could be 
best described as temporary imbalance between the amount of bone being 
removed and the amount being added. The mechanism behind the bone 
remodelling transient was first postulated by Frost (Frost, 1973) almost 26 years
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ago, and tested by Parfitt in a clinical settings (Parfitt, 1980). It is called a 
transient because the change in bone mass persists for only one remodelling 
cycle with the bone mass reverting to its original state when the remodelling 
change is in the opposite direction (Heaney, 1994).
It is thought that most antiresorptive therapies used for the prevention of 
osteoporosis work by altering bone remodelling balance. How much of the 
change in bone reported by calcium supplementation studies represents a 
remodelling transient and how much represents modelling is not clear. The 
reason for this is that until recently, the concept of the bone remodelling transient 
has been poorly understood and hard to apply in a clinical situation (Heaney,
1994).
An increased remodelling space results in an apparent loss of bone mass 
while a reduction in bone remodelling space promotes an apparent increase in 
bone mass (Heaney, 1994). With the recent advance in technology, it is now 
possible to monitor the size of the remodelling space of bone by computer 
simulation which demonstrates that the size of the remodelling transient 
correlates with the amount of calcium supplement (Heaney, 1994). It is likely that 
current technologies to measure bone mineral content in vivo also are able to 
record marked changes in remodelling space given their high precision 
(Prentice, 1997).
Biochemical markers of skeletal metabolism are thought to reflect both 
resorption and formation (Kelly etal., 1991; Garnero et al., 1996a; Gamero et al., 
1996b; Parfitt, 1994). Because of the tight coupling between bone formation and 
resorption in a healthy adult, the response of markers to therapies like calcium is
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generally regarded as a reduction in the concentration of both formation and 
resorption markers (Ganero et al., 1994; Ganero et al., 1995). However, in 
children, these markers are not specific to either modelling or remodelling 
because of the fact that these processes proceed simultaneously during growth, 
and the fact that both bone modelling and remodelling involve resorption and 
formation of bone (Slemenda et al., 1997). Clearly, more studies in children 
need to include a more detailed investigation of biochemical markers to give 
insight into mechanisms.
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3 Study location and initial design
Figure 3.1 Map of The Gambia showing Keneba and surrounding villages
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3.1 Keneba
The study was carried out in the rural subsistence-farming village of 
Keneba, The Gambia. The Gambia is the smallest country in sub-Saharan 
Africa, with a population of one million people and occupying an area 30 
kilometres wide and 600 kilometres long, either side of the River Gambia.
Keneba is a relatively isolated village situated in the West Kiang district 
and has a population of 1,800 people. It is 100 miles by road from the capital city
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of Banjul, the last 15 miles of which are dirt road. The village is bounded on the 
south by mangrove swamps, and seven miles to the north by the River Gambia.
Keneba is situated 13° 20' north of the equator and has two main seasons. 
The rainy (wet) season begins in July and ends in October and the dry season 
extends from November to June. The way of life of the people depends on the 
season of the year. The people are less mobile in the rainy season as this is the 
time of the year when farmers are busy cultivating their crops and have less 
money to spend. In contrast, in the dry season, there is sufficient food available 
and with some money to spend, and men have little or no farming to do. The 
prevalence of diseases in the West Kiang district is influenced by season. 
Childhood gastroenteritis and malaria reach their peak prevalence during the 
later part of the wet season.
3.2 Inhabitants of Keneba
The inhabitants of Keneba are Muslim, predominantly of the Mandinka 
tribe or descendants of the Jola tribe, with well-defined and distinct roles for men 
and women according to the Islamic law. The village is divided into compounds 
which are separated from one and another by a fence, usually made of a variety 
of local dried plant materials such as millet stalks and occasionally of corrugated 
iron. People live in compounds defined as a group of families living together 
where the people in the group are generally related in one way or another. The 
villagers are mainly farmers. The women are the main work-force in the village 
and in addition to cooking meals for the family, they are also largely responsible
Chapter 3 Study location and initial design
for the growing and harvesting of the staple food and cash crops. The main cash 
crop and the major source of dietary protein and fat for the villagers is groundnuts 
(Arachis hypogaea) and is virtually the sole source of income. The staple cereal 
foods are millet (Pennisetum typhoideum), sorghum (Sorghum margaritiferum), 
rice (Oryza sativa), suno (Pennisetum gambiense) and to a lesser extent, maize 
(Zea mays) and findo (Digitaria exilis). Although there are cattle owners, the 
villagers are predominantly vegetarian. Fish is regularly eaten and is usually 
purchased from the neighbouring villages of Jali and Tankular.
The diet of children in rural Gambia is based on groundnuts, cereals, and 
vegetables. The main staple cereals are rice (mano), millet (sanyo), sorghum 
(kinto), maize (tubanyo) and findo (wild grass). Rice is eaten either as boiled rice 
or prepared as porridge. All other cereals are eaten as nyelengo, futo or 
porridge. Boiled rice and cereals eaten as nyelengo and futo are consumed with 
a sauce, often made with groundnuts (durango). Nyelengo is prepared after 
washing the grain, pounding and removal of the husk. The flour is steamed with 
water and dried baobab added during the steaming process. Futo is produced 
by steaming but the flour is subjected to more numerous steamings than 
nyelengo. In addition the flour obtained from pounding the grain is sifted to fine 
powder and a little water is added during stirring to form small balls. The balls 
are steamed several times to achieve a fine consistency. It is finally removed 
from heat and pounded again at which time flavourings such as baobab leaf 
(dried) may be added. Because of the addition of dried baobab leaves during 
steaming, the calcium contents of nyelengo and futo are higher than other cereal 
dishes.
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Other common methods of preparation include nyankatango, where 
previously cooked cereal is steamed together with pounded raw groundnuts plus 
dry fish, locust bean, oil or onion added. Addition of dried fish and locust bean 
increase the calcium content of nyankatango, Fajiringo refers to a term used for 
boiling and is usually connected with rice only (manifajiringo). The grains are 
washed, steamed and then boiled or they may only be boiled without no 
preliminary steaming. The water is drained off before the rice is fully cooked and 
it is dried out by steaming. Because of the method of preparation, the water 
content of cooked rice is high but calcium content low, generally being mostly 
associated with calcium in the local salt which is added during preparation. 
Several types of porridge are common in the rural Gambia, depending on 
method of preparation and consistency. Mono is the thinnest, sato is thickest, 
while churo refers to a rice porridge of intermediate thickness. All these dishes 
except mono are eaten with dark green leaves sauces and fish. Dark green 
leaves, groundnuts and fish are the major source of calcium in the gambian diet 
(see appendix 7), and special attention needs to be paid to recording the 
amounts of these in each meal, especially when they are added in small 
amounts as flavouring, when estimating calcium intakes.
Fruits, groundnuts and vegetables, are common ingredients and the staple 
diet usually consists primarily of cereals. There is a high prevalence of 
inadequate intakes of vitamins and minerals, and anaemia and iron deficiencies 
are common (Bates etal, 1993; Bates et al., 1994). The inadequacy of vitamin 
and mineral intakes may be further complicated by factors which may reduce 
absorption, which is likely to be poor due to phytate and oxalate content of the 
Gambian diet (Prentice & Bates, 1993; Bates etal., 1994).
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At the time of this study, there was neither electricity nor telephone in the 
village. Until recently, the main form of communication with the outside world 
was through the national radio. The first ever television station built in The 
Gambia was opened two years ago.
All the children in Keneba are breast-fed on demand for 18 - 24 months. 
Breast-feeding is exclusive for about the first 3 months of life, with traditional 
weaning foods introduced as a complement after 3 months. All children 
consume weaning and adult foods by 9 - 12 months. However breast milk 
remains as a major source of nutrients throughout infancy and early childhood 
(Prentice etal., 1990).
Previous studies in Keneba have shown that rural Gambia children have a 
growth pattern that resembles that of Western children in the first 3 - 4 months of 
life (Hoare, 1994; Weaver, 1994). Growth faltering starts at about the time solid 
foods are introduced (Weaver, 1994; Prentice et a/., 1990; Whitehead & Paul, 
1984), caused mainly by repeated illness, particularly, diarrhoea (Rowland etal., 
1977; Rowland etal., 1978, Weaver, 1994). Children in Keneba experience 
severe growth faltering (in terms of both weight and height) during the second six 
month of life (Prentice etal., 1986; Hoare, 1994). Over half of children in Keneba 
are below 80% expected weight for age by the time they reach the age of 1 year 
(Cole, 1993). There is relatively little catch-up once growth faltering has 
occurred. Introduction of a food supplement aimed at increasing the energy 
intake of Keneba children failed to improve their growth (Prentice, 1993).
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3.3 Effect of season
Food is not abundant at all times of the year and the eating pattern in The 
Gambia reflects the pattern of food supply. There is a seasonal variation in the 
pattern of growth of rural Gambian children. Growth is particularly poor during 
the wet season, when the diet is severely marginal for many nutrients and food 
stocks from the previous year's harvest are depleted. The problem of food 
shortages for growth is compounded by increased bacterial contamination of 
weaning foods (Barrel! & Rowland, 1979), reduced standards of mother-care 
caused by heavy agricultural activities, increased diarrhoea! and other infections, 
all of which have a detrimental effect on child growth (Rowland et al., 1977; 
Whitehead, 1979).
In contrast, children grow better in the dry season when there is plenty of 
food to eat and people are less active due to reduced farming activities 
(McGregor etal., 1968, Prentice etal., 1981).
The extent to which illness is responsible for growth faltering in Gambian 
children and its association with inadequate nutrition is still under intensive 
investigation. In other populations, some studies have shown that up to one third 
of the total amount of linear growth failure can be attributed to illness (Allen, 
1994; Martorell etal., 1975; Martorell & Klein, 1980). Guatemalan children who 
were free from diarrhoea during the first seven years of their life were 13 cm 
shorter than well-nourished children in the United States - although 3.5 cm taller 
than children who had more diarrhoea (Martorell et al., 1975). This study 
suggests that poor infant growth in the developing countries could be partly 
related to infection and bacterial contamination of weaning foods (Rowland etal.,
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1978). Although diarrhoeal infections were thought to be the major causes of 
growth faltering in rural Gambian children (Barrel & Rowland, 1979; Rowland et 
al., 1977; Whitehead, 1979), recent reviews on morbidity and mortality have 
shown that reduction in diarrhoea alone fails to improve growth (Poskitt et al., 
1999). This suggests that a combination of undemutrition (Sullivan et al., 1992a; 
Sullivan etal., 1992b; Lunn etal., 1996) and persistent gastrointestinal disease 
may be more important (Bunn etal., 1997).
3.4 Low birth weight
Over 50% of children bom annually in The Gambia have birth weight less 
than the World Health Organization cut-off point for low birth weight, of 2500 g 
(Ceesay eta l., 1997). The low birth weight of Gambian babies has-been 
associated with short birth spacing and undernutrition of the mother both before 
and during pregnancy (Rowland, 1977; Whitehead & Paul, 1984). Provision of a 
high energy supplement in late pregnancy has been shown to improve the birth 
weight of Gambian babies (Ceesay et al., 1997).
3.5 The Medical Research Council in Keneba
The study was conducted from the MRC Dunn Nutrition Unit's Laboratory 
and clinic located in Keneba (recently renamed MRC Keneba). The Medical 
Research Council (MRC) has had a field station since 1950 in Keneba, which 
was initiated by Professor Sir I. A. McGregor, the Director of MRC Gambia 
Laboratory from 1954 -1973  and 1979 -1981. Since 1949 all births and deaths 
in the village of Keneba, and the three neighbouring villages of Kantong Kunda, 
Manduar and Jali have been recorded by a senior villager, literate in Arabic. In
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the early fifties, all the compounds in Keneba were identified and numbered, and 
this identification was used in the current study.
3.6 The Dunn Nutrition Unit
In 1974 the overseas programme of the Cambridge-based Dunn Nutrition 
Unit directed by Dr R. G. Whitehead, was transferred to Keneba, The Gambia. 
Before that Professor Sir Ian McGregor had already highlighted the poor growth 
performance in the Keneba children (McGregor et a i, 1968) and Keneba was an 
ideal place to conduct scientific research into the aetiology of malnutrition and 
growth faltering. The infant mortality in the area at that time was > 500 per 1000 
live births (McGregor etal., 1968). The initial aim of the programme of the Dunn 
Nutrition Unit was to identify the nutritional and health related factors that 
underlay the high mortality, morbidity, and poor nutritional status of the mothers 
and children in the West Kiang district and to introduce appropriate interventions 
in a scientifically controlled manner, aimed at improving growth and child health.
Keneba has been the focal point of numerous nutritional and demographic 
studies by the MRC Dunn Nutrition Unit since 1974. The availability of detailed 
records of births and deaths of the three study villages which include Keneba 
over the last 50 years, means that accurate records of birth date are available. 
Previous studies on growth and calcium requirements of children in Keneba 
have demonstrated that rural Gambian children have poor growth and low bone 
mineral status. Their calcium intake is low (300 - 400 mg/d) (7.5 - 10 mmol/d) 
(Prentice etal., 1990). The availability of this background information on calcium 
intake and bone growth made Keneba an ideal place to conduct a study to
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examine the benefit of an increase in calcium intake on growth and bone mineral 
development, in children accustomed to a low calcium diet.
3.7. Objectives of the study 
3.7.1. Research questions
The main aim of the study was to determine the influence of calcium intake 
on longitudinal growth and bone mineral development of Gambian children 
accustomed to low calcium intakes. To do this a randomised, double-blind, 
placebo-controlled calcium supplementation study was designed and conducted 
on 160 Gambian children, age 8 - 1 2  years for 12 months. The study also aimed 
to provide detailed information about the calcium intake and growth pattern of 
this age group and to determine the biochemical indices of calcium metabolism 
before and after calcium supplementation. The age group was chosen to allow 
recruitment of the target of 160 children required to provide sufficient statistical 
power (see section 3.8.1 for detail). Because of the delayed puberty of rural 
Gambian children, most subjects were likely to be prepubertal with some of the 
older children progressing through to puberty during the study.
3.8 Initial Study Design
This study was designed to be conducted on a group of older Gambian children.
Considerations about ah appropriate sample size had to take into account two 
issues.
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1. Sample size needed to be statistically large enough to detect any meaningful 
change in bone mineral status associated with the calcium supplement over a 
12 month period.
2. Recruitment of the sample needed to be achievable within the study period.
In addition, the design of the study needed to take into account the 
possibility of seasonal effects which had to be minimised. The choice of the 
calcium supplement also had to be considered in the light of the cost, 
absorbability and its acceptability.
3.8.1 Sample size and statistical power
Based on statistical considerations, a sample size of 160 children (80 
boys, 80 girls) turned out to be an appropriate number. The between-subject 
coefficient of variation for forearm bone mineral content adjusted for bone width, 
taken from published data and previous studies in Keneba, is 9% (Johnston et 
a/., 1992; Prentice etal., 1990; Lo etal., 1990; Prentice etal., 1995). A sample 
size of 160 children provided a treatment group size of 40 in each sex and 80 
with sexes combined. This has statistical power to detect a supplement effect on 
bone mineral status equal to or greater than 5% and 4% respectively (using a = 
0.05, 1 - p = 80%). Therefore, a sample size of 160 children (40 boys, 40 girls) in 
each of the supplemented and placebo groups was expected to give sufficient 
statistical power to detect meaningful differences in bone mineral status 
associated with calcium supplementation which are similar to those reported in 
previous calcium supplementation studies of the same age group in American 
and Chinese children (Johnston etal., 1992; Lloyd et al., 1993; Lee et a!., 1994). 
This study was conducted to examine the effect of increase calcium intake in
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older children who were pre- or peripubertal. The birth rate of Keneba is such 
that recruitment of 160 children between the age of 8 - 12 years should be 
possible over one calendar year.
Calculation of sample size for this study was based on the following 
equation:
With 40 subjects in each of the supplemented and placebo groups
2(1.96 + 0.842)2x92/r2 = 40 
r = 5.64
where 1.96 and 0.842 are standard errors at a  = 5% and p = 20% respectively
(Florey, 1993) and r = percent change (A%) in bone mineral content. Nine is the 
calculated between-subject coefficient of variation for forearm BMC adjusted for 
BW from published data and previous studies in Keneba (see begining of 
section).
/. r = 5.65%A can be seen at a  = 5% and p = 20%.
and for n= 80 in each group,
2(1.96 + 0.842)2*92/r2 = 80 
r = 4.00
r = 4%A can been seen at a  = 5% and p = 20%.
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3.8.2 Effect of season
In order to account for differences due to season, recruitment of subjects 
was spread over 12 months. To achieve this and to ensure all measurements 
are completed within a week, the aim was to recruit 4 subjects each week.
3.8.3 Choice of calcium supplement
Calcium supplementation studies generally use calcium salts especially 
calcium citrate malate dr calcium carbonate (Johnston etal., 1992; Lloyd et al., 
1993; Lee etal., 1994). However, calcium citrate malate is expensive compared 
with calcium carbonate arid this has limited its use in supplementation studies. 
Calcium carbonate, in the form of palatable orange flavoured chewable tablets, 
was selected in preference because of its low cost.
Studies comparing calcium carbonate and calcium citrate malate have 
had conflicting results in adults. Some studies demonstrated no differences in 
the fraction absorbed between the two calcium salts whether given with meals or 
under fasting conditions (Smith et al., 1987; Recker, 1985). In contrast, calcium 
citrate malate have been shown to be better absorbed than calcium carbonate in 
a number of studies of healthy subjects (Miller et al., 1988; Nicar & Park, 1985; 
Harvey etal., 1988).
However, results from a calcium supplementation study in children using
calcium carbonate (Lee etal., 1994) demonstrated a similar effect of supplement
on bone mineral status to studies using calcium citrate malate (Johnston, et al.,
1992; Lloyd et al., 1993), thus justifying its use in this study. Also calcium
carbonate tablets used in a previous calcium supplementation study in Keneba,
among lactating women were well accepted by villagers (Prentice etal., 1995).
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3.8.4 Main outcome
The main outcome of the study was forearm bone mineral content and was 
measured using single photon absorptiometry (SPA). The same technique has 
been used in two earlier calcium supplementation studies (Johnston et al., 1992; 
Lee et al., 1994) and is sensitive enough to detect changes in bone mineral 
status at mid-shaft radius within a duration of 6 - 18 months (Johnston et al., 
1992; Lee et al., 1994). A similar duration of supplementation was used in this 
study. Bone mineral status of the study children was assessed at baseline, at the 
end of supplementation (outcome) and 12 months after supplementation (follow- 
up), in order to determine the effect of supplementation on bone mineral 
accretion rate and whether any effect on bone is sustained after the withdrawal of 
supplement.
3.8.5 Biochemical assessment
Blood and urine tests to measure the effect of calcium supplement on 
biochemical markers of calcium and bone metabolism were also performed in 
order to give an insight into mechanism. Changes in bone mineral status have 
been shown to correlate with changes in biochemical markers in the blood and 
urine, especially osteocalcin, parathyroid hormone, urinary calcium and 
deoxypyridinoline (Johnston etal., 1992; Sebastian etal., 1994; Matkovic etal., 
1990; Matkovic, 1992; Matkovic etal., 1995; Lian & Gundberg, 1988; Ismail etal., 
1986; Canalis etal., 1989; Christenson, 1997; Seibel etal., 1993).
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3.8.6 Dietary calcium intake
To quantify calcium intake in this age group of Keneba children, a 2 day 
weighed intake was used. A study comparing group mean values obtained 
using a 7-day with 2-day weighed intakes in Keneba had demonstrated no 
difference between the two because of the relative homogeneity of diet in rural 
Gambia (Prentice etal., 1995; Prentice etal., unpublished data).
3.8.7 Comparative study
A comparative study of age and sex matched Gambian and British 
children was conducted to examine whether differences in growth and bone 
mineral development between The Gambian and British infants (Prentice et al., 
1990) were also observed in older children.
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3.9 Study Design
Table 3.1
calcium su, cementation
Baseline year 1 Year 2
SPA bone measurements x x x
Ultrasound bone measurements x x x
Height, weight, size, grip x x x
Blood sample x x x
24h urine sample x x x
Dietary measurements x x x
Questionnaire x x x
3.10 Scientific and ethical approvals
The investigation was approved by MRC Scientific Coordinating 
Committee and MRC Gambian Government Ethics Committee. Informed-consent 
was obtained after the children and their parents, most of whom were illiterate, 
had been given verbal explanation of the study in their own language (see 
appendix 1 for detail). The consent form was signed or marked with thumb print 
by one of the child’s parents before the study began.
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4.1 Subjects
One hundred and sixty healthy Gambian children (80 boys and 80 girls) 
aged 8.3-11.9 years from the village of Keneba, West Kiang district, The Gambia, 
took part in the study. All the subjects were born and lived in Keneba. Most of 
the children were Mandinka but four children were from a Fula tribe. The 
subjects were healthy children with no history of any medical condition known to 
affect calcium and bone metabolism or of recent bone fractures. None were 
taking any calcium supplement or antacids at study entry, none smoked or 
consumed alcohol, and none of the girls was on contraceptive medication.
All subjects were measured three times (at baseline, outcome, and follow- 
up). Both outcome and follow-up measurements were conducted in each child 
as far as possible during the same calendar week as baseline measurements. 
Baseline measurements were conducted in the week prior to the start of 
supplementation, outcome measurements were made after 12 months (385 ± 4 1  
days), in the week before the supplement was withdrawn, and follow-up 
measurements were conducted 12 months after supplementation was finished 
and 24 months after baseline measurements were made (752 ± 27 days).
At each time point, each subject visited the MRC Keneba Laboratory 
(formerly MRC Dunn Nutrition Group), where bone measurements were made 
and anthropometry performed. Each subject provided a fasting blood sample 
collected between 6.30 a.m. and 7 a.m. to avoid introducing errors due to diurnal 
variation, and each completed a 24 hour urine collection. All subjects completed 
a questionnaire on lifestyle and calcium intake and a 2-day weighed dietary 
intake.
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4.2. Calcium supplementation
Subjects were stratified by sex and randomised, double-blind, to receive 
the calcium supplement or a placebo. The randomisation procedure was 
conducted by a member of staff in Cambridge who was otherwise not involved in 
the study. The subjects, field and lab staff remained unaware of the allocations 
throughout the study. Allocations to supplementation group were by randomised 
permuted block of 4 to ensure that an equal number of subjects were allocated to 
the supplement and placebo groups each fortnight, to minimise the potential for 
seasonal confounding. Four children started the study each week to allow 
recruitment to be spread over one calendar year. All measurements per subject 
were completed within a 7 day period.
The calcium supplement consisted of two chewable calcium carbonate 
tablets (Calcichew, Shire Pharmaceuticals Ltd, Andover, UK and Nycomed 
Pharma Oslo, Norway), containing 500 mg (12.5 mmol) elemental calcium per 
tablet. The placebo consisted of two tablets of similar shape, taste and texture, 
produced by the manufacturer of the calcium tablets. Each subject received 
either the calcium supplement or the placebo, 5 days each week for 12 months, 
starting the week following baseline measurements. The tablets were dispensed 
to the subjects at a centrally-located building in the village and were consumed 
under strict supervision. To achieve regular attendance, a youth club was 
organised every week-day evening. For children who were unable to attend the 
youth club for any reason, tablets were dispensed at the child's home by the 
fieldworkers on the same day. The tablets were administered away from food, in 
the early evening, between 17.00h - 19.00h. This allowed the supplement to be
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consumed between lunch, generally eaten at 14.00h - 15.00h, and dinner, eaten 
around 20.30h, to minimise possible interference with absorption of other 
minerals, such as iron and zinc. During the fast month of Ramadan, tablets were 
consumed later in the evening immediately after the subject had broken fast but 
before the main meal. Supplements that were missed due to illness or absence 
from the village were consumed at weekends. The tablets were well accepted, 
there were no reports of adverse side effects and the overall compliance for each 
child was 100% in that by the end of the 12 months supplementation period 
every child had consumed all the tablets that had been assigned to them at the 
start of the study.
4.3 Anthropometry
Each subject was weighed to the nearest 0.1 kg, in light clothing without 
shoes. Standing height without shoes was recorded to the nearest 0.1 cm with a 
stadiometer (CMS Weighing Equipment Ltd, 18 Camden st, London, UK). This 
requires the subject to stand upright with heels and shoulders against the 
support, knees and back straight and the head in the Frankfort horizontal plane. 
Mid-upper arm circumference (MUAC) was measured using a graduated tape 
and triceps skinfold thickness was assessed using calipers. The mid-upper arm 
circumference was measured with the arm hanging by the side at the mid point of 
the arm, measured from the lower border of the acromial process of the scapula 
to the tip of the olecranon and parallel to the long axis of the arm. The mean of 
the three measurements was used.
All anthropometry measurements were made on the same day that the 
subject was scanned.
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4.4 Grip Strength
All subjects had their grip strength measured on both hands with a hand 
grip dynamometer (CMS Weighing Equipment Ltd, London). The subject 
remained standing during the measurement with the arm straight by the side, 
resting between each measurement and the next. Three measurements on each 
hand were carried out and the mean of the 6 measurements was used in the data 
analysis.
4.5 Lifestyle assessment
A questionnaire was designed to look for possible confounding factors 
which could confuse the interpretation of any supplement effect or which could 
explain differences in the growth pattern and calcium intake of children who took 
part in this study.
Information concerning place of birth, socio-economic grouping, physical 
activity levels, school enrolment, education attainment, medical and fracture 
history were obtained using a questionnaire. Additional information on 
medication was also obtained (see appendix 2).
Families were ranked (A) poor, (B) average or (C) well-off according to 
whether (A): they experienced food shortages during the wet season, had one or 
more thatched houses, had no radio or cassette player, both of the parents were 
farmers with a normal or low yield or the father was a herdsman and there was 
no wage earner in the family, (B): had no thatched house in the compound but 
experienced food shortages in the wet season, had parents who were farmers 
but usually had good yields, came from a family that owned a radio and/or
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cassette player, did not have a herdsman father but had no employee in the 
family or (C) had sufficient food to support the family throughout the year, no 
thatched houses in the compound and had one or more wage earners in the 
family.
Nineteen families were considered poor according to these criteria 
(Category A, 12%), one hundred and twenty-seven children came from families 
with average earning power (category B, 79%), and 14 were ranked as well-off 
(category C, 9%). There was no indication of a difference in the distribution of 
children in the supplemented group or placebo group according to socio­
economic group (supplement : placebo, 49% versus 51%). For more details of 
the outcome of the questionnaire, see appendix 3.
4.6 Activity
The activity patterns of the children were investigated by questionnaire to 
determine if the supplemented and placebo groups differed in their physical 
activity (see appendix 4). Although the physical activity questionnaire was based 
on local customs, all the children were shown to be active and the questionnaire 
lacked discrimination. There was no indication of a difference in activity patterns 
between supplemented and placebo groups.
4.7 Urine
A 24-hour urine collection was obtained from each subject at the three 
timepoints (baseline, outcome, and follow-up) for the determination of daily 
urinary output of minerals, markers of bone turnover. Urines were collected
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during the same week that bone measurements were made. All containers for 
urine collection and processing were acid-washed prior to use. Three two-litre 
plastic containers were provided for each collection, and taken to the subject's 
home. Verbal instructions were given to each subject about the collection with 
advice as to how to avoid contamination as far as possible. To preserve the 
urine, the subjects were provided with an insulated "cool bag" in which the urine 
bottles were surrounded by ice packs. Filled urine bottles were collected during 
the day and placed in the laboratory refrigerator. Urine samples were processed 
within a few hours of finishing the collection. Urine from the collection bottles 
was pooled and the total volume of urine collected from each child was recorded 
after thorough mixing. Two 20 mis aliquots were acidified with 200|llI 
concentrated hydrochloric acid (HOI spectrosol) and frozen at -20°C. . This 
method had been shown in previous studies to be successful in preventing the 
deposition of calcium-containing precipitates during storage (Prentice et a/.,
1995).
4.8 Blood sampling
A venous blood sample was collected from antecubital veins in each 
subject at the three timepoints (baseline, outcome and follow-up). Samples were 
taken at the MRC Keneba Laboratory (formerly MRC Dunn Nutrition Laboratory). 
All samples were collected by venepuncture after an overnight fast (6.30 a.m. 
and 7 a.m.) with the subject lying down. Approximately 10 ml blood were 
collected into a lithium heparin monovette and about 2.5 ml into an EDTA 
monovette, avoiding contamination as much as possible. The blood was kept 
cold throughout the collection on ice. Samples were spun in a refrigerated
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centrifuge and stored at -20°C and within 45 minutes after collection. They were 
transported to Cambridge and subsequently stored at -80°C.
4.9 Pubertal assessment
Pubertal status of subjects was assessed according to Tanner staging. 
The assessment of the pubertal status of the girls, based on breast (B) and pubic 
hair (P) development was carried out by a female paediatric consultant. The 
pubertal status of the boys was assessed by myself, and was based on genital 
(G) and pubic hair (P) development. For boys, Tanner stage I suggests pre­
puberty, stage II and III are regarded as early puberty, stage IV is advanced 
puberty, and stage V indicates the end of puberty. For girls, a pubertal growth 
spurt occurs as breast development reaches Tanner stage II.
However, because of the fact that most of the study children were 
prepubertal at the end of the study, subjects were grouped as either prepubertal 
or pubertal. For detail of the method used in this study, see appendix 6.
4.10 Dietary measurements
4.10.1 Weighed intake
Dietary intake at baseline was determined by 2-day direct-weighing in all
but one subject (Prentice etal., 1993). Subjects were visited several times in the 
day during the measurement period starting before breakfast and ending after 
evening meal. At each visit, all food items consumed and any leftovers were 
weighed and recipes for all dishes recorded. Consumption of snacks
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during and between meals was determined by recall at the next visit. 
Computation of nutrient intakes was carried out using “Gambian Dido” and 
‘MW1N4’ software programmes (Price & Thompson, 1995) based on McCance 
and Widdowson's food composition data (Paul and Southgate, 1978), 
supplemented by information on the composition of Gambian foods (Prentice et 
al., 1993). The additional information on dietary intake was achieved by 
analysing raw ingredients and cooked dishes, taking into account foods that are 
high in calcium but are either eaten in small quantity or infrequently, such as 
certain vegetables and a small type of fish which is eaten with bones (Prentice et 
al., 1993). Drinking water in Keneba has only a low concentration of calcium (10 
mg/L) (Prentice et al., 1995) and was not quantified. The calcium contents of 
typical Gambian foods are presented in appendix 7.
4.10.2 Food frequency questionnaire
Dietary intake assessment from weighed-records was supplemented with 
a calcium frequency questionnaire to give an insight into eating habits over the 
long-term, and covered the common calcium-containing foods consumed by the 
subjects. Examples were leaf sauce, baobab fruit and leaf on its own, fruits 
collected from the bush, milk, fresh and fermented locust bean (appendix 5).
100
Chapter 4 Materials and Methods
4.11 Bone mineral measurements
4.11.1 Single photon absorptiometry (SPA)
Measurements of bone mineral content (BMC), bone width (BW) and bone 
mineral density (BMC) at the mid-shaft and distal-radius of the left arm were 
made using single photon absorptiometry (Lunar SP2 scanner, Lunar Radiation 
Corporation 313 W. Beltline HWY, Madison, Wl 53713, U.S.A). Measurements 
were made on the left arm unless this had previously been broken, in which case 
the right was used. The region scanned was encased in a tissue equivalent 
mould.
The forearm measurement was made at the mid-shaft radius (33% or 1/3 
distal site on the ulna). This site was determined by measuring the distance 
between the mid-point of the ulnar styloid process and the proximal edge of the 
olecranon and marking the position which is 1/3 of this length from the ulnar 
styloid process. The instrument made three transverse scans across the forearm 
at the same position and the mean of the three scans was recorded.
The wrist measurement was made at the 5 mm distal site, defined as the 
site where the inter osseous (IO) space (distance between the radius and ulna) is 
5 mm. This site was identified by performing a rectilinear scan with a step 
distance of 1.5 mm and using the value where the IO space was closest to 5 mm 
but between 4 and 6 mm. For both the forearm and wrist scanning speed was 
1.0 mm/sec. The area scanned was encased in a tissue equivalent mould. The 
total set of scans took about 15 minutes to perform for each subject. Bone
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mineral content (BMC, g/cm for SPA) was expressed in grams and divided by the 
bone width (BW, cm) to derive the bone areal density (BMC) in g/cm2.
4.11.2 Calibration
The instrument was calibrated daily and the long term stability was 
assessed by measuring phantoms. The overall coefficients of variation over the 
study period for BMC, BW and BMC of the small phantom (BMC = 0.374 g/cm) 
were, 1.11%, 0.94%, and 0.82%, and of the large phantom (BMC = 1.196 g/cm) 
were, 0.52%, 0.41% and 0.53% respectively. These indicate good stability of the 
measurements over the entire study period.
Table 4.1 Mean and coefficient of variation for BMC, BW, and BMC of small and large
phantoms for 1210 individual measurements performed over the 24 months study period.
Mean CV(%)
Small
BMC (g/cm) 0.374 1.11
BW (cm) 0.860 0.94
BMC/BW (g/cm2) 0.435 0.82
Large
BMC (g/cm) 1.196 0.52
BW (cm) 1.423 0.41
BMC/BW (g/cm2) 0.841 0.53
4.12.1 Ultrasound measurements
Broadband ultrasound attenuation and velocity of sound of the left heel 
were assessed using computer-controlled bone ultrasonography of the 
calcaneum (CUBA Clinical, McCue, Parsonage Barn, Compton, Hampshire,
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S021 2AS, England). Measurements were performed with the subject’s heel 
positioned between two ultrasound transducers using a gel to ensure coupling 
between the heel and transducer. A complete series of measurements on each 
foot took approximately 5 minutes to complete. The results are given in velocity 
of sound (VOS), a measure of the quality of bone, and broadband ultrasound 
attenuation (BUA) a measure of the mineralisation of the bone (Brandenburger, 
1993; Miller etal., 1993, Moris et al., 1995). Normalised BUA (nBUA), i.e, which 
takes into account the width of the heel, and velocity of sound (VOS) were used 
in the data analysis in this study.
4.12.2 Calibration and quality control assessment
The instrument was calibrated daily as in SPA measurements and its 
stability assessed by measuring range of phantoms provided by the 
manufacturer.
Table. 4.2 Mean and coefficient of variation for VOS and BUA of all phantoms measured
over the study period.
Phantom Mean CV (%) no. of scans
Low BUA1t 39.8 1.26 881
Low BUA2 34.3 0.91 987
Low BUA3 26.7 1.51 438
Medium BUA 60.2 1.42 183
High BUA1 65.5 0.69 1209
High BUA2 58.5 0.61 78
Velocity (VOS)* 2723 0.40 1098
i Unit of broadband ultrasound attenuation (BUA) is dB/MHZ, *velocity of sound (VOS) is in metre/second 
(m/s).
Calibration of the instrument was performed 2 - 3  times weekly over the 
study period. Table 4.2 summarises the performance of the instrument over the
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36 month period. The results indicated that the machine had attained a 
reasonable stability during this period.
In vivo reproducibility of the instrument was also determined using a 
volunteer’s foot which was measured weekly. The coefficients of variation (CV) 
over the study period for VOS and BUA were, 0.65% and 2.10% for VOS and 
BUA respectively.
4.13. Comparative study
Comparative data were provided from a study conducted by Dr Mary 
Fewtrell in Cambridge. Subjects were 85 British (45 boys, 40 girls) children aged 
8.6 - 11.99 years living in Cambridge, UK. The subjects gave informed written 
consent to take part in the study. Bone measurements were made with a Lunar 
SP2 scanner (Lunar Radiation Corporation 313 W. Beltline HWY, Madison, Wl 
53713, U.S.A) at the same skeletal sites as for the Gambian children. Cross­
calibration of the two instruments was made using phantom materials in previous 
study (Prentice etal., 1995) and gave good agreement. In addition, weight and 
height measures in the two studies were compared.
4.14 Blood assays
These were conducted by staff of the Bone Indices Laboratory, MRC 
Human Nutrition Research, Cambridge (formerly MRC Dunn Nutrition 
Laboratory). Plasma samples for all three timepoints for each subject were 
analysed together in a randomised order in a single run to avoid bias. A similar 
method of analysis was used for biochemical markers in urine.
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4.14.1 Osteocalcin
Plasma osteocalcin concentration was determined using an 
immunoradiometric assay (N-TACT Osteocalcin, INCStar Corporation, Stillwater, 
USA). The method involved the addition of rabbit anti-bovine osteocalcin 
antibody and 125l bovine osteocalcin to the sample. The mixture was incubated at 
2 - 8°C overnight, washed several times with wash buffer, followed by the 
addition of a complex goat anti-rabbit serum, carrier rabbit serum and 
polyethylene glycol. The mixture was centrifuged and decanted after a 2 hour 
incubation at 2 - 8°C. The radioactivity present in the precipitate of each tube 
was measured using a gamma scintillation counter (1470 Wizard, Wallac Oy, 
TurKu, Finland). The concentration of osteocalcin present in the sample is 
inversely proportional to the radioactivity measured.
Between-run precision of the assay was 6% during the study period for a 
control sample with a concentration of 26 jig/L, measured on each occasion in 
duplicate.
4.14.2 Plasma Total Alkaline Phosphatase (TAP) and Bone Specific Alkaline
Phoshatase (BSAP)
Plasma immunoreactive bone specific alkaline phosphatase was 
determined using a precipitation method using lectin (Boehringer Mannheim 
Company). After the total alkaline phosphatase had been determined, bone- 
specific alkaline phosphatase precipitated using lectin supplied by the 
commercial kit from Boehringer Mannheim company. The enzyme activity was 
measured by colorimetry using a Cobas Bio centrifugal analyser (Roche 
Diagnostica, Switzerland).
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4.14.3 Parathyroid hormone (PTH)
Plasma intact parathyroid hormone was determined using an 
immunoradiometric (IRMA) assay (Incstar Corporation - Stillwater, Minnesota, 
USA). Only the intact PTH and PTH fragments contain the amino acid sequence 
(1 - 34) with biological activity. It is this active component of PTH that correlates 
with calcium nutritional status, and only the intact PTH was measured in this 
study. The Incstar intact PTH SP IRMA utilises 2 distinct polyclonal antibodies 
that have been purified using affinity chromatography. The purified antibodies 
are specific for 2 different regions of the PTH molecules. The first antibody is 
specific for 39 - 84 amino acid sequence and is bound to a solid phase 
(Polystyrene beads). The second antibody is specific for the amino acid 
sequence 1 - 3 4  and is labelled with 1251. Samples are incubated simultaneously 
with both antibodies. Intact PTH 1 - 8 4  contains both the 1 -34 and the 39 - 84 
amino acid sequences and hence will be bound by both the antibody bound to 
the solid phase and antibody labelled with iodine-125. Since the antibody 
coupled to the solid phase is specific for the C - terminal and mid-region 
fragments in addition to the intact PTH, the capacity of the solid phase is 
designed to accommodate high concentrations of PTH. This prevents 
interference with elevated C - terminal and mid-region PTH fragments in 
measured sample. After incubation, each bead is washed to remove any 
unbound labelled antibody. The radioactivity present in the remaining bound 
labelled antibody is measured using a gamma counter (Wallac, Finland). The 
concentration of intact PTH present in the sample is directly proportional to the 
radioactivity measured.
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4.14.4 Plasma Calcium (Ca), Inorganic Phosphorus (P), Albumin (Alb) and 
Creatinine
Plasma calcium, creatinine, and inorganic phosphate were measured by 
colorimetry using a Cobas-Bio centrifugal analyser (Roche Diagnostica, 
Switzerland). Blood creatinine was measured using a kinetic, buffered Jaffé 
method without deproteinisation where creatinine reacts with picric acid in 
alkaline solution to form a yellow-red coloured complex. The rate of colour 
formation is directly proportional to the creatinine concentration.
Plasma albumin was analysed using a specific immunonephelometric 
procedure on a centrifugal analyser (Cobas-Bio).
Plasma calcium concentrations were determined using the methyl thymol 
blue method. The blue-coloured chelate formed by the reaction of calcium ions 
with methyl thymol bluo is directly related to calcium concentration in the plasma. 
Because up to 80% of plasma calcium is bound to albumin in the blood, serum 
calcium was corrected for albumin content according to the method described by 
Willatts (Willatts, 1987).
Albumin-adjusted Ca concentration (mmol/L) = measured Ca concentration 
(mmol/L) + 0.1 mmol/l for every 4 g/l albumin below 36 g/l, or measured Ca 
concentration - 0.1 mmol/l for every 4 g/l albumin above 36 g/l.
Inorganic phosphate is measured using phosphomolybdate reaction in which 
phosphate ions react with ammonium molybdate In acid solution to form 
unreduced phosphomolybdate complex. The complex thus formed is determined 
by spectrophotometry.
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4.15 Urine assays
These were performed by staff of the Bone indices Laboratory, MRC 
Human Nutrition Research, Cambridge (formerly MRC Dunn Nutrition 
Laboratory).
4.15.1 Urinary Deoxypyridinoline (D-pyr)
Urinary immunoreactive free deoxypyridinoline crosslinks was measured 
by competitive enzyme linked immunosorbent assay (Pyrilinks-D, Metra 
Biosystem mountain view, CA, USA) using an ELISA (cups) technique. The 
method is a competitive enzyme immunoassay, and utilise a monoclonal anti- D- 
pyr antibody coated on a microtitre stripwell to capture D-pyr. D-pyr in the 
sample competes with conjugated D-pyr -alkaline phosphatase for the antibody 
and the reaction detected with a p-nitrophenyl phosphate substrate. The results 
were expressed as a ratio to urinary creatinine concentration.
Samples, standards and controls were diluted by 1:10 prior to assay. 50 
pi diluted standards, controls and samples were then added to strips coated with 
the anti-D-pyr antibody, 100 pi of the reconstituted enzyme conjugate was added 
to each well. The strips were incubated for 2 hours at 2 - 8 °C in the dark. The 
strips were washed three times, 150 pi of the substrate solution was added and 
incubated for another 60 minutes at room temperature. This was followed by 
adding 100 pi of stop solution to each well, and the optical density of each well 
was measured in a microplate reader at a wavelength of 405 nm.
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4.15.2 Creatinine (Or), Calcium (Ca) and Inorganic phosphorus (P)
The concentration of creatinine, calcium, and inorganic phosphate in urine 
were assayed by colorimetric methods (Cobas-Bio) using centrifugal analyser 
kits (Roche Products, Welwyn Garden City, Uk.). The methods used for 
determination of urinary creatinine, calcium, and phosphorus were the same as 
those used for their blood counterparts.
4.15.3 Sodium (Na) and potassium (K)
Urinary sodium and potassium were measured by flame photometer (IL 
943 Flame Photometer, Instrumentation Laboratory, Italy). In a flame photometric 
measurement, when a substance is exposed to a high temperature, it becomes 
excited through thermal collision. In the excited state, sodium and potassium 
atoms emit light with a characteristic set of wavelengths. The intensity of the light 
emitted is directly proportional to the number of atoms undergoing the transition. 
The method allows the concentration of Na and K in a sample to be measured 
directly against a standard solution.
In this study, all urines were diluted prior to analysis using 1% 
hydrochloric acid. Samples were thoroughly mixed and allow to stand for 5 
minutes until all the sediment had settled. 250 pi of the diluted urine was 
measured by flame photometry. Quality-assuranee materials (Lyphochek Normal 
Urine Control, Bio-Rad, Anaheim, CA, Roche Control Serum N, Roche controls, N 
& P, Switzerland) were included with all batches of samples to monitor precision 
and accuracy. All values of the controls used in blood and urine assays were 
within the expected range.
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5.1 Single photon absorptiometry
The principle of absorptiometry is based on the exponential attenuation of 
penetrating photons as they pass through tissue or similar medium (Cameron & 
Sorenson, 1963; Mazess, 1971; Wahner et al., 1983; Prentice et al., 1994). 
When a monochromatic beam passes through a region of the body consisting of 
two tissues, the intensity of the emerging beam is related to the initial intensity as 
follow:
I f # . )  = - (1)
Where I = final intensity, lo = initial intensity, pa =mass attenuation coefficient of 
tissue a, ma = mass of tissue a, = mass attenuation coefficient of tissue b, mb = 
mass of tissue b. The mass attenuation coefficients are constant that are 
characteristic of the tissues at the energy of the photon beam.
The technique of single photon absorptiometry (SPA) was first described 
by Cameron and Sorenson (Cameron & Sorenson, 1963). With this method, 
bone mineral content is determined by measuring the transmission of a 
monoenergetic photon beam from I125 (27.5 keV) through bone and soft tissue. 
The amount of mineral in the path of the photon beam is related to the 
transmission rates l*0and I according to the equation below.
mB=_e6!nti^ !l 
(M-bPb - UbPs)
In this equation, mB is the mass of mineral per unit area (g) in the path of the 
photon beam, \Lq and p8 are the mass absorption coefficients (cm2/g) of bone 
mineral and soft tissue, respectively, and pBand pe are their densities. I*0is the
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beam intensity through tissue outside the bone, and I is the beam intensity after 
passage through bone and tissue.
5.1.1 Radiation dose
The measurement of bone mineral using single photon absorptiometry 
involves exposure of the subject to small amounts of ionising radiation (I125 
gamma-rays) with a maximum strength of 7.4 Gbq (200 millicurie, (mCi)) and a 
half life of six months. Effective doses for children, which take account of the 
vulnerability of different tissues to radiation and the penetrating power of the 
specific radiation energies used for a set of mid-shaft and wrist measurements 
were calculated to be 0.04 pSv (Dr Philip Dendy, personal communication). The
maximum ED for each subject can be compared to typical effect dose of natural 
background radiation in the Cambridge area (ED = 6 - 7  pSv/day), which is likely 
to be lower than that in The Gambia, or to a return transatlantic flight in a jet 
aircraft (ED = 80 pSv), or a standard AP x - ray film of the lung (ED = 50 pSv) 
(Kalender, 1992).
Table. 5.1.1 Effective dose for shaft and distal radius for both children and adults are
presented.
Adult
p,Sv
Infant
p,Sv
Mid-shaft (3 X1 line scan)
Wrist 5 mm site (5X1 line scan) 
Total 0.27
0.09
0.18
0.54
0.54
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5.1.2 Expression of bone mineral measurements
The basic principle of absorptiometric measurements depends on the 
attenuation of beam of penetrating gamma or x-ray energy photons across the 
scan region. The attenuation between bone edge is converted into bone mass 
using calibration materials supplied by the manufacturer.
Bone mineral measurements are commonly expressed as bone mineral 
content (BMC) and bone mineral density (BMD). However, BMC has more than 
one unit and has different interpretation depending on the method used. In 
single photon absorptiometric (SPA) measurement, BMC is defined as bone 
mineral content (BMC) per unit length of bone and the unit is g/cm. In contrast, in 
dual energy x-ray absorptiometric method, the results are expressed as bone 1 
mineral mass per area scanned and the unit is in gm. This is also called BMC. 
There have been suggestions that the latter should be called bone mineral mass 
(BMM) instead of bone mineral content (BMC), to distinguish between the two 
methods (Jonson, 1993), but the term is yet to be adopted widely.
The other variable commonly used in absorptiometric measurements is an 
areal bone mineral density (BMD, g/cm2) expressed as the amount of mineral 
(grams) divided by bone width (BW, cm) for SPA, and bone area (BA, cm2) for 
DXA. These BMD values are not true volumetric density but areal density 
measurements because absorptiometry cannot measure the depth of bone in the 
scan path. Secondly, the technique is unable to distinguish between bone and 
other tissues within the area regarded as bone (Prentice etal., 1994).
Expression of bone mineral measurements as BMD provide information 
about differences in bone size between individuals, comparison of individuals
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with reference populations (Prentice et al., 1994, Jonson, 1993), and is a useful 
index in the assessment of fracture risk between individuals of different bone and 
body sizes in the clinical setting.
Expression of bone data as BMD assume that BMC is directly proportional 
to BMD multiplied by BW, in other words that BMC = k.BMD where k is a constant 
called BW. However, there is no evidence that BMC is directly proportional to 
BW, as an increase in BMC is not matched by an equal increase in BW. In many 
studies, a significant association exists between BMD and BW, showing that the 
calculation of BMD does not completely correct the variation in BMC due to 
differences in BW (Prentice etal., 1994).
The relationship between BMC and BW is rather complex and depends on 
the population and the skeletal site measured. When BMC is not directly 
proportional to BW, differences in BMD between individuals within a population 
will be partly due to differences in bone size between individuals. Therefore use 
of BMD in this case will lead to spurious associations of BMD with other variables 
such as calcium, grip strength and age, as each of these variables relates with 
BMC. A procedure to minimise such problems is to adjust BMC for BW, body 
weight and height using multiple regression models (Prentice et al., 1994). 
Correct adjustments for bone and body size are important in evaluating the 
relative BMC for size, otherwise using BMD could result in errors of interpretation, 
particularly the possibility of reporting artifactual relationships with other size- 
related variables (Cole & Prentice, 1992; Prentice etal., 1994).
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The coefficients and SB’s of the relationships between BMC and BW 
(bone variables were converted to natural logarithms and multiplied by 100) for 
shaft and distal sites, calculated using baseline data obtained during the study 
are shown in Tables 5.1.2a and 5.1.2b below.
Table. 5.1.2a Coefficient and SB's for the regression of InBW on InBMC for the
two sites measured at baseline, for all subjects, boys and girls separately.
all subjects (n = 160) Boys (n = 80) Girls fn = 80)
coefficient SB coefficient SB coefficient SB
shaft 1.29" 0.09 1.24" 0.12 1.35" 0.13
wrist 1.81" 0.13 1.71" 0.18 1.90" 0.20
Correlations of BMC and BW were; shaft, all subjects, r = 0.76, boys, r = 0.75, girls, r = 0.76; wrist, all 
subjects, r = 0.74, boys, r = 0.74, girls, r = 0.74. All correlations were significant at p50.0001. Significance of
difference of power coefficient from 1 (t = [coefficient - 1J/SE) a p^0.0001
The variables BMC and BW were converted to natural logarithms to 
investigate proportional differences. Analyses were performed using multivariate 
regression analysis of In BMC against In BW (Data Desk 4.1).
There was a highly significant correlation between bone mineral content 
(BMC) and bone width (P<0.0001). At both sites, the coefficient of the regression 
of In (BMC) on In (BW) was significantly different from one (Table 5.1.2a) 
indicating that BMC was not directly proportional to BW but was proportional to 
BW raised to power 1.3 (mid-shaft) and 1.8 (wrist). Thus in this study full 
correction for BW was performed in regression models since BMD would not 
have removed the interference of bone size completely.
Some studies have used body mass index (weight/height2) to adjust bone 
measurements by single photon absorptiometry, dual photon absorptiometry,
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and dual energy x-ray absorptiometry in an attempt to normalise bone mineral 
data (Elders et al.t 1989b; Pocock et a/., 1989; Murphy et al, 1994). However, 
concerns have been raised about the appropriateness of adjusting bone mineral 
for BMI (Cole & Prentice, 1992), because many studies have shown that 
measurements of BMC and BMD are positively and independently, correlated 
with body weight and height (Nilas et al., 1986; Prentice et al., 1991). This 
suggests that BMC and BMD are predicted by body size and not by adiposity. 
Therefore use of BMI when adjustment for body size is required could lead to 
dubious relations appearing or genuine relations being obscured. It has been 
suggested that both BMC and BMD should be adjusted for both weight and 
height independently in a multiple regression (Cole & Prentice, 1992).
Table 5.1.2b Coefficient and SB’s for regression of weight and height on BMC
for mid-shaft and distal radius measured, at baseline for all subjects and boys
and girls after adjusting for BW.
All subjects Boys Girls
coefficient SE coefficient SE coefficient SE
shaft
weight 2.88" 0.32 0.85" 0.12 0.71" 0.11
height 2.22" 0.23 2.25" 0.35 2.17" 0.32
distal
weight 1.13® 0.10 1.26" 0.14 1.05" 0.14
height 2.78" 0.31 3.03" 0.44 2.59" 0.43
a
All data were transformed to natural logarithms prior to analysis. p^0.0001 for relationship with BMC.
To overcome problems associated with the use of BMD and to carry out 
comparisons between groups of different size, a statistical model has been
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developed at MRC Human Nutrition Research (formerly MRC Dunn Nutrition 
Unit) in Cambridge for the analysis of bone mineral data from absorptiometric 
measurements (Prentice et a/., 1994). In this model, adjustment for bone and 
body size is achieved by entering bone width, body weight and height as 
independent variables in multiple regression models with bone mineral content 
(BMC) as the dependent variable, non-significant variables are removed by 
backwards elimination.
The advantage of this approach is that no assumptions are made about 
the nature of the relationship between BMC and those variables that are related 
to size. The method is equally applicable to bone mineral density provided that 
bone width is use in the model as independent variable.
5.2. Ultrasound
In ultrasound measurement, one transducer, a transmitting transducer is 
electrically excited to produce a broadband spectra. The ultrasonic wave is 
transmitted through the heel, which is detected by a receiving transducer - the 
second transducer and digitised for computer analysis (Gluer etal., 1994; Hans 
etal., 1994; Jonson, 1993). The two parameters of interest were, BUA and VOS. 
The VOS (m/s) is the velocity of the ultrasonic wave as it passes through the heel. 
The BUA (dB/MHZ) is a measurement of the frequency-dependent attenuation of 
the ultrasonic wave as it passes through the heel (Kann et al., 1995). The 
measured BUA and VOS are compared with the reference BUA and VOS 
provided by the manufacturer, expressed as mean value for the young normal 
and age-matched reference populations.
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The measurement of broadband ultrasound attenuation provides 
information about trabecular bone status. A low broadband ultrasound 
attenuation (BUA) of the calcaneus has been demonstrated in patients with wrist 
and spine fracture compared to controls (Agren et al., 1991; Bernecker et al., 
1992, McCloskey etal., 1990, Resch etal., 1990). Similar low ultrasound values 
were reported in individuals with hip fracture when compared with normal 
population (Baran etal., 1988; Stewart etal., 1994; Sakata et al., 1994; Schott et 
al., 1995). Most traditional bone densitometer techniques estimate bone mineral 
density which accounts for about seventy percent of bone strength. However, 
fragility of bone relates not just to density of bone, but also with bone quality 
(Brandenburger, 1993; Moris et al., 1995). Qualitative ultrasound provides 
information on bone architecture and quality (Brandenburger, 1993).
The calcaneum is an easily accessible site and is rich in trabecular bone 
which develops with age paralleling trabecular bone growth lumbar vertebrae 
(Miller etal., 1993). Bone ultrasound parameters have been shown to have a 
negative correlation with age in both males and females (Moris et al., 1995). 
Studies comparing bone ultrasound and bone densitometer techniques such as 
DXA in assessing bone status have demonstrated good agreement between the 
two methods (Moris etal., 1995; Stewart etal., 1994; Mautalen etal., 1995). In 
the study of Moris et al., the significance of correlation between BUA and dual x - 
ray absorptiometry (DXA) of the lumbar spine was, R = 0.67, p< 0.01 for SOS, R = 
0.57 p< 0.02 (Moris et al., 1995). An association was also found between 
velocity of sound (VOS), broadband attenuation (BUA) and stiffness of the left
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and right foot in healthy volunteers (Moris et al.t 1995). Quantitative ultrasound 
(QUS) techniques have recently been introduced as possible alternative 
methods free of ionising radiation for noninvasive assessment of skeletal status 
in osteoporosis (Heaney, 1989; Baran etal., 1988; Langton etal., 1984; Antich et 
al., 1991; Kaufman & Einhorn, 1993; Hans etal., 1993; Smith etal., 1992).
5.3 Statistical analyses
5.3.1 Significance tests
A significance test makes it possible to measure the strength of evidence 
which the data supply for or against some proposition of interest. For example, in 
this study, testing the effect of supplement on bone mineral acquisition, one could 
test the questions, would children have more bone mineral accretion while 
receiving supplement, and will bone mineral acquisition be different between 
boys and girls?
In a significance test, we ask the question whether differences in bone 
mineral mass at outcome between the supplemented and placebo groups; 
between boys and girls, etc., were small enough to have occurred by chance. If it 
were the case, then the evidence in favour of there being a difference between 
the supplemented and placebo groups or between boys and girls would be 
weak. On the other hand, if the difference between the groups were much larger 
than one would expect the evidence that there is a real difference between the 
calcium and placebo group or between boys and girls becomes strong.
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To carry out the test of significance we need to assume that there is no 
difference between the supplemented and placebo groups or between boys and 
girls. The hypothesis of ‘no difference’ or ‘no effect’ is called the null 
hypothesis. This is compared with the alternative hypothesis of a difference 
between supplement and placebo groups or between boys and girls. If the 
difference between groups is large (P <0.05) the null hypothesis that there is no 
difference between supplemented and placebo or between boys and girls is 
rejected. If on the other hand, the difference is small (p>0.05) the data are 
consistent with the null hypothesis, that there is no difference between the 
groups. The test of significance of the null hypothesis of no difference is based 
on the t-distribution.
5.3.2 Student’s t-test
The student’s t-test is commonly used in statistical analysis to compare two 
groups or sets of observations, for example, comparing supplemented and 
placebo groups, boys and girls etc. To use this test, it requires that a probability 
level is chosen which measures the degrees of freedom of the variance estimate. 
The Student’s t-test is a parametric test, which is based on the assumption that 
each set of observations is sampled from a population with a normal distribution 
(Bland, 1987). In this study, 2-tailed t-tests were used to examine differences 
between supplemented and placebo groups, and between boys and girls.
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5.3.3 Pearson product-moment correlation
The product-moment correlation measures linear association between two 
variables, how one changes with the other. The correlation coefficient r 
describes the closeness of the relationship between two variables. The 
correlation coefficient is based on the sum of products about the mean of the two 
variables. In this method, a positive correlation between two variables exists if 
the increase in one variable, follows the increases in the other. If one variable 
decreased as the other increased, the sum of the products is negative, this 
indicates there is a negative correlation between the variables. When two 
variables are not related the correlation produces a scatter, there are as many 
positive as negative products, and the sum is zero. This means there is no 
correlation between the variables. The value of the sum of products depends on 
the units in which the two variables are measured. The sum of the products is 
divided by the square roots of the sums of squares of x and y. This gives the 
product moment correlation coefficient, or correlation coefficient, denoted by r. 
The effect of dividing the sum of products by the root sum of squares of deviations 
of each variables is to make the correlation coefficient lie between -1.0 and +1.0. 
When all the points lie exactly on a straight line such that y increases as x 
increases, r = 1. Similarly, when all the points lie exactly on a straight line with 
negative slope, r = -1.
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5.3.4 Regression Analysis
Comparisons of percentage increases and absolute increases in BMC,
BW and BMD and body size (weight and height) between the supplemented and 
placebo groups and between boys and girls were examined using a multiple 
regression approach. Multiple regression analysis using backward elimination 
method to remove nonsignificant variables was performed to identify 
determinants of bone mineral content. Baseline values of the independent 
variable were included in regression model to adjust for regression toward the 
mean, except when the influence of BMC itself was examined; To examine the 
effects of supplement, sex and season, dummy binary variables were used as 
follows; female = 1, male = 0; supplement = 1, placebo = 0; wet/dry variables 
were coded as w = 1, d = 0. This test make the assumption that the associations &
between y-variable and each of the x-variables are linear and that the data are 
normally distributed (Bland, 1987). All continuous variables except age, sex and f
pubertal status in this study, were transformed to natural logarithms. Conversion i
to natural logarithms is a convenient way of expressing proportional differences 
between groups (Prentice et al., 1990). For example, differences between 
supplemented and placebo groups or between boys and girls. Transformation of 
variables to natural logarithms in regression analysis has the added advantage 
that the regression coefficients provide information in proportional terms about 
the influence of each factor on the dependent variable. If the coefficient for 
discrete, binary variables is multiplied by 100, this approximates to the 
percentage difference between the two groups as defined by
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(difference/mean)x100 (Prentice etal., 1994). The level of significance used in 
this study was <0.05.
Examples of regression analysis models set up to investigate the effect of 
bone width (BW) and sex on bone mineral content (BMC) at the midshaft are 
given below:
Fig.5.1 data untransformed
Dependent variable is: sbmc
No Selector
R squared = 57.9% R squared (adjusted) = 57.4%
s=  0.0561 with 1 6 0 - 3  = 157 degrees of freedom
Source Sum of Squares df Mean Square F- ratio
Regression 0.681016 2 0.340508 108
Residual 0.494725 157 0.003151
Variable Coefficient s.e. of Coeff t- ratio prob
Constant -0.1090 0.0387 -2.81 0.0055
sbw 0.5694 0.0389 14.6 <0.0001
Sex 0.0021 0.0089 0.237 0.8132
Fig. 5.2 data transformed to natural logarithms
Dependent variable is: Lnsbmc
No Selector
R squared -  57.6% R squared (adjusted) = 57.0%
s = 0.1314 with 1 6 0 - 3 = 157 degrees of freedom
Source Sum of Squares df Mean Square F- ratio
Regression 3.67877 2 1.83939 106
Residual 2.71237 157 0:017276
Variable Coefficient s.e. of Coeff t- ratio pr ob
Constant -0.7834 0.0149 -52.7 < 0.0001
Lnsbw 1.2928 0.0892 14.5 <0.0001
Sex 0.0027 0.0209 0.131 0.8959
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Fig. 5.3 data transformed to natural logarithms and multiplied by 100
Dependent variable is: 100*lnsbmc
No Selector
R squared = 57.6% R squared (adjusted) = 57.0%
s = 13.14 with 1 6 0 - 3  = 157 degrees of freedom
Sour ce Sum of Squares df Mean Square F- ratio
Regression 36787.7 2 18393.9 106
Residual 27123.7 157 172.762
Var iable Coefficient s.e. of Coeff t- ratio pr ob
Constant -78.3413 1.487 -52.7 <0.0001
100*lnsbw 1.2928 0.0892 14.5 <0.0001
Sex 0.2743 2.094 0.131 0.8959
In example (i) above,
BMC = 0.57 BW + 0.002 sex + constant
This shows that a 1 cm difference in bone width corresponds to a 
difference in mid-shaft BMC of 0.57g/cm. The constant is the value of intercept 
and value for boys is 0.002 g/cm higher. To interpret this finding requires 
knowledge of typical values of BMC for this age group of children. In this 
example, there was no evidence of a sex difference in BMC adjusted for BW (p = 
0.81).
(ii)
LnBMC = 1.29 LnBW +0.003 sex + constant
This means a 1 % change in BW corresponds to a 1.29% change in BMC 
at the mid-shaft and this result could be interpreted directly without knowledge of 
units or typical values. The intercept for boys is 0.003 times higher than girls, but 
no sex difference in size-adjusted BMC was found (p = 0.90),
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(iii)
LnBMC = 1.29 LnBW + 0.27 sex + constant
In example (iii) below, the interpretation for BW and constant is the same 
as (ii), but the difference between boys and girls is expressed as a percentage. 
Therefore, for the same BW, boys have 0.3% more bone mineral content than 
girls.
5.3.5 Analyses of variance (ANOVA)
A two-way analysis of variance (ANOVA) test is used to examine whether 
more than two groups have the same mean or not. ANOVA is a parametric 
method based on the assumption that samples are from normally distributed 
populations and have the same underlying variance. In this study, a two-way 
analysis of variance test was used to test the effects of sex group and treatment 
effect (calcium or placebo) and their interaction on the variance of the net gains 
as well as percentage gains in bone measurements and weight and height. The 
principle of this test is based on the same concept as that described above 
(significance of test), that is the null hypothesis that there is no difference 
between the groups (between supplemented and placebo, between boys and 
girls). The p value for the two-way analysis of variance shows the probability of 
observing an F value as large as the one observed if the null hypothesis is true. 
A small p value indicates it is unlikely that the F values observed occur by 
chance. The test used to compare pairs of groups considered in the study was 
the Scheffé post-hoc test, which allows the interpretation of significant variation
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between the means of two; three or more groups, for example, comparing one 
group with a number of other groups. Multiple testing is subjected to a high 
probability of giving false positive results (Type 1 errors) due to chance. Scheffé 
post-hoc tests have the advantage of controlling and minimising type 1 error. In 
this study, type 1 error was set at the limit of 5%.
5.3.6 Chi-Squared Distribution
The Chi-squared test is a non-parametric method used to test the degree of 
association between two variables in which results are tabulated. For example, a 
cross tabulation of frequencies and is called contingency table or cross­
classification. The test can be used even when the observations are not 
measurements but ranking of the experimental material. For example, by testing 
the strength of a particular drug in a clinical trial by comparing the treatment and 
control groups. In a Chi-square test, the null hypothesis is that there is no 
association between the two variables, the alternative being that there is an 
association. It requires that the data are from a normal distribution.
5.4 Effect of calcium supplement
The effect of the calcium supplement on bone mineral variables and 
biochemical markers at outcome were examined after correcting for differences 
at baseline. The basic model was In(outcome) = k + In(baseline) + s/p (1/0). 
Interaction terms between s/p (s = supplement, p = placebo) and age, sex, and
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pubertal status were tested by including s/p multiplied by the variables in the 
regression model but none were significant.
In this study, differences in BMC, BW, and BMD, and differences in 
anthropometric variables and biochemical markers were expressed as percent 
change in calcium supplemented minus percent change placebo from baseline 
to outcome and followrup. A similar method was used to express differences 
between boys and girls.
There were no significant differences in subject characteristics or bone 
variables between boys and girls at baseline, except that girls had significantly 
greater triceps skinfold thickness (1.6 (SE 0.3), p<0.0001) (Table 7.5). The effect 
of supplement was therefore examined with sexes combined.
5.5 Supplemented and placebo groups by sex
The effect of calcium supplement on bone variables and biochemical markers 
disappeared when data were grouped by sex, reflecting the decrease in power 
associated with splitting the data by sex. The effect of the supplement on 
variables were therefore examined, with sexes combined. A supplement x sex 
interaction term was included in all regression analyses to examine whether 
there was any evidence that the effect of the supplement was different between 
boys and girls.
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6 Results: Dietary intake
6.1.1 Calcium and phosphorus intake
The calcium intake of the children was low. The arithmetic mean of 
calcium intake was 338 SD 141 mg/d (8.45 SD 3.53 mmol/d), phosphorus 834 
SD 310 mg/d (26.9 SD 10 mmol/d), and calcium-to-phosphorus ratio, 0.42 SD 
0.12 (Table 6.1 and 6.2). The calcium-to-phosphorus ratio of the Gambian diet 
was substantially lower than that reported in United Kingdom diet (0.7 mg/mg) 
(Department of Health, 1992).
6.1.2 Sex difference
Table 6.1 gives calcium and phosphorus intakes and calcium-to- 
phosphorus ratio in boys and girls. There were no significant differences in 
calcium and phosphorus intake between boys and girls. Calcium-to-phosphorus 
ratio of the two sexes were identical (boys: = 0.42 SD 0.12 mg/mg, girls = 0.42 
SD 0.13 mg/mg).
Table 6.1 Dietary calcium and phosphorus intake and calcium-to-phosphorus 
ratio for all subjects, and for boys and girls at baseline1
Total_______  Boys_______  Girls_______
(159) (n = 79) (n = 80 )
Calcium (mg/d) 338 ± 141 355 + 160 321 ± 118
Phosphorus (mg/d) 834 ± 310 863 ± 307 807 ± 312
Ca:P (mg/mg) 0.42 ±0 .12  0.42 ±0.11 0.42 ±0 .13
f Mean ± SD. No significant difference between the groups in any of the variables, mg/d to mmol/d: calcium 
40; phosphorus h- 31.
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6.1.3 Effect of age on intake of calcium and phosphorus
Dietary phosphorus intake was significantly negatively related to age (p = 
0.018) but there was no significant association between calcium intake and age. 
Differences between sexes and supplement effect on phosphorus intake were 
therefore examined after adjusting for age.
6.1.4 Differences between the supplemented and placebo groups
There were no significant differences in calcium and phosphorus intake or 
calcium-to-phosphorus ratio between the supplemented and placebo groups at 
baseline (Table 6.2).
Table 6.2 Calcium and phosphorus intake and calcium-to-phosphorus ratio for all 
subjects, and for supplemented and placebo groupt.
Total Supplement Placebo
(n = 159) (n = 79) (n = 80)
Calcium(mg/d) 338 ±141 342 ± 129 334 ± 1 5 3
Phosphorus(mg/d) 834 ± 3 1 0 825 ± 289 844 ± 330
Ca:P (mg/mg) 0.42 ±0.12 0.43 ±0.12 0.41 ±0.1
tMean ± SD. mg to mmol/d calcium + 40, phosphorus 
groups in any of the variables.
+ 31. There was no significant difference between the
6.1.5 Additional calcium intake from the supplement
The additional intake of calcium from the supplement after taking account 
of compliance and the fact that the tablets were provided on 5 days each week 
was 714 mg per day (17.85 mmol/d) spread over the entire supplementation 
period. Calcium supplementation raised the total calcium intake of the 
supplemented group from 342 to 1056 mg per day (8.55 to 26.4 mmol/d) during
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the 12 months as compared with 334 mg per day (8.35 mmol/d) in the placebo 
group.
6.1.6 Intake of other nutrients including sex differences
The intakes of other nutrients for all subjects, and for boys and girls 
separately are given in Table 6.3. The results indicate the Keneba children had 
a low fat but a moderate protein intake. Fat intake was negatively related to age 
(-7.7 (SE 2.1) p = 0.0004) but none of the other nutrient intakes were influenced
by age. Boys had a significantly higher intake of calories, protein, fat and 
carbohydrate than girls.
Table 6.3 Nutrient intakes for all subjects, divided by sex at baseline1
Total
(159)
Boys 
( n = 79)
Girls 
(n = 80 )
Energy (kcal/d) 1763± 447 1867 ± 463a 1662 ± 4 0 7
Protein (g/d) 55.4 ± 16.6 58.1 ±  17.8" 52.8 ± 15.0
Fat (g/d) 38.0 ± 26.0 40.9 ±  29.4" 35.3 ± 22.9
CHO (g/d) 326.2 ± 75.9 345.3 + 71.6" 307.3 ± 75.7
tMean ± SD. CHO, carbohydrate. a*bcd Significantly different between sexes after adjusting for age 
(regression - data desk 4.1), a p = 0.007, bp = 0.020, Cp = 0.034, d p = 0.018. kcal to kJ, multiply by 4.18.
6.1.7 Differences between the supplemented and placebo groups in the intake of 
other nutrients
There was no significant difference between the supplemented and 
placebo groups in the intake of other nutrients (Table 6.4).
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Table 6.4. Nutrient intake for all subjects, and for supplemented and placebo
groups at baseline*
Total 
(n = 159)
Supplement 
(n = 79)
Placebo 
(n = 80)
Energy (kcal/d) 1763 ±4 47 1756 ±418 1771 ±  476
Protein (g/d) 55.4 ± 16.6 55.5 ± 15!5 55.3 ±17 .7
Fat (g/d) 38.0 ± 26.4 37.3 ± 23.6 38.8 ± 29.0
Carbohydrate (g/d) 326.2 ± 75.9 326.9 ±72.1 325.5 ± 79.9
tMean ± SD. kcai to kJ, multiply by 4.18
6.1.8 Distribution of calcium intake
The distribution of calcium intake was slightly positively skewed. This was 
caused by the calcium intake of one subject, which averaged 984 ± 1066 mg/d 
(24.6 ± 26.7 mmol/d) and varied from 230 mg/d (5.8 mmol/d) on one day to 1737 
mg/d (43.4 mmol/d) on the following day. This was due to the consumption on 
day 2 of an exceptionally calcium-rich dish of millet (sanyo) steamed with dried 
baobab leaf (naa) and small fish eaten with bones. Otherwise, there was 
reasonable agreement between measurement of calcium intake for the rest of the 
children on the two days.
The geometric mean of calcium intake for the group as a whole was 311 
mg/d (7.78 mmol/d). The mean ±  SD of loge was 5.74 ± 0.40.
6.1.9 Major foods sources of calcium
In this study, dark green leaves were the major source of calcium and 
contributed 29.4% to the mean daily calcium intake (Fig. 6.1). The other major
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calcium providers were cereals, fish and groundnuts which contributed 24.7% (of 
which rice provided 15.8%), 16.8%, and 15.9%, respectively to the daily calcium 
intake. Milk provided only 5.7% of the mean calcium intake.
Fig. 6.1. Percentage contribution of major foods to the mean daily calcium intake
5.7%
Although milk and fish were the most calcium rich sources in the diet of the 
rural Gambia children, milk was very rarely consumed and therefore contributed 
little to the mean daily calcium intake. Leaf sauces, including those made from 
dried baobab leaves (naa), contributed more calcium to the diet than any other 
food items. This is because many of the meals included leaf sauces and 
traditional leaves sauces are rich in calcium. Cereals together (rice, sorghum, 
millet, maize, findo) represented the second highest calcium source of the diet. 
Salt in cooked rice provides most of the calcium in rice dishes. Although, the 
calcium content of these items is low compared with green leaves, fish and milk,
15.8%
8.9%
Leaves
Fish
Groundnuts
Rice
Other cereals
Others
Milk
15.9%
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cereals form a large part of the diet and they are the main staple foods of this 
community.
6.1.10 Seasonal variation in calcium and phosphorus intake
Calcium and phosphorus intake of subjects in the two seasons (dry and 
wet season) were compared. The wet (rainy) season begins in July and ends in 
October and the dry season extends from November to June. The mean calcium 
and phosphorus intake did not differ between seasons (Dry season : Wet 
season, calcium: 344 ± 137 vs 331 ± 1 4 7  mg/d (8.6 ± 3.43 vs 8.28 ± 3.68 
mmol/d); phosphorus: 860 ± 247 vs 803 ± 372 mg/d (27.74 ± 7.97 vs 25.90 ± 
12.00 mmol/d).
6.1.11 Differences between supplemented and placebo groups and 
between boys and girls
There were no significant differences between either the supplemented 
and placebo groups or between boys and girls in the intake of calcium and 
phosphorus in the dry or wet season, nor was there an effect of season on 
calcium and phosphorus intake in either sex or supplement group (Tables 6.5 
and 6.6).
Table 6,5 Calcium and phosphorus intake for all subjects, divided by boys and girls and
by season.
Bovs Girls
Total 
(n = 15)
Dry season 
(n = 44)
Wet season 
(n = 35)
Dry season Wet season 
(n = 44) (n = 36)
Calcium(mg/d) 338 ±141 368 ±160 338 ±161 319 ± 104 325 ±135
Phosphorus (mg/d) 834 ±310 886 ±258 834 ± 361 834 ±237 773 ± 386
tMean ± SD. There was no significant difference between the sexes in any of the variables, mg/d to mmol/d: 
calcium + 40; phosphorus + 31.
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Table 6.6 Calcium and phosphorus intake by the supplemented and placebo groups,
divided by season.
_______ Dry season______  Wet season_______
Total Supplement Placebo Supplement Placebo
(n = 159) (n = 44) (n = 44) (n = 35) (n = 36)
Calcium(mg/d) 338 ±141 347 ±136 340 ±139 336 ±122 326 ±170
Phosphorus (mg/d) 834 ± 310 852 ±258 869 ±239 791 ± 326 814 ± 417
Mean ± SD. There were no significant differences between the groups in any of the variables in either 
seasons, mg/d to mmol/d: calcium + 40; phosphorus + 31.
6.1.12 Seasonal variation in calcium sources
Table 6.7 gives the proportion of calcium contributed by different food 
sources in the wet and dry season by the subjects. There was a seasonal 
variation in the types of food contributing to calcium intake. Leaves were 
abundant in the wet season and were consumed in greater quantity in the wet 
season but the difference between seasons did not reach significance (leaves, 
wet vs dry, 33% versus 28%, NS, Chi-squared test). Milk consumption was 
similar in the two seasons but was slightly raised in wet season. This may have 
been due to the fact that cows yield more milk in the rainy season when there is 
plenty of fresh green grass compared with the dry season (milk, wet : dry, 6.8%  
versus 4.8%, NS). On the contrary, groundnuts were harvested during the early 
part of the dry season and their contribution to the daily calcium intake in the dry 
season was two-fold higher than in the wet season (groundnuts, dry:wet, 18% 
versus 9%, p<0.0001, Chi-squared test). A similar amount of fish was eaten in 
the wet and the dry season (dry : wet, 16% versus 18% NS). Rice was consumed
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throughout the year and its intake was also not significantly different between the 
seasons (dry : wet, 15.5% versus 15.9%)
Table 6.7 Seasonal variation in calcium sources1
Foods Total Dry season Wet season
Leaves 30.5 28.0 33.0
Rice 15.7 15.5 15.9
Groundnuts 13.5 18.0
oO)
Other cereals 9.5 8.0 11.0
Fish 17.0 16.0 18.0
Milk 5.8 4.8 6.8
Others 8.5 9.0 8.0
f % of total calcium intake. Dry season significantly different from wet ap<0.0001 (Chi-squared test)
6.1.13 Seasonal variation in other nutrients
6.1.13.1 Differences between supplemented and placebo groups, and between 
boys and girls
Table 6.8 gives the intake of other nutrients in boys and girls. After 
adjustment for age, the intakes of calories and fat in girls were significantly 
greater in the dry season than the wet season. There were no significant 
differences between dry and wet. season in the intake of protein and 
carbohydrate in girls. The intake of all these nutrients in boys was significantly 
greater in the dry season compared with the wet season.
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After adjustment for age and sex, there were no significant differences 
between the supplemented and placebo groups in the intake of any nutrient 
either in the dry or wet season (Table 6.9).
Table 6.0 Daily intake of other nutrients for all subjects, divided by boys and girls and by
season^
_______ Boys  Girls______
Total Dry season Wet season Dry season Wet season
(n = 159) (n = 44) (n = 35)_______(n = 44) (n = 36)
Energy (kcal/d) 1763 ±447 2000 ±401® 1698 ±486 1761 ±345® 1541 ±448
Protein (g) 55 ±17 63±17b 52 ±17 55 ±12 50 ±18
Fat (g) 38 ±26 49±25c 31 ±32 43 ±24* 26 ±18
Carbohydrate (g) 326 ± 76 360 ± 68d 327 ±73 314 ±67 299 ±85
ŸMean ± SD. Significant difference between seasons after adjusting for age were, *  p = 0.003; bp = 0.012 
Cp = 0.006, dp = 0.020, °  p = 0.017, * p = 0.0001. kcal to kJ, multiply by 4.18.
Table 6.9 Daily intake of nutrients by supplemented and placebo group, and by season^
Dry season_________ Wet season
Total 
(n = 159)
Supplement 
(n = 44)
Placebo 
(n = 44)
Supplement 
(n = 35)
Placebo 
(n = 36)
Energy (kcal/d) 1763 ±447 1862 ±397 1899 ±389 1623 ±411 1614 ±528
Protein (g/d) 55 ±17 58 ±15 59 ±16 52 ±16 50 ±19
Fat (g) 38 ±26 46 ±25 46 ±24 27 ±16 30 ±32
Carbohydrate (g) 326 ± 76 334 ±64 340 ±78 318 ±82 308 ±79
fMean ± SD. After adjustment for age and sex, there were no significant differences between the groups in 
either seasons, kcal to kJ, multiply by 4.18.
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7 Results: Anthropometry and pubertal status
7.1 Anthropometry results .
7.1.1 Baseline anthropometry
Table 7.1. shows the characteristics of the 160 children who took part in 
the study.
Table 7.1 Baseline characteristics for all subjects, supplemented and placebo groups and
for boys and girls separately.
Total Supplemented Placebo Boys Girls
(n = 160) (n = 80) (n = 80) (n = 80) (n = 80)
Age (y) 10.3 ±1.0 10.3 ±1.0 10.3 ±1.0 10.5 ±0.8 10.1 ±1.1
Weight (kg) 25.2 ± 4.0 25.5 ±4.0 24.9 ±4.1 25.5 ±3.6 25.0 ±4.4
Height (cm) 132.1 ±7.2 132.5 ±6.9 131.6 ±7.6 132.5 ±6.6 131.6±7.8
Mean ± SD. There were no significant differences either between sexes or between the groups in any of the 
variables.
There were no significant differences in subject characteristics between 
either the supplemented and placebo groups or between boys and girls at 
baseline (Table 7.1).
Table 7.2 Age, weight and height of the supplemented and placebo group at baseline, by
sex.
__________________ Boys_____________ : _________ Girls___________
Supplemented Placebo Supplemented Placebo
(n = 40) (n = 40) (n = 40) (n = 40)
Age (y) 10.4 ±0.8 10.5 ±0.8 10.1 ±1.1 10.0 ±1.1
Weight (kg) 25.7 ±3.3 25.4 ±3.9 25.4 ±4.6 24.5 ±4.2
Height (cm) 132.5 ±5.7 132.5 ±7.5 132.6 ±8.0 130.7 ±7.6
Mean ± SD When subjects were divided into sexes, no significant difference was found either between the 
sexes or between the groups in any of the variables.
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When subjects were divided into sexes, there was no significant difference 
between the supplemented and placebo group in age, weight and height at 
baseline (Table 7.2).
7.1.2 Z score
Weight, height and body mass index (BMI) in this study were adjusted for 
age and sex by Z score to compare weight, height and BMI of Gambian children 
with the age and sex matched British reference (Table 7.3).
There was no significant difference either between the sexes or between 
the supplemented and placebo groups in any of the variables at baseline. The Z 
scores for the Gambian children were considerably lower than for the British 
children with the mean differences more than 1 standard deviation below the 
British mean for each of the growth variables. This represents 78, 94 and 87 
percent weight, height and body mass index for age of the British reference. The 
results indicate that the growth of rural Gambian children was poor compared 
with British reference population and confirm the reports from previous studies in 
Keneba.
Table 7.3 Mean ± SD Z-score for weight, height, and body mass index by group
and sex at baseline
Supplement 
(n = 80)
Placebo 
(n = 80)
Boys 
(n = 80)
Girls 
(n = 80)
weight -1.67 ±0 .77 -1.86 ±0.93 -1.82 ±0 .92 -1.70 ±0 .78
height -1.10 ±0 .77 -1.24 ±0.94 -1.26 ±0 .85 -1.09 ±0 .87
BMI -1.53 ±0 .80 -1.62 ±0.81 -1.53 ±0 .84 -1.62 ±0 .77
BMI, body mass index. No significant differences between the sexes and between groups in any of the 
variables. Z scores compared with British reference data (Cole, 1990; Cole, 1997).
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7.1.3 MUAC, triceps skinfold thickness and grip strength
Both the mid-upper arm circumference (MUAC) and grip strength were 
positively related to age (p<0.0001). After adjusting for age, a positive 
association between MUAC and pubertal status was also evident indicating 
greater MUAC in these children who were pubertal (stage II - IV) compared with 
those who were prepubertal (MUAC, +2.5 (SE 0.8)%, p = 0.003). There was no 
correlation between either triceps skinfold thickness with either age or pubertal 
status.
After adjusting for age, there were no significant differences in MUAC, 
triceps skinfold thickness and grip strength between either the supplemented and 
placebo groups or between boys and girls at baseline. An exception was for 
triceps skinfold thickness which was significantly greater in girls than boys (+20 
(SE 3.4)%, p< 0.0001, Table 7.4).
Table 7.4 Baseline anthropometry variables for all subjects, and by group and
sex
Total
(160)
Supplement 
( n = 80)
Placebo 
( n = 80 )
Boys 
(n = 80)
Girls 
(n =80)
MUAC (cm) 18.1 ±1 .6 18.2 ± 1.6 18.0 ± 1.6 17.9 ±1 .4 18.3 ±1 .8
Triceps (mm) 7.9 ± 1.9 8.0 ± 1 .7 7.9 ±2.1 7.1 ±1 .5 8.8 ± 1 .9 '
Grip (kg) 10.9 ± 2 .9 11.1 ±3.1 10.7 ± 2 .7 11.2 ±2 .6 10.7 ±3 .2
f Mean ± $D. MUAC, mid-upper arm circumference, Triceps = triceps skinfold thickness, Grip = grip strength .
Girls held significantly greater triceps skinfold thickness than boys *  P = 0.0001. otherwise, there was no 
significant difference between sexes or between groups in any of the variables.
138
Chapter 7 Anthropometry
7.2 Anthropometry measures at outcome
Mean weight and height and other anthropometric variables at outcome 
are presented in Table 7.5 After allowing for age and pubertal stage, there was 
no significant difference either between the supplemented and placebo groups 
or between boys and girls. An exception was in triceps skinfold thickness which 
was significantly greater in girls than boys as it had been at baseline (P <0.0001).
Table 7.5 Anthropometry measures of the supplemented and placebo groups,
boys and girls at out come
Total 
(n = 160)
Supplement Placebo 
(n = 80) (n = 80)
Boys 
(n = 80)
Girls 
( n = 80)
Weight (kg) 27.3 ± 4.7 27.7 ± 4.8 26.8 ± 4.6 27.1 ±3 .9 27.4 ±5 .5
Height (cm) 137.2 ± 7.4 137.7 ±7.1 136.8 ± 7 .7 137.2 ± 6 .5 137.2 ± 8 .2
MUAC (cm) 19.1 ± 1 .6 19.3 ± 1.7 18.9 ±1 .6 18.8 ±1 .3 19.3 ± 1.9 v
Triceps (mm) 8.6 ± 2.6 8.6 ± 2.3 8.6 ±2 .8 7.5 ±1 .6 9.7 ±2.9"
Grip (kg) 14.9 ±3 .3 15.1 ± 3 .2 14.7 ± 3 .3 15.1 ±3 .2 14.8 ± 3 .4
Mean ± SD. MUAC, mid-upper arm circumference; Triceps, triceps skinfold thickness; grip, grip strength.
Triceps skinfold thickness significantly greater in girls than boys at outcome, a pSQ.QOQT There were no 
significant differences in any of the other variables between sexes or between groups.
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7.3. Change in anthropometric variables over 12 months
7.3.1 Differences between boys and girls
After adjusting for baseline value, girls showed a greater percentage gain 
in weight, height and triceps skinfold thickness than boys (Table 7.6). There 
were no significant differences between boys and girls in changes in mid-upper 
arm circumference and grip strength, after correcting for baseline value (Table 
7.6). After correcting for baseline value and sex, gain in triceps skinfold 
thickness, was significantly greater in older children (+0.8 (SE 0.1 )mm, p< 
0.0001, regression).
Table 7.6 Change in anthropometric variables in boys and girls over the 12
month period
Outcome - Baseline A%difference at outcome
Boys Girls Boys vs Girls
Mean SE significance
Weight (kg) 1.6 ± 1.4 2.4 ± 1.7 -2.7 0.8 p=0.0009
Height (cm) 4.7 ±1 .8 5.6 ±2.1 -0.6 0.2 p=0.009
MUAC (cm) 0.9 ± 0 .9 1.0 ± 0.8 -0.5 0.7 p=0.43 (ns)
Triceps (mm)0.4 ± 1.6 0.9 ±2.1 -10.0 3.5 p=0.005
Grip (kg) 3.9 ± 1.5 4.1 ±1 .9 -2.0 1.8 p=0.27 (ns)
Mean ± SD. Triceps, triceps skinfold thickness, Grip, grip strength, MUAC, mid-upper arm circumference. 
Data transformed to natural logarithms before analysis (regression). A% = percentage difference at outcome 
after correcting for baseline value and age. After correcting for baseline value, girls had a significantly 
greater gain in weight, height and triceps skinfold thickness at outcome than boys. After adjusting for 
baseline value, there were no significant differences in MUAC and grip strength between the sexes. Ns, not 
significant.
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7.3.2 Differences between supplemented and placebo groups
After adjustment for baseline value, age and sex, there was no significant 
difference between the supplemented and placebo groups in any of the 
anthropometric measures at outcome (Table 7.7).
After adjusting for baseline value and age, the anthropometric variables in 
either sex considered separately also did not differ significantly between the 
supplemented and placebo groups at outcome.
7.3.3 Effect of supplement on weight and height and other 
anthropometric variables at outcome
After correcting for the initial value, differences in weight and height gain 
were not significantly different between the supplemented and placebo groups 
(height, -0.0 SE 0.0%, p = 0.88; weight, +0.8 SE 0.8%, p = 0.32, Table 7.7). This 
indicates that there was no effect of supplement on longitudinal growth. There 
were also no differences in gain in MUAC, triceps skinfold thickness or grip 
strength.
141
Chapter 7 Anthropometry
Table 7.7 Change in anthropometric variables in the supplemented and placebo 
groups over the 12 month period
Outcome - Baseline A%difference at outcome
Supplement Placebo Supplement vs Placebo
(n = 80) (n = 80)
Mean SE significance
Weight (kg) 2.2 ± 1 .7 1.9 ± 1.4 +0.8 0.8 p=0.32 (ns)
Height (cm) 5.1 ±2.1 5.2 ±1 .9 -0.0 0.0 p=0.88 (ns)
MUAC (cm) 1.0 ±0 .9 0.9 ± 0.8 +1.0 0.7 p=0.13 (ns)
Triceps (mm) 0.6 ±1 .8 0.7 ±1 .9 -0.4 3.2 p=0.91 (ns)
Grip (kg) 4.0 ± 1 .8 4.0 ± 1.5 +1.2 1.8 p=0.51 (ns)
Mean ± SD. Triceps, triceps skinfold thickness, Grip, grip strength, MUAC, mid-upper arm circumference. 
A% = percentage difference at outcome after correcting for baseline value, age and sex. Data transformed to 
natural logarithms prior to analysis (regression data desk 4.1). Changes in anthropometry variables over 12 
month were not significantly different between the supplemented and placebo group. Ns, not significant.
7.3.4 Z score at outcome
There were no significant difference in Z scores for weight, height and BMI 
relative to the British reference either between the supplemented and placebo 
groups or between boys and girls at outcome (Table 7.8). There was no increase 
in Z scores in either the supplemented and placebo group or in boys and girls 
over the 12 month period. In fact, weight and BMI Z scores for boys and girls and 
for the supplemented and placebo groups at outcome were significantly lower 
than baseline (Table 7.9). Height Z scores did not differ significantly between 
outcome and baseline in either of the sexes or in the supplemented and placebo 
groups. This further indicates that there was no influence of the calcium 
supplement on growth. The results also suggest that there was no improvement
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in growth of these children over the 1 year period as assessed by Z scores and 
they continued to fall behind their British counterparts.
There were no sex x supplement interactions seen in percent change from 
baseline to 12 months in any of the anthropometric variables.
Table 7.8 Z-score for weight, height, and body mass index by groups and by sex
at outcome1
Supplement 
(n = 80)
Placebo 
(n = 80)
Bpys 
(n = 80)
Girls 
(n = 80)
weight -1.84 ±0 .79 -2.08 ±0.99 -2.07 ± 0.94 -1.85 ±0 .86
height -1.13 ±0 .74 -1.26 ±0 .94 -1.28 ±0.81 -1.10 ±0 .88
BMI -1.78 ±0 .83 -2.03 ±0.89 -1.94 ± 0.86 -1.86 ±0 .88
fMean ± SD. BMI, body mass index. There was no significant difference between either the supplemented 
and placebo groups or between boys and girls in any of the variables.
Table 7.9 Change in Z scores over 12 months by group, and by boys and girls*
 Outcome - Baseline___________ Outcome - Baseline_____
Bovs Girls Supplement Placebo
(n = 80) (n = 80) - (n = 80) (n = 80)
weight 0.25 ±  0.40" -0.14 ± 0.33* -0.17 + 0.36* -0.22 ±0.38*
height -0.03 ± 0.31 -0.02 ± 0.34 -0.03 ±  0.33 -0.01 ± 0.32
BMI________-0.41 ± 0 .7 7 *  -0.25 ±  0.54* -0.25 ±0 .6 1 * -0.41 ±  0.72*
tMean ± SD. BMI, body mass index. In both sexes, weight and body mass index Z scores were significantly 
lower at outcome compared with baseline. ap^0.0001, b p = 0.0002. In both the supplemented and placebo 
groups, weight and body mass index Z scores were significantly lower at outcome compared with baseline. 
"pSO.QOOl, bp = 0,0005. There was no significant difference in height Z scores between baseline and outcome 
in either boys or girts or in the supplemented and placebo groups. Change in Z scores over the 12 month 
period was not significantly different between either boys and girls or between the supplemented and placebo 
groups in any of the growth variables. However, there was a trend towards a groator docrease in weight Z 
score over the 12 months in boys than girls but the difference between the two was not statistically significant 
(p = 0.059).
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7.4 Anthropometry measures at follow-up
7.4.1 Differences between boys and girls
There were no significant difference in weight and height between boys 
and girls at follow up. Girls were slightly heavier and taller than boys, but the 
differences between the two did not reach statistical significance. Mid-upper arm 
circumference and triceps skinfold thickness were significantly greater in girls 
than boys at follow-up (Table 7.10), but there was no significant difference 
between the sexes in grip strength.
7.4.2 Differences between supplemented and placebo groups
There were no significant differences between the supplemented and 
placebo groups in body weight and statural height at follow-up. After adjusting 
for sex, there were no significant differences between the supplemented and 
placebo group in MUAC, triceps skinfold thickness and grip strength at follow-up 
(Table 7.10).
Table 7.10 Mean ± SD of characteristics and anthropometry variables for all subjects, 
supplemented and placebo and by sex at follow upf.
All subjects 
(n = 160)
Supplement 
(n = 80)
Placebo 
(n = 80)
Boys 
(n = 80)
Girls 
(n = 80)
Weight (kg) 30.4 ±5.9 30.9 ± 6.3 29.9 ±5.6 29.9 ±4.6 30.9 ±7.0
Height (cm) 141.9 ±8.4 142.4 ±8.1 141.4 ±8.7 141.5 ±7.5 142.3 ±9.2
MUAC (cm) 19.9 ±2.0 20.1 ±2.1 19.7 ±1.9 19.6 ±1.5 20.2 ± 2.4a
Triceps (mm) 8.3 ±2.8 8.4 ±2.7 8.3 ±2.9 7.2 ±1.5 9.5 ± 3.3b
Grip (kg) 16.7 ±3.6 17.1 ±4.0 16.3 ±3.1 16.5 ±2.7 16.9 ±4.3
t mean ± SD. Girls had significantly greater mid-upper arm circumference and triceps skinfold thickness than 
boys at follow-up, *  p = 0.049, b p = 0.0001.
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Table 7.11 Change in anthropometric variables over the 2 year period in boys and girlst
Baseline Follow-up
Boys 
(n = 80)
Girls 
(n = 80)
Boys 
(n = 80)
Girls 
( n = 80)
Weight (kg) 25.5 ± 3.6 25.0 ±4.4 29.9 ± 4.6a 30.9±7.0a
Height (cm) 132.5 ±6.6 131.6 ±7.8 141.5 ± 7.5a 142.3 ±9.2a
MUAC (cm) 17.9 ±1.4 18.3 ±1.8 19.6 ± 1.5a 20.2 ± 2.4a
Triceps (mm) 7.1 ±1.5 8.8 ±1.9 7.2 ±1.5 9.5 ± 3.3b
Grip (kg) 11.1 ±2.6 10.7 ±3.2 16.5 ±2.6a 16.9 ± 4.3a
*Mean ± SD. MUAC, mid-upper arm circumference; Triceps, triceps skinfold thickness, grip, grip strength. 
Follow-up values were significantly greater than at baseline, a p^0.0001, b p = 0.01 T An exception was 
triceps skinfold thickness in boys at follow-up which was not significantly different from 0.
Table 7.12 Change in weight, height, mid-upper arm circumference, triceps and 
grip strength after 24 month in boys and girls1
Follow-up- Baseline #A%difference at follow-up
Boys 
(n = 80)
Girls 
(n = 80)
Boys vs Girls
Mean SE p value
Height (cm) 9.0 ± 2 .8 10.7 ± 3.3a -1.3 0.4 0.0003
Weight (kg) 4 .4 ±  1.7 5.9 ±  3.2" -5.3 0.9 <0.0001
MUAC (cm) 1.7 ±1 .0 1.9 ± 1.2 -1.7 0.8 0.037
Triceps (mm) 0.1 ± 1 .5 0.7 ± 2.5" -14.0 3.5 <0.0001
Grip strength 5.4 ± 1.6 6.2 ± 2.7d -3.5 2.1 0.11 (ns)
f Mean ± SD. #A% = percentage difference at follow-up, after correcting for baseline value. Data transformed 
to natural logarithms before analysis (regression). Changes in weight, height, triceps and grip strength over
24 months were significantly greater in girls than boys. 8 p=0.0006, b p=0.0002, ° p=0.041, d p=0.018. After 
correcting for baseline value, girls had a significantly greater increases in all cases except grip strength than 
boys at follow-up. Ns, not significant.
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Table 7.13 Differences in weight, height, mid-upper arm circumference, triceps 
and grip strength between the supplemented and placebo groups after 24
months^
Follow-up- Baseline #A%difference at follow-up 
Supplement Placebo Supplement vs placebo 
(n = 80) (n = 80)
Mean SE p value
Height (cm) 9.9 ±3.1 9.8 ±3 .2 +0.2 0.9 0.85 (ns)
Weight (kg) 5.3 ±3.1 5.0 ±2 .2 +0.1 0.4 0.89 (ns)
MUAC (cm) 1.9 ±1 .2 1.8± 1.1 +0.3 0.8 0.76 (ns)
Triceps (mm) 0.4 ± 2.2 0.4 ±2.1 -0.4 3.1 0.89 (ns)
Grip strength (kg) 6.0 ± 2.5 5.6 ±1.9 +0.1 3.3 0.98 (ns)
f Mean ± SD. MUAC, mid-upper arm circumference. Triceps, triceps skinfold thickness, MUAC, mid-upper 
arm circumference. #A% = percentage difference at follow-up, after correcting for baseline value. Data 
transformed to natural logarithms before analysis (regression) There was no significant difference in the 
incremental gain between the supplemented and placebo group in any of the anthropometric variables. Ns, 
not significant.
7.4.3 Change in anthropometry over the 24 month period
7.4.3.1 Differences between boys and girls
Both boys and girls had a significant gain in anthropometric variables over 
the 2 year period (Table 7.11). An exception was in triceps skinfold thickness in 
boys which was not significantly different from baseline.
Girls had significantly greater gains in triceps skinfold thickness and grip 
strength than boys (Table 7.12). The incremental gain in mid-upper arm 
circumference over 24 months was not significantly different between boys and 
girls (Table 7.12).
After correcting for baseline value, gain in weight and height over the 2 
year period was significantly greater in girls than boys (p<0.0001 and p = 0.0003
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respectively, Table 7.12). After adjusting for differences at baseline, girls had 
significantly greater gain in mid-upper arm circumference and triceps than boys 
at follow-up (Table 7.12). Gain in adjusted grip strength was not significantly 
different between boys and girls at follow-up.
7.4.3 2 Differences between supplemented and placebo groups
After adjusting for the baseline value and sex, there were no significant 
differences between the supplemented and placebo groups, in height and weight 
increment at follow-up (difference in increment between groups: height, + 0.2 (SE 
0.9)%, p = 0.85; weight, + 0.1 (SE 0.4)%, p = 0.89, Table 7.13).
After correcting for baseline value, there were no significant differences 
between the supplemented and placebo groups in gain in MUAC, triceps and 
grip strength over 24 months (Table 7.13).
7.5 Z scores at follow-up
Table 7.14 Mean ± SD Z-score for weight, height, and body mass index for all
subjects, supplement and placebo groups, and boys and girls at follow upf
All subjects 
(n = 160)
Supplement Placebo Boys 
(n = 80) (n = 80) (n = 80)
Girls
(n=80)
weight -1.92 ±0 .92 -1.82 ±0 .85 -2.02 ±0 .97  -2.04 ±0 .89 1.79+0.93
height -1.26 ±0 .90 -1.19 ± 0.81 -1.33 ±0 .99  -1.39 ±0 .86 1.13±0.93
BMI -1.84 ±0 .89 -1.77 ±0 .89 -1.91 ±0 .88  -1.90 ±0 .78
COO)1
fMean ± SD. BMI, body mass index. No significant differences either between boys and girls or between the 
groups.
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There was no significant difference between either the supplemented and 
placebo group or between boys and girls in Z scores relative to the British 
reference at follow up (Table 7.14). Z scores for all growth variables measured 
were still more than 1 SD below the age and sex matched British reference.
There was a significant decrease over the 2 year period in weight, height 
and BMI Z scores relative to the British reference in boys (Table 7.15). In girls, 
there was a trend towards lower Z scores in weight and height and BMI relative to 
British reference at follow-up compared with baseline but only the BMI Z scores 
were significantly lower than baseline.
In both the supplemented and placebo groups, weight and BMI Z scores 
relative to the British reference at follow-up were significantly lower than at 
baseline (Table 7.15). Height Z scores at follow-up did not differ significantly 
from baseline in either group. There was no difference between the 
supplemented and placebo groups in change over 2 years in any of the Z scores. 
The results of the follow-up confirm the observations at baseline and outcome 
that the Z scores for the Gambian children were remarkably lower than for the 
British children, and remained so during the peripubertal period.
Sex differences in change from baseline to 24 months in anthropometric 
variables were independent of supplement effect. There were no sex x 
supplement interactions in changes from baseline to 24 months in any of the 
anthropometric variables.
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Table 7.15 Change in Z scores over 2 years by supplemented and placebo
groups, and by boys and girlsf
Follow-uo - Baseline Follow-uo - Baseline
Boys 
(n = 80)
Girls 
(n = 80)
Supplement 
(n = 80)
Placebo 
(n = 80)
weight -0.22 ± 0.36a -0.09 ± 0.46 -0.16 + 0.44" -0.16 ±0.40*
height -0.14 ±0.44" -0.04 ± 0.49 -0.09 ±  0.46 -0.09 ±  0.48
BMI -0.36 ±  0.67“ -0.16 ±  0.65e -0.24 ± 0.67* -0.29 ± 0.66s
+Mean ± SD. BMI, body mass index. In both sexes, weight, height and body mass index Z scores were 
significantly lower at follow-up than at baseline. ap^0.0001, bp = 0.007, Cp = 0.029. An exception was in
height Z scores in girls which was no significant difference between baseline and follow-up. Change in weight 
and BMI Z scores over the 2 year period were different between boys and girls. Weight: ’p = 0.044, BMI: *p = 
0.051. In both the supplemented and placebo groups, weight and body mass index Z scores were 
significantly lower at follow-up than at baseline. d p = 0.003, ep = 0.0006, fp = 0.002, flp = 0002.
7.6.Pubertal status
7.6.1 Pubertal status at baseline
Table 7.16 shows the percent of children at Tanner stage 1 and II - IV in 
each group and by sex at baseline. Using a Chi-squared test, there was no 
significant difference either between the sexes or between the supplemented 
and placebo groups in the percentage of children who had entered puberty at 
baseline. However, the trend was for more girls than boys to be in Tanner stage 
II - IV.
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Table 7.16 Pubertal status at baseline.
Total Supplemented Placebo Boys Girls
§iic (n = 80) (n = 80) (n = 80) (n = 80)
N % N % N % N % N %
Stage
1 130 81.2 65 81.2 65 81.2 68 85.0 62 77.5
II - IV 30 18.8 15 18.8 15 18.8 12 15.0 18 22.5
N, number of subjects. There was no significant difference between either the supplemented and placebo 
groups or between boys and girls in percentage of children reaching puberty.
7.7. Pubertal status at outcome
Table 7.17 Pubertal status at outcome
Total 
(n = 80) 
N %
Supplement 
(n = 80)
N %
Placebo 
(n = 80) 
N %
Boys 
(n = 80) 
N %
Girls <
( n = 80) 
N %
Stage
I 111 69.4 55 68.8 56 70.0 54 67.5 57 71.2
II - IV 49 30.6 25 31.2 24 30.0 26 32.5 23 28.8
N, number of subjects. There was no significant difference between either the supplemented and placebo 
groups or between boys and girls in percentage of children reaching puberty.
Table 7.17 gives the percent of children at Tanner stage I and II - IV in 
each group and by sex at outcome. There was no significant difference either 
between boys and girls or between the supplemented and placebo groups in the 
percentage of children who had entered puberty at outcome (Chi-squared test). 
The percentage of children who had entered puberty had increased over the 12 
month period in both the supplemented and placebo groups and in boys and 
girls.
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7.7.1 Comparison of pubertal status at baseline and outcome by sex (%)
Fifteen percent of boys were in Tanner stage II- IV at baseline, 33% at 
outcome. In girls, pubertal stages II -IV was seen in 23% at baseline and 29% at 
outcome. When subjects were grouped into sexes, there was no significant 
difference in pubertal status between supplement and placebo groups in either 
sex at outcome.
7.7.2 Menarche
At baseline, none of the girls had started menstruation. At outcome, 2 girls 
had started menstruation and the rest of the girls had not had any periods.
7.7.3 Pubertal status at follow-up
Table 7.18 Pubertal status at follow-up
Total 
(n = 80) 
N %
Supplement 
(n = 80)
N %
Placebo 
(n = 80) 
N %
Boys 
(n = 80) 
N %
Girls 
( n = 
N
80)
%
Stage 
1 87 54.5 38 47.5 49 61.2 42 52.5 45 56.2
I l - IV 73 45.6 42 52.5 31 38.8 38 47.5 35 43.8
N, number of subjects. There was no significant difference between either the supplemented and placebo 
groups or between boys and girls in percentage of children reaching puberty.
Table 7.18 shows the percent of children at Tanner stage I and II - IV in each 
group and by sex at follow-up. There was no significant difference between 
either boys and girls or between the supplemented and placebo groups in 
percentage of children who progressed into puberty at follow-up.
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The percentage of children who had entered puberty had increased over the 2 
year period in both the supplemented and placebo groups and in boys and girls. 
At follow-up, puberty was seen in 46% of children as opposed to 19% at 
baseline. The total number of children who had entered puberty at follow-up was 
significantly greater than that at baseline (P<0.0001, Chi-squared test). Forty- 
eight percent of boys and 44% of girls (baseline 15% and 23% respectively) 
were pubertal at follow-up.
7.7.4 Pubertal status in percentage at follow-up by sex
None of the boys had reached advanced puberty at follow up. At follow- 
up, six percent of girls had advanced puberty. The number of girls who had 
started menstruation had increased to 4 at follow-up.
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8 Results: Bone mineral status and ultrasound
measurements
8.1 Bone mineral status at baseline
Bone mineral status of the subjects was assessed at baseline to examine 
whether there was any difference between the supplemented and placebo 
groups, or between boys and girls which could account for any differences that 
might emerge at outcome or follow-up and to provide information about bone 
mineral accretion rate of pre- and peripubertal rural Gambian children.
The baseline bone mineral content, bone mineral density and bone width 
for all subjects, for supplemented and placebo groups, and for boys and girls 
separately are shown in Table 8.1. There were no significant differences either 
between the supplemented and placebo groups or between boys and girls in any 
of the bone variables at baseline.
8.2 Comparative data
Table 8.2 gives the comparative data obtained in British children of the 
same age. Using regression analysis, the Gambian children were shown to have 
13% lower BMC (SB 2.5), P<0.0001, Figure 8.1), 4% lower BW (SB 1.4), 
p=0.003) and 9% lower BMD (SB 1.8), p<0.0001, Figure 8.2) than the British 
children. After adjusting for weight, height, age and sex, the difference in BMC 
was reduced to 4% which was no longer significant (SB 2.6, p=0.10). The 
Gambians also had lower height 6 (SB 0.6)%, p<0.0001) and weight 33 (SB 
2.1)%, p<0.0001) than the British children (Figures 8.3 and 8.4).
The results indicated that there were significant differences in growth and 
bone variables between Gambian and British children and that the Gambian 
children were significantly lighter and shorter and had lower bone mineral status
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Chapter 8 Comparative data
X
than the age and sex matched British children. However, after adjusting for 
differences in bone and body size, differences between the British and Gambian 
children in BMC and BMD were no longer significant.
Table 8.2 Comparison of anthropometric and mid-shaft radius bone variables between
Gambian and British children*
Gambian 
(n = 160)
British 
(n = 85)
Weight (kg) 25.2 ±4.0 36.7 ± 8.5*
Height (cm) 132.1 ±7.2 142.2 ±8.0*
Mid-shaft radius BMC (g/cm) 0.443 ±0.086 0.493 ± 0.083*
Mid-shaft radius BW (cm) 0.968 ±0.115 1.045 ±0.121b
Mid-shaft radius BMD (g/cm2) 0.456 ± 0.060 0.471 ± 0.054*
f Mean ± SD BMC = bone mineral content, BW, bone width, BMD, bone mineral density. British values 
significantly greater than Gambian., ap<0.0001, b p=0.003.
Data from Cambridge children aged 8.9 -11.97 years (see methods).
Fig.8.1
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Figure 8.2
Comparative data
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Fig.8.4
Comparative data
Baseline Height vs Cambridge
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8.3 Bone mineral status at outcome
8.3.1 Differences between boys and girls
There was no significant difference between boys and girls in any of the 
bone variables at outcome (Table 8.3).
8.3.2 Differences between supplemented and placebo groups
Bone mineral content and bone mineral density at the mid-shaft radius 
were significantly greater in the supplemented compared with placebo group at 
outcome (Table 8.3). There was a trend towards a smaller bone width at the mid­
shaft radius in the supplemented group compared with the placebo group at 
outcome but the difference between the two was not significant (Table 8.3). At 
the distal radius, the supplemented group had significantly greater bone mineral 
content (BMC), bone width (BW) and bone mineral density (BMD) than placebo 
group at outcome (Table 8.3).
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Chapter 8 Bone mineral status
8.4 Change in bone variables over 12 months
8.4.1 Differences between boys and girls
Tables 8.4 and 8.5 show changes in bone mineral over the 12 month 
period for the supplemented and placebo groups and for boys and girls. After 
adjustment for baseline value, there was no significant difference between boys 
and giris in any of the bone variables at outcome (Table 8.4).
Table 8.4 Differences in bone measures between boys and girls after 12 months of the
trial*
Outcome - Baseline* #A%difference at outcome
Boys Girls Boys vs girls
(n = 80) (n = 80) .
mean SE significance
Mid-shaft BMC (g/cm) 0.037 ± 0.040 0.037 ±0.049 +0.1 1.4 0.96 (ns)
Mid-shaft BW (cm) 0.025 ± 0.053 0.018 ±0.066 +1.1 0.9 0.23 (ns)
Mid-shaft BMD (g/cm2) 0.025 ± 0.029 0.030 ±0.031 -1.1 1.0 0.27 (ns)
Distal BMC (g/cm) 0.043 ±0.109 0.060 ±0.093 -4.3 3.2 0.18 (ns)
Distal BW (cm) 0.063 ±0.148 0.061 ±0.138 +0.2 1.2 0.84 (ns)
Distal BMD (g/cm2) 0.014 ±0.047 0.025 ±0.046 -4.1 2.7 0.14 (ns)
t Mean ± SO. BMC, bone mineral content; BW, bone width. #A% = percentage difference at outcome, after 
correcting for baseline value. Data transformed to natural logarithms before analysis (regression). Changes 
in bone variables were not significantly different between boys and girls. After correcting for baseline value, 
there was no significant difference between boys and girls in any of the bone variables at outcome, ns, not 
significant.
8.4.2 Effect of the calcium supplement
The gain in BMD at the mid-shaft and distal radius BMC over the 12 month 
period was significantly greater in the supplemented than placebo group (Table
8.5). The increment in BW at the mid-shaft radius was significantly smaller in the 
supplemented than the placebo group, an effect that was not seen in distal BW.
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After correcting for baseline value there was a significantly higher BMC 
and BMD at the mid-shaft and distal radius in the calcium supplemented group 
compared with placebo (Table 8.5). There was a trend towards a smaller BW in 
the supplemented group at the mid-shaft radius but the difference did not reach 
statistical significance (p = 0.06).
After adjusting for differences in BW, statural height and body weight at 
baseline, sizb-adjusted BMC at the mid-shaft and distal radius was significantly 
greater in the supplemented than placebo group (mid-shaft, +4.8 SE 0.9 %, 
p<0.0001; distal radius, +5.5 SE 2.7%, p=0.042). There was no interaction of 
supplement effect with age, sex, dietary calcium intake, or pubertal status. This 
demonstrates a significant effect of calcium supplementation on bone mineral 
accretion of Gambian children accustomed to a low calcium intake. Since the 
calcium supplementation for 12 months had no significant effect on height (S - P, 
-0.0 SE 0.0%, p = 0.88), body weight (+0.8 SE 0.8%, p = 0.32) (see section 7.3.3) 
or BW at either the mid-shaft radius (-1.6 SE 0.9%, p = 0.064) or distal radius 
(+2.0 SE 1.2%, p = 0.086), the effect of calcium supplement appears to have 
been on bone mineralisation rather than on skeletal growth.
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Table 8.5 Differences in bone measures between the supplemented and placebo groups
after 12 months of the trial1
Outcome - B ase lin e*_____________ #A%difference at outcome
Supplement Placebo Supplement vs placebo
(n -  80) (n -  80)
mean SE significance
Mid-shaft BMC (g/cm) 0.041 ± 0.044 0.033 ± 0.045 +3.0 1.4 0.034
Mid-shaft BW (cm) 0.012 ±0.062 0.031 ±0.056* -1.6 0.9 0.064(ns)
Mid-shaft BMD (g/cm2) 0.037 ± 0.027* 0.019 ±0.030 +4.5 0.9 <0.0001
Distal BMC (g/cm) 0.068 ±0.102b 0.035 ±0.099 +8.4 3.2 0.009
Distal BW (cm) 0.075 ±0.154 0.049 ±0.131 +2.0 1.2 0.086(ns)
Distal BMD (g/cm2) 0.026 ±0.045 0.014 ±0.048 +7.0 2.7 0.011
f Mean ± SD. BMC, bone mineral content; BW, bone width. #A% = percentage difference at outcome, after
correcting for baseline value. Data transformed to natural logarithms before analysis (regression). Changes 
in shaft BMD, distal radius BMC over the 12 month period were significantly greater in the supplemented than 
placebo group. Change over the 12 month period in shaft BW was significantly greater in the placebo group
compared with supplemented group but became non significant after correcting for baseline value. ap50.0001 ; 
b p=0.040; Cp=0.044. ns, not significant.
8.5 Size correction
To examine the effect of calcium supplement and other variables on bone 
mineral status independently of bone and body size, bone mineral content (BMC) 
was corrected for bone width (BW), body weight and height, using multiple 
regression analysis (see methods). The baseline value was entered as an 
independent variable in all regression analysis to adjust for regression towards 
the mean (method section for detail). All continuous variables were converted to 
natural logarithms prior to analysis. Example of the full model and after 
backwards elimination (parsimonious model) are given below.
161
Chapter 8 Bone mineral status
8.5.1 Example
Fig.8.5 Effect of supplement on BMC at the mid-shaft radius at outcome. Full 
model
Dependent variable is: 100Alnsbmc*
No Selector
R squared = 73.0%  R squared (adj usted) = 71.0%  
s = 5 .342  w ith 160 - 12 = 148 degrees of freedom
Source Sum of Squares df Mean Square F ratio
Regression
Residual
11446.5
4224 .18
11
148
1040.59
2 8 .5417
36.5
Variable Coefficient s.e. of Coeff t- ratio pr ob
Constant -1 4 0 .6 4 4 80.52 -1 .7 5 0 .0828
-0 .2 3 8 8 0 .0364 -6 .5 6 S 0.0001
1.0564 0.0801 13.2 3 0.0001
lOOInmBW 0.2358 0 .0610 3.86 0 .0002
100Alnwt -0 .0 4 7 6 0 .0942 -0 .5 0 5 0 .6143
100lnwtm 0 .0635 0 .0706 0 .898 0 .3705
lOOAInht 0 .9318 0.3031 3.07 0 .0025
lOOInhtm 0 .2286 0 .1986 1.15 0 .2514
Sex 0 .4489 0 .9209 0 .487 0 .6266
pub2 -0 .8 1 8 9 1.201 -0 .6 8 2 0 .4964
Agem -1 .0 0 0 2 0 .6718 -1 .4 9 0 .1387
S /P 4 .5955 0 .8718 5.27 3 0.0001
All variables are in natural logathrims, except sex, pubertal status and age mean. lOOAInsBMC, change in 
mid-shaft BMC multiplied by 100; at baseline 100ln1SBMC, mid-shaft radius BMC at baseline multiplied by 100; 
100Alnsbw, change from baseline to outcome in BW multiplied by 100; lOOInmBW, mean BW multiplied by 100; 
100Alnwt, change in weight multiplied by 100; 100lnwtm, mean weight multiplied by 100; lOOAInht, change in 
height multiplied by 100; lOOInhtm, mean height multiplied by 100; Sex, boys = 0, girls = 1; S/P refers to 
supplemented and placebo groups respectively, where s = 1, p = 0; pub2 is pubertal stage at outcome (year2), 
Tanner stage 1 =0 ,  stage 2 - 4  = 1; Agem, mean age of subjects at baseline plus outcome.
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Figure 8.6 Effect of supplement on BMC at the mid-shaft radius at outcome. After
backward elimination.
Dependent variable is: 10OAInsbmc*
No Selector
R squared = 72.3% R squared (adjusted) = 71.2%  
s = 5.330 with 1 6 0 - 7  = 153 degrees of freedom
Sour ce Sum of Squares df Mean Square F- ratio
Regression 11323.9 6 1887.32 66.4
Residual 4346.77 153 28.4103
Var iable Coefficient s.e. of Coeff t- ratio pr ob
Constant -145.364 51.98 -2.80 0.0058
100*lnsbmc1* -0.2575 0.0342 -7.52 <0.0001
10OAInsbw* 1.0799 0.0780 13.8 <0.0001
lOOInmBW* 0.2586 0.0581 4.45 <0.0001
lOOAInht 1.0347 0.2768 3.74 0.0003
lOOInhtm 0.2534 0.1040 2.44 0.0160
S/P 4.8268 0.8547 5.65 <0.0001
All variables are in natural logathrims, except sex, pubertal status and age mean. lOOAInsBMC, change in 
mid-shaft BMC multiplied by 100; 100*lnSBMCV, mid-shaft radius BMC at baseline multiplied by 100;,. 
100Alnsbw, change from baseline to outcome in BW multiplied by 100; lOOInmBW, mean BW multiplied by 100; 
lOOAInht, change in height multiplied by 100; lOOInhtm, mean height multiplied by 100; S/P refers to 
supplemented and placebo groups respectively, where s = 1, p = 0.
8.6 Differences in bone mineral status between the supplemented 
and placebo groups, divided by sex
In both sexes, many of the changes in bone variables over the 12 month period 
were similar in the supplemented and placebo groups (Table 8.6).
After correcting for baseline value, the supplemented group in boys had 
significantly greater radial bone mineral density at mid-shaft and distal radius 
than placebo group at outcome (mid-shaft BMD, +4.6 (SE 1.3)%, p = 0.0007; 
distal radius BMD, +10.1 (SE 3.9)%, p = 0.012, Table 8.6). In girls, the increase 
in BMD at the mid-shaft and BW at distal radius was significantly higher in the 
supplemented than placebo group at outcome, after adjustment for baseline
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value (mid-shaft BMD, +4.3 (SE 1.3)%, p = 0.001; distal radius BW, +3.8 (SE
1.6)%, p = 0.018, Table 8.6).
However, the magnitude of the effects at the mid-shaft was similar in both 
boys and girls. No interactions were observed between supplement group and 
age, sex, dietary calcium intake or pubertal status, indicating that the response to 
the supplement was not influenced by any of these variables.
Table 8.6 Differences in bone variables of the supplemented and placebo groups, by sex
over 12 months'
Outcome - Baseline #A%difference at outcome
supplemented placebo supplemented vs placebo
(40 M, 40 F) (40 M, 40 F)
Boys
Mid-shaft BMC (g/cm) 0.041 ±0.040 0.033 ± 0.040
mean SE 
+3.0 1.9
significance 
p-O.11 (ns)
Mid-shaft BW (cm) 0.015 ±0.054 0.035 ±0.050 -1.6 1.1 p=0.16 (ns)
Mid-shaft BMD (g/cm2) 0.035 ±0.025® 0.016 ±0.030 +4.6 1.3 p=0.0007
Distal BMC (g/cm) 0.062 ±0.106 0.023 ±0.108 +9.4 4.8 p=0.056(ns)
Distal BW (cm) 0.062 ±0.166 0.065 ±0.130 -0.2 1.7 p=0.91 (ns)
Distal BMD (g/cm2) 0.025 ± 0.043" 0.004 ± 0.050 +10.1 3.9 p=0.012
Girls
Mid-shaft BMC (g/cm) 0.042 ±0.048 0.032 ±0.050 +2.8 2.1 p=0.18 (ns)
Mid-shaft BW (cm) 0.010 ±0.069 0.027 ± 0.062 -1.5 1.4 p=0.27 (ns)
Mid-shaft BMD (g/cm2) 0.039 ± 0.029° 0.021 ± 0.031 +4.3 1.3 p=0.001
Distal BMC (g/cm) 0.073 ±0.100 0.047 ±0.088 +7.4 4.1 p=0.077(ns)
Distal BW (cm) 0.088 ±0.141 0.034 ±0.131 +3.8 1.6 p=0.018
Distal BMD (g/cm2) 0.027 ± 0.049 0.023 ± 0.044 +3.8 3.7 p=0.31 (ns)
+ Mean ± SD. BMC, bone mineral content; BW, bone width. *A% = percentage difference at outcome, after 
correcting for baseline value. Data transformed to natural logarithms before analysis (regression). Change 
over the 12 month period in mid-shaft radius BMD and distal BMD in boys were significantly greater in the
supplemented compared with placebo group.9 p=0.002,^ p=0.045. In girls, gain In mid-shaft radius BMD was 
significantly greater in the supplemented than placebo group, c p=0.009. There were no significant 
differences between the supplemented and placebo group in either sex in the incremental gain in other bone 
variables, ns, not significant
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8.7 Bone mineral status at follow-up
Bone variables at follow-up for all subjects, for boys and girls and for 
supplemented and placebo groups separately are summarised in Tables 8.7 - 
8.10.
8.7.1 Differences between boys and girls
There were no significant differences between boys and girls in any of the 
bone variables at follow-up.
8.7.2 Differences between supplemented and placebo groups
Unadjusted bone mineral content (BMC) and bone mineral density (BMD) 
at the mid-shaft radius and distal radius were significantly higher in the 
supplemented than placebo group at follow-up (Table 8.7). There was no 
significant difference in BW at either the mid-shaft or distal radius between the 
groups at follow-up.
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8.8.1 Change in bone mineral status over the 24 month period
8.8.1.1 Differences between boys and girls
Both boys and girls had significant gains in BMC, BW and BMD at the mid­
shaft and distal radius over the 24 month period (Table 8.8). The increases in 
mid-shaft radius BMC and BMD were significantly greater in girls than boys 
(Table 8.8). Girls had greater gains in BMC and BMD at distal radius than boys, 
but differences did not reach statistical significance. Gain in BW at distal radius 
over 24 months was similar in boys and girls (Table 8.8).
After adjustment for baseline value, the incremental gain in BMC and BMD 
at the mid-shaft were significantly greater in girls than boys at follow up (Table 
8.8). These differences remained even after correcting for supplement effect (see 
8.8.3.2). BW adjusted for baseline at mid-shaft was not significantly different 
between the sexes at follow-up. After correcting for baseline value there was no 
significant difference in the distal radius bone variables between boys and girls 
at follow-up, but there were trends towards greater BMC and BMD in girls.
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Table 8.8 Difference between boys and giris in the incremental gain in mid-shaft radius and
distal radius variables at follow-up*
Follow-up - Baseline_______  #A%difference at follow-up ,
Boys Girls Boys vs Girls
(n = 80) (n = 80 )
mean SE significance
Mid-shaft BMC (g/cm) 0.067 ±0.051® 0.089 ±0.056® -4.4 1.7 p=0.010
Mid-shaft BW (cm) 0.058 ±0.054® 0.066 ±0.061® -0.6 0.8 p=0.51 (ns)
Mid-shaft BMD (g/cm2) 0.038 ± 0.035® 0.057 ±0.039® -3.8 1.2 p=0.002
Distal radius BMC (g/cm) 0.086 ±0.113® 0.104 ± 0.088® -4.0 3.0 p=0.20 (ns)
Distal radius BW (cm) 0.180 ±0.208® 0.194 ±0.137® -0.8 1.3 p=0.54 (ns)
Distal radius BMD (g/cm2)
sd-H§d 0.031 ±0.043® -2.4 2.5 p=0.33 (ns)
t Mean ± SD. BMC, bone mineral content; BW, bone width. Data transformed to natural logarithms prior to
analysis. Follow-up significantly different from baseline. *  p<0.0001 (paired t- test). Change in mid-shaft
BMC, and BMD over the 24 month period were significantly greater in giris than boys, p=0.011, p=0.001 
respectively. #A% = percentage difference at follow-up after correcting for baseline. After adjusting for 
baseline value, giris had a significantly greater BMC and BMD at mid-shaft radius than boys at follow-up. The 
BW at mid-shaft radius was not significantly different between the boys and giris. After correcting for the 
initial value, there was no significant difference between boys and giris in any of the distal radius bone 
variables at follow-up. ns, not significant.
8.8.1.2 Differences between supplemented and placebo groups at 
follow-up
Bone mineral status of the supplemented and placebo group were 
compared at follow-up to examine whether the effect of calcium supplementation 
on bone mineral accretion observed at outcome remain after supplement 
withdrawal. The comparisons were made after the variables at follow-up were 
adjusted for baseline value, sex and pubertal status.
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8.8.2.1 Gain in bone mineral at mid-shaft radius
Both the supplemented and placebo groups showed significant gains in 
BMC, BW and BMD at the mid-shaft and distal radius over the 2 year period 
(Table 8.9). Gains in BMC and BMD at mid-shaft radius were significantly greater 
in the supplemented than placebo group (Table 8.9). Change at the mid-shaft 
BW was not significantly different between the groups at follow-up.
After correcting for baseline value and sex, the gain in BMC and BMD at 
the mid-shaft were significantly greater in the supplemented compared with 
placebo group (Table 8.9). The percentage differences (mean SE) at follow-up 
between supplemented and placebo groups after correcting for baseline were, 
mid-shaft radius, BMC = + 4.5 SE 1.7%, p = 0.007, BMD = + 5.0 SE 1.2%, p 
<0.0001. There was no interaction of supplement effect with age, sex, dietary 
calcium intake or pubertal status.
Table 8.9 Comparison of gain in bone variables over 24 months between the 
supplemented and placebo groups*
Follow-up - Baseline #A%difference at follow-up
supplement 
(n = 80)
Placebo 
(n = 80 )
supplement vs placebo
mean SE significance
Mid-shaft BMC g/cm) 0.087 ± 0.055® 0.068 ±0.051® +4.5 1.7 p=0.007
Mid-shaft BW (cm) 0.059 ±0.062® 0.065 ± 0.052® -0.4 0.8 p=0.66 (ns)
Mid-shaft BMD (g/cm2) 0.058 ± 0.036® 0.037 ± 0.038® +5.0 1.2
ooo«Œ
Distal radius BMC (g/cm) 0.101 ±0.098® 0.090 ±0.105® +4.1 3.0
100!
Distal radius BW (cm) 0.189 ±0.157® 0.185 ±0.194® +0.9 1.3 p=0.47 (ns)
Distal radius BMD (g/cm2) 0.029 ± 0.043® 0.025 ± 0.047® +4.0 2.5 p=0.11 (ns)
f Mean ± SD. BMC, bone mineral content; BW, bone width. #A% = percentage difference at follow-up after 
correcting for baseline value and sex. Data transformed to natural logarithms prior to analysis. Follow-up
significantly different from baseline (paired t- test), *  p<0.0001. Changes in mid-shaft radius BMC and BMD
were significantly greater in the supplemented than placebo groups, p=0.021, p=0.0003 respectively. 
Changes in distal radius variables were not significantly different between the groups, ns, not significant.
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After adjusting for differences at baseline, and for body and bone size 
(size-adjustment), BMC at the mid-shaft was significantly greater in the 
supplemented than placebo group at follow-up (+5.0 (SE = 1.1)%, p<0.0001). 
There were no interactions between the supplement effect with age, sex, dietary 
calcium intake or pubertal status, indicating that the effect of supplement was not 
influenced by any of these variables.
8.8.3.1 Change at distal radius
There was an incremental gain in BMC, BW and BMD at the distal radius 
over the 24 month period (Table 8.9). There were no significant differences 
between the supplemented and placebo group in gain in BMC, BW, and BMD at 
distal radius at follow-up (Table 8.9). After adjustment for baseline value, the 
supplemented group had greater BMC and BMD than placebo group at follow-up 
which was similar to the differences observed at mid-shaft radius but was not 
statistically significant. The percentage difference between the supplemented 
and placebo groups after adjusting for baseline value, were, BMC, +4 .1  SE 
3.0%, p = 0.18 (ns); BMD, +4.0 SE 2.5%, p = 0.11 (ns), (Table 8.9). After 
correcting for baseline value, there was no significant difference between the 
supplemented and placebo groups in change in BW at distal radius over the 2 
year period (S -R, +0.9 SE 1.3%, p = 0.47).
After adjustment for differences at baseline, and for bone and body size 
size-adjusted BMC at the distal radius was not significantly different between the 
supplemented and placebo group at follow-up (+2.7 SE = 2.4%, p = 0.27).
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The results at follow-up indicate that the effect of calcium supplementation on 
bone mineral accretion of rural Gambian children was sustained 12 months after 
supplement withdrawal especially at mid-shaft radius.
8.8.3.2 Differences between the supplemented and placebo groups by sex
Table 8.10 shows supplement effect in each sex. After correcting for the 
initial value, effects of supplement were still visible in boys and girls when each 
sex was looked at separately. After correcting for baseline value, differences in 
the incremental gain in BMC, BW or BMD at either the mid-shaft or distal radius 
between the supplemented and placebo groups were not statistically significant 
in any of the sexes (Table 8.10).
The results provided no evidence that the supplement effect was different 
in boys and girls and the magnitude of the effects were similar. The lack of 
significance probably reflects the decrease in power associated with splitting the 
data by sex. This analysis confirms the lack of a sex interaction in the regression 
models examining the effect of supplement in the total group (see section 8.5).
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Table 8.10 Changes in bone variables over 24 months of the supplemented and placebo
groups, by sex*
Follow-up - Baseline #A%difference at follow-up
supplemented placebo supplement vs placebo
(40 M, 40 F) (40 M, 40 F)
Boys
Mid-shaft BMC (g/cm) 0.072 ±0.048 0.061 ±0.053
mean
+0.5
S E
2.3
significance 
p=0.81 (ns)
Mid-shaft BW (cm) 0.053 ±0.054 0.063 ± 0.053 -1.2 1.2 p=0.32 (ns)
Mid-shaft BMD (g/cm2) 0.046 ±0.033® 0.030 ±0.037 +2.2 1.7 p=0.20 (ns)
Distal BMC (g/cm) 0.089 ±0.104 0.083 ±0.123 +2.6 4.8 p=0.58 (ns)
Distal BW (cm) 0.184 ±0.167 0.175 ±0.245 +1.2 2.2 p=0.58 (ns)
Distal BMD (g/cm2) 0.025 ± 0.041 0.021 ±0.052 +2.9 3.7 p=0.43 (ns)
Girls
Mid-shaft BMC (g/cm) 0.103 ± 0.058b 0.075 ±0.049 +3.3 2.6 p=0.20 (ns)
Mid-shaft BW (cm) 0.065 ±0.069 0.067 ±0.052 -0.0 1.3 p=1.00 (ns)
Mid-shaft BMD (g/cm2) 0.071 ±0.035® 0.044 ±0.039 +3.8 2.0 p=0.06 (ns)
Distal BMC (g/cm) 0.112 ±0.090 0.096 ±0.085 +4.4 3.9 p=0.26 (ns)
Distal BW (cm) 0.194 ±0.148 0.195 ±0.127 -0.4 1.5 p=0.77 (ns)
Distal BMD (g/cm2) 0.033 ± 0.044 0.029 ±0.041 +3.9 3.5 p=0.27 (ns)
f Mean ± SD. BMC, bone mineral content; BW, bone width, BMD, bone mineral density. #A% = percentage 
difference at follow-up, after correcting for baseline value and sex at mid-shaft radius and after variables at 
distal radius were adjusted for the initial value. Data transformed to natural logarithms before analysis. 
Change over the 24 month period at shaft BMD in boys were significantly greater in the supplemented than
placebo group a p=0.0408. In giris, gain at mid-shaft BMC and BMD were significantly greater in the 
supplemented than placebo group, bp=0.023, 0 p=0.002. There were no significant differences between the 
groups in the incremental gain in other bone variables in either sex. ns, not significant.
8.9 Ultrasound at baseline
8.9.1 Effect of age and other characteristics on ultrasound variables
Normalised bone ultrasound attenuation (nBUA, dB/MHZ) was positively 
related to age at baseline. There was an increase with age (p<0.0001). There 
was no association between velocity of sound (VOS, m/second) and age at 
baseline.
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There was no effect of weight or height on VOS at baseline (weight, p = 
0.18; height, p = 0.054). After adjusting for age and pubertal status, there were 
significantly positive effects of weight and height on nBUA at baseline (p<0.0001, 
p = 0.001 respectively). When boys and girls were considered separately, weight 
and height were associated with nBUA in girls (weight, p<0.0001; height, p = 
0.0007) but not in boys (weight, p = 0.19; height, p = 0.31).
There was a significantly positive correlation between nBUA and pubertal 
status at baseline (p<0.0001) but no association between VOS and pubertal 
status (p = 0.26).
Table 8.11 gives mean ± SD of baseline VOS and BUA. After correcting 
for age, weight, height and pubertal status, there was no significant difference 
between either the supplemented and placebo groups or between boys and girls 
in any of the ultrasound variables at baseline.
Table 8.11 Baseline ultrasound VOS and nBUA for all subjects, by supplemented and
placebo group, and by sex*.
Total Supplement Placebo Bovs Girls
(n = 160) (n = 80) ( n = 80 ) (n = 80) (n = 80)
VOS (dB/MHZ) 1744 ±51 1741 ±49 1745 ±52 1737 ±48 1750 ±52
nBUA(m/s) 60.3 ±13.1 60.2 ±11.1 60.4 ±14.9 61.3 ± 11.7 59.3 ±14.4
+ Mean ± SD. VOS, velocity of sound, nBUA, broadband ultrasound attenuation. After correcting for age, 
there was no significant difference between either the supplemented and placebo groups or between boys and 
girls in any of the ultrasound variables at baseline.
8.9.2 Correlations between ultrasound and SPA variables
Correlations between ultrasound and SPA variables were tested using 
Pearson Product-moment. nBUA measurement was significantly correlated with
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mid-shaft radius BMC (r = 0.40, p = 0.032) and BW (r = 0.38, p = 0.009) but not 
BMD (r = 0.27, p = 0.40) using SPA. There were also significant correlations 
between nBUA and BMC (r -  0.42, p -  0.001), BW (r = 0.35, p = 0.025) and BMD 
(r = 0.36, p = 0.003) at distal radius. No significant correlations were found 
between VOS and SPA measurements.
8.10 Ultrasound measurements at outcome
After correcting for age and pubertal status, there were no significant 
differences in ultrasound variables either between the supplemented and 
placebo groups or between boys and girls at outcome (Table 8.12).
Table 8.12 Velocity of sound and broadband ultrasound attenuation of supplemented and
placebo groups, and by sex at outcome^
Total Supplement Placebo Bovs Girls
(n=160) (n = 80) (n = 80) (n = 80) (n = 80)
VOS (dB/MHZ) 1716 ±82 1716 ±79 1717 ± 85 1710 ±76 1723 ±87
nBUA (m/s) 60.6 ±10.7 60.4 ± 9.3 60.8 ±12.0 59.3 ±9.2 62.0 ±11.9
f Mean ± SD. VOS, velocity of sound, nBUA, broadband ultrasound attenuation. After adjusting for age and 
pubertal status, there was no significant difference between either the supplemented and placebo groups or 
between boys and girls at outcome.
8.10.1 Gain in ultrasound measures
8.10.1.1 Differences between boys and girls
Girls had a significant change in VOS and nBUA over the 12 month period 
(Table 8.13). Only the VOS at outcome in boys was significantly different from 
baseline (Table 8.13).
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Table 8.13 Changes in ultrasound variables in boys and girls over 12 months*
Baseline Outcome
Boys Girls Boys Girls
(n = 80) (n = 80) (n = 80) (n = 80)
VOS (dB/MHZ) 1737 ±48 1750 ±52 1710*76" 1723 ±87"
nBUA (m/s) 61.3 ± 11.7 59.3 ±14.4 59.3 ±9.2 62.0 ±11.9"
fMean ± SD. VOS, velocity of sound; nBUA, broadband ultrasound attenuation. Baseline not significantly 
different between the sexes. Change in VOS and nBUA over 12 months were significantly greater in girls.
Change over 12 month in VOS but not nBUA was significant in boys. *  p = 0.001, b p = 0.008, Cp = 0.012.
Changes in ultrasound variables over 12 month were significantly different 
between boys and girls (Table 8.14). After adjustment for age and pubertal 
status, change in VOS and nBUA in girls were 1.1% lower and 7.4% greater than 
boys respectively (p = 0.032 and p = 0.0006). After further correction for baseline 
value, age and pubertal status, girls had significantly lower VOS and higher 
nBUA than boys (Table 8.14).
Table 8.14 Gains in ultrasound measures, of boys and girls after 12 months of the study*
Outcome - Baseline 
Boys Girls 
( n = 80) ( n = 80 )
#A%difference at outcome 
Boys vs Girls
Mean SE significance
VOS (dB/MHZ) -27.5 ± 72.0 -26.5 ± 86.6* +1.0 0.5 p—0.043.
nBUA (m/s) -2.0 ±11.2 2.6 ± 9.3b -7.7 2.1 p=0.0004
f Mean ± SD. #A% = percentage difference at outcome after correcting for baseline value, age and pubertal 
status. Data transformed to natural logarithms before analysis. VOS, velocity of sound; nBUA, broadband 
ultrasound attenuation. Change in ultrasound variables over 12 month was significantly different between 
boys and girts, "p = 0.032, " p = 0.0006.
175
Chapter 8 Ultrasound measurements
8.10.1.2 Differences between supplemented and placebo groups
Both the supplemented and placebo groups had a significant decrease in 
VOS over the 12 months (Table 8.15). After correcting for baseline value, age, 
sex and pubertal status, there were no significant differences between the 
supplemented and placebo groups in percentage change in VOS and nBUA at 
outcome (Table 8.15). There were no interactions between the supplemented 
group and age, sex or pubertal status.
Table 8.15 Gains in ultrasound measures of the supplemented and placebo groups after
12 months of the study?
Outcome - Baseline 
Supplemented Placebo 
( n = 80) ( n = 80 )
#A%difference at outcome 
Supplement vs Placebo
Mean SE significance
VOS (dB/MHZ) -25.9 ± 74.7a -28.1 ±84.2b +0.6 0.7 p=0.95 (ns)
nBUA (m/s) 0.24 ± 9.2 0.44 ±11.7 -0.6 2.2 p=0.78 (ns)
f Mean ± SD. Data transformed to natural logarithms before analysis. VOS, velocity of sound; nBUA, 
broadband ultrasound attenuation. VOS at outcome was significantly different from baseline. 9p = 0.003, ^p 
= 0.004. There was no significant difference between the supplemented and placebo group in change in 
ultrasound variables over the 12 month period, ns, not significant.
8.11 Ultrasound measures at follow-up
8.11.1 Differences between the supplemented and placebo groups and between 
boys and girls in ultrasound variables at follow-up
After correcting for age and pubertal status, there was no significant 
difference between either the supplemented and placebo groups, or boys and 
girls in any of the ultrasound variables at follow-up (Table 8.16).
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Table 8.16 Ultrasound VOS and nBUA for all subjects, divided by supplemented and 
placebo groups and by sex at follow-up^
Total Supplement Placebo Boys Girls
(n = 160) ( n = 80) (n = 80 ) (n = 80) (n = 80)
VOS (dB/MHZ) 1730 ±42 1725 ±41 1734 ±43 1727 ±42 1732 ±43
nBUA(m/s) 63.1 ±11.4 62.3 ±11.2 64.0 ±11.7 64.0 ±11.4 62.4 ±11.5
f Mean ± SD. VOS, velocity of sound, BUA, broadband ultrasound attenuation. After correcting for age, 
height and pubertal status, there was no significant difference between either the supplemented and placebo 
groups, or boys and girls in any of the ultrasound variables at follow-up.
8.11.2 Change in ultrasound variables over 24 months
8.11.2.1 Differences between the supplemented and placebo groups and 
between boys and girls
After adjustment for baseline value, age and pubertal status, there were no
significant differences in percentage VOS and nBUA between boys and girls at 
follow-up (Table 8.17). After correcting for baseline value, age, height and 
pubertal status, changes in nBUA and VOS over the 2 year period were not 
significantly different between the supplemented and placebo groups (Table 
8.18).
Table 8.17. Difference between boys and girls in the incremental gain in ultrasound
variables at follow-up^
Follow-up - Baseline #A%difference at follow-up
Boys Girls Boys vs Girls
( n = 80) ( n = 80)
mean SE significance
VOS (dB/MHZ) -9.9151.0 -17.9154.3" +0.2 0.4 p=0.68 (ns)
nBUA (m/s) 2.5112.8 3 .0 i13.1b -0.1 2.7 p=0.98 (ns)
t Mean ± SD. vos, velocity of sound, BUA, broadband ultrasound attenuation. Data transformed to natural 
logarithms prior to analysis. Change in ultrasound variables over 24 months were not significantly different 
between the sexes. #A% = percentage difference at follow-up after correcting for baseline value, age and
pubertal status. Follow-up significantly different from that at baseline. ap = 0.042, bp = 0.004. After adjusting
for baseline value, age and pubertal status, there was no significant difference between boys and giris in any 
of the variables at follow-up. ns, not significant.
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Table 8.18 Difference between the supplemented and placebo group in the incremental
gain in ultrasound variables at follow-up^
Follow-up - Baseline 
Supplemented Placebo 
(n = 80) (n = 80 )
#A%difference at follow-up 
Supplement vs Placebo
mean SE significance
VOS (dB/MHZ) -16.8 ±55.0" -11.1 ±50.4"
oo
p=0.26 (ns)
nBUA (m/s) 2.1 ±10.9 3.5 ±14.7" -4.0 2.7 p=0.14 (ns)
f Mean ± SD. VOS, velocity of sound, BUA, broadband ultrasound attenuation. Data transformed to natural
logarithms prior to analysis. Follow-up significantly different from baseline,” p=0.008, b p=0.053, 0 p=0.040.
Change in ultrasound variables over 24 months were not significantly different between the groups. #A% = 
percentage difference at follow-up after correcting for baseline value, age, sex and pubertal status, ns, not 
significant.
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9. Results: Biochemical markers of calcium and bone 
metabolism
9.1 Skewed distributions
The distributions of most of the markers of bone metabolism in blood and 
urine were positively skewed. Data were, therefore, transformed to natural 
logarithms prior to analysis. Summary statistics for all biochemical markers for 
this study, are presented as geometric mean unless otherwise stated.
9.2. Effect of age and other characteristics on biochemical markers
in blood
There were associations between age, pubertal status and number of 
biochemical markers measured in blood. A positive association between plasma 
osteocalcin concentration and age at follow-up (p = 0.014) but not at baseline (p 
= 0.57) or outcome (p = 0.85) was seen. There was a positive effect of age on 
alkaline phosphatase at baseline (p = 0.036) and follow-up (p< 0.0001) but not at 
outcome. Plasma concentration of calcium was negatively related to age at 
baseline (p = 0.036) and follow-up (p = 0.030) but not at outcome (p = 0.062). 
There was an age effect on calcium adjusted for albumin at follow-up (p = 0.025) 
but not at other timepoints. There was a positive correlation between plasma 
concentration of phosphorus and age at follow-up (p = 0.004) but not at baseline 
(p = 0.39) or outcome (p = 0.092). There was a positive effect of age on PTH at 
outcome (P = 0.0006) but not at baseline (p = 0.12) or at follow-up (p = 0.614). A 
negative effect of age on albumin and a positive effect on creatinine 
concentration at outcome were also observed (p = 0.0006 and p<0.0001) but not 
at baseline or follow-up.
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After adjusting for age, a positive effect of puberty was seen on the 
following: plasma osteocalcin concentration at baseline (p = 0.006) and outcome 
(p = 0.020) but not at follow-up, PTH at follow-up only (p = 0.040), alkaline 
phosphatase at outcome (p<0.0001) and follow-up (p = 0.0008), phosphorus at 
outcome only (p = 0.010).
On the basis of the effect of age and pubertal status on some of the blood 
markers and the differences between boys and girls in some of the variables (see 
section 9.3), the effect of supplement on blood markers of calcium and bone 
metabolism was examined after values at outcome and follow-up were 
appropriately adjusted for these confounding variables.
9.3 Differences between boys and girls
9.3.1 Differences between boys and girls in bone markers at baseline
There were no significant differences between boys and girls in plasma 
osteocalcin concentration or parathyroid hormone concentration at baseline but 
boys had significantly lower total plasma alkaline phosphatase, bone-specific 
alkaline phosphatase and calcium corrected for albumin than girls (Table 9.1).
9.3.2 Differences between boys and girls in bone markers at outcome
There were significant changes in some of the blood markers over the 12
month period. Plasma osteocalcin concentration in both boys and girls was 
significantly reduced (Tables 9.2, 9.3). Other markers had increased significantly 
in both boys and girls: total alkaline phosphatase, bone specific alkaline 
phosphatase and creatinine (Table 9.3). Plasma PTH concentration was 
significantly increased in girls over the 12 month period (Table 9.3).
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After correcting for baseline value, the change in plasma osteocalcin 
concentration was more negative in boys than girls (-18.1 SE 6.6%, p = 0.008, 
Table 9.3) and in those who were prepubertal (prepubertal versus pubertal, -15.8 
SE 7.2%, p = 0.003), but was influenced independently by age after correcting for 
puberty. After correcting for baseline and for confounders, boys had significantly 
lower increases in plasma concentration of total alkaline phosphatase, bone- 
specific alkaline phosphatase and parathyroid hormone than girls at outcome 
(Table 9.3).
9.3.3 Differences between boys and girls in bone markers at
follow-up
Both boys and girls had significant increases in plasma osteocalcin, total 
alkaline phosphatase, bone specific alkaline phosphatase concentration over the 
24 month period (Tables 9.4, 9.5). PTH concentration was significantly increased 
in girls over the 2 year period (Table 9.5). After adjusting for baseline value, age, 
pubertal status and supplement group, the change in plasma osteocalcin 
concentration at follow-up was significantly lower in boys than girls (-18.3 SE 
6.9%, p = 0.009, Table 9.5). Plasma concentrations of total alkaline phosphatase 
and bone-specific alkaline phosphatase were significantly lower in boys than 
girls at follow-up (Table 9.4). After correcting for the initial values and other 
confounders, the incremental gains in plasma total and bone specific alkaline 
phosphatase were significantly lower in boys than girls at follow-up (Table 9.5).
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9.3.4 Differences between boys and girls in other circulating biochemical 
markers
Both boys and girls had significant increases in creatinine concentration 
over the 24 month period (Table 9.5). Plasma concentration of albumin was 
significantly reduced in girls over the 2 year period (Table 9.5). Plasma 
concentration of albumin was significantly lower in boys than girls at baseline 
(Table 9.1). Otherwise, there was no significant difference between the sexes in 
albumin concentration at either outcome or follow-up (Tables 9.2 and 9.4). There 
were no significant differences between boys and girls in other biochemical 
markers measured in blood at baseline, outcome or at follow-up before or after 
adjusting for baseline value and other confounders (Tables 9.1, 9.2, 9.4). An 
exception was in plasma creatinine concentration which was higher in boys than 
girls at outcome and at follow-up (Tables 9.2 and 9.4). After adjusting for 
baseline value, age, pubertal status and supplement group, the change was 
larger in boys by +8.2% (p =0.0002) compared with girls at follow-up (Table 9.5).
9.4 Effect of supplement on blood markers
9.4.1 Differences between supplemented and placebo groups in bone markers at 
baseline
On the basis of the effect of sex, age and pubertal status on biochemical 
markers in blood, the effect of calcium supplement on biochemical markers was 
explored after appropriate adjustments were made.
Plasma concentrations of osteocalcin, PTH or any other bone marker did 
not differ significantly between the supplemented and placebo groups at 
baseline (Table 9.1).
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9.4.2 Differences between the supplemented and placebo groups in bone markers 
at outcome
At outcome, the supplemented group had a significantly lower plasma 
osteocalcin concentration than at baseline and exhibited a greater decrease over 
12 month period compared with the placebo group (supplemented, -26.4 SE 
5.01% vs placebo, -3.9 SE 6.44%, Tables 9.2 and 9.6). In contrast, the 
osteocalcin concentration of the placebo group at outcome was not significantly 
different from the baseline value (Tables 9.1 and 9.6). After adjusting for 
baseline value, sex and pubertal status plasma osteocalcin concentration in the 
supplemented group was significantly lower than in the placebo group by -21.9 
SE 6.5%, p = 0.001 (Table 9.6). There was no evidence of any interaction 
between the supplement effect and age, sex or pubertal status.
Plasma concentration of PTH at outcome was significantly greater than 
baseline in the placebo group (Table 9.6). In contrast, PTH concentration 
decreased over the 12 month period in the supplemented group but the 
difference between outcome and baseline was not statistically significant (Table
9.6). At outcome, the plasma concentration of parathyroid hormone was 
significantly lower in the supplemented group compared with the placebo group 
(Table 9.2). After correcting for the initial value and other confounders, plasma 
concentration of parathyroid hormone in the calcium supplemented group was 
significantly lower than the placebo group (-20.1 SE 5.8%, p = 0.0008, Table
9.6). There were significant increases in total alkaline phosphatase, bone 
specific alkaline phosphatase and creatinine concentration in the supplemented 
and placebo groups over the 12 month period (Table 9.6). There were no 
significant differences between the supplemented and placebo group in plasma
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concentration of either total alkaline phosphatase or bone-specific alkaline 
phosphatase at outcome before or after adjustment.
9.4.3 Differences between supplemented and placebo groups in bone markers at 
follow-up.
Plasma concentration of osteocalcin, total alkaline phosphatase and bone 
specific alkaline phosphatase in the supplemented and placebo groups at follow- 
up were significantly greater than at baseline (Tables 9.7). After correcting for 
baseline value, age and puberty, there was no significant difference between the 
supplemented and placebo group in osteocalcin concentration at follow-up 
(supplement : placebo, -0.5 SE 6.5%, p = 0.94, Table 9.7). By follow-up PTH had 
increased above baseline in the placebo group but not in the supplemented 
group (Table 9.7). After adjusting for baseline value and other confounders, the 
supplemented group had significantly lower parathyroid hormone than placebo 
group at follow-up (-19.3 SE 5.4%, p = 0.0006, Table 9.7). Testing of a calcium 
by sex interaction term in PTH at follow-up did not achieve statistical significance. 
There were no significant differences between the supplemented and placebo 
group in other bone formation markers at follow-up before and after adjustment 
for baseline and other confounders (Tables 9.4, 9.7).
9.4.4 Differences between supplemented and placebo groups in other markers 
in blood.
Among other markers in the blood, concentration of plasma creatinine at
follow-up was significantly different from baseline in the two groups (Table 9.7).
Phosphorus concentration in the placebo group was significantly increased and
albumin concentration in the supplemented group was significantly reduced over
the 2 year period. Concentrations of other markers in blood were not significantly
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Chapter 9 Biochemical markers of bone metabolism
different between the supplemented and placebo groups at either baseline, 
outcome or follow-up (Tables 9.1, 9.2, 9.4, 9.6, 9.7). An exception was the 
adjusted plasma concentration of phosphorus which was significantly lower in 
the supplement compared with placebo group at outcome (After adjustment: -4.8 
SE 1.6%, p = 0.004, Table 9.6) but not at follow-up. There was no evidence that 
plasma calcium was affected by the supplement (Tables 9.6, 9.7).
9.4.5 Differences in blood markers between the supplemented and placebo 
groups, by sex.
Although no significant interaction between the effect of supplement and 
sex was observed (see section 9.4.2), the effect of calcium supplementation on 
plasma concentration of some of the biochemical markers was examined in each 
sex separately to investigate whether there was any evidence that the effect of 
supplement on blood markers differed between boys and girls. Only the blood 
markers that were affected by calcium supplementation when sexes were 
combined are presented here. Similar analyses on the remaining analytes did 
not reveal any effect of supplement in either sex.
Plasma concentration of osteocalcin in the supplemented group in boys
and girls, and PTH in placebo group in girls at outcome were significantly
different from baseline (Table 9.8). Changes over the 1 year period of
supplementation in plasma osteocalcin, PTH and phosphorus concentrations
were not significantly different between the groups in boys. In all variables,
changes over 12 months were significantly different between the supplemented
and placebo groups in girls (Table 9.8). The magnitude of the change in PTH in
the placebo group in boys was lower than that of the placebo group in girls but
the difference was not significant as indicated by a lack of supplement x sex
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interaction. The effect of the supplement on osteocalcin and phosphorus was of 
similar magnitude in the two sexes.
After correcting for baseline value, age and pubertal status, there were no 
significant differences between the supplemented and placebo groups in boys in 
the incremental gain in plasma concentration of parathyroid hormone and 
phosphorus at outcome. The decrease in plasma osteocalcin concentration in 
boys over the 12 month period was greater in the supplemented than placebo 
group but the difference did not reach statistical significance. After correcting for 
baseline value and other confounders, the supplemented group in girls had 
significantly lower plasma concentration of parathyroid hormone (-31.9 SE 8.1%, 
p = 0.0003) and phosphorus (-5.2 SE 2.6%, p = 0.048) than placebo group at 
outcome. After correcting for baseline, age and pubertal status, the supplement 
effect on plasma PTH concentration was still apparent at follow-up in both sexes 
(supplement - placebo, boys: -15.8 SE 7.7%, p = 0.047; girls: -23.6 SE 7.6%, p = 
0.003). Interaction terms between calcium supplement and age, and between 
calcium supplement and pubertal status in girls were not statistically significant.
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Table 9.8 Changes in blood variables over 12 months of the supplemented and placebo
groups, by sext
Supplement Placebo #A%difference at outcome
*A% N #A% N supplement vs placebo
Boys
moan SE significance
Osteocalcin (p.g/1) -28.1 ±8.24" 25 -9.5 ±10.12 25 -20.8 9.9 P-O.O5O
PTH (pg/ml) -8.6 ±7.37 24 +1.9 ±6.61 25 -10.0 8.0 p=0.18 (ns)
Phosphorus (mmol/l) -1.6 ±1.63 40 +1.6 ± 1.65 40
CMcxiGOCO p=0.092(ns)
Girls
Osteocalcin (pg/l) -25.8 ± 5.62b 25 +2.7 ±7.62 25 -25.4 8.6
81
PTH (pg/ml) -5.1 ± 6.50 25 +31.4 ±5.60" 25 -31.9 8.1 p=0.0003
Phosphorus (mmol/l)
i_________________
-3.4 ±2.27 31 +3.4 ±2.16 35 -5.2 2.6 p=0.048
_________ i
f Mean ± SE. #A% = percentage difference at outcome, after correcting for baseline value and age. Data 
transformed to natural logarithms before analysis. Variables at outcome corrected for baseline value, 
pubertal status and age. Differences between outcome and baseline significantly different from nought
(paired t - test): *  p = 0.0012, b p = 0.0002, c p^0.0001. PTH , parathyroid hormone, N, number of subjects in
each data set. ns, not significant.
9.5 Effect of age and other characteristics on urinary biochemical 
markers
There was a significant effect of age on the daily outputs of potassium, 
creatinine, deoxypyridinoline and deoxypyridinoline-to-creatinine ratio at 
baseline, with output higher in the older children (p = 0.0006, p<0.0001, p = 
0.0002 and p = 0.042 respectively). There was a negative association between 
the deoxypyridinoline-to-creatinine ratio and age (p = 0.036). This was due to 
the highly positive correlation of creatinine and less positive correlation of 
deoxypyridinoline with age. For similar reasons, urinary phosphorus-to- 
creatinine ratio at baseline was negatively related to age (p<0.0001). At 
outcome, the following were negatively related to age: calcium, sodium, calcium-
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to-creatinine, sodium-to-creatinine and potassium-to-creatinine ratio (p = 0.036, p 
= 0.019, p = 0.016, p = 0.017, and p = 0.008 respectively).
After adjusting for age, urinary outputs of creatinine, potassium, sodium, 
deoxypyridinoline, sodium-to-creatinine and deoxypyridinoline-to-creatinine ratio 
were positively related to pubertal status (p = 0.039, p = 0.036, p = 0.0005, p = 
0.023, p = 0.034 and p = 0.005 respectively). In contrast, the phosphorus-to- 
creatinine ratio was significantly negatively related to pubertal status (p = 0.013).
On the basis of the effect of age and pubertal status on some of the urinary 
markers, and the pronounced differences between boys and girls in many of the 
urinary variables (see section 9.6), the effect of supplement onx the urinary 
markers of calcium and bone metabolism was examined, after values at outcome 
and follow-up were appropriately adjusted for confounding variables.
9.6 Differences between boys and girls in urine markers
9.6.1 Differences between boys and girls at baseline
The outputs of biochemical markers measured in urine were similar in 
boys and girls at baseline (Table 9.9).
9.6.2 Differences between boys and girls at outcome
Both boys and girls had significant increases in urinary outputs of calcium, 
calcium-to-creatinine and calcium-to-sodium ratio and a significant decreases in 
potassium, deoxypyridinoline-to-creatinine, phosphorus-to-creatinine and 
potassium-to-creatinine ratios over the 12 month period (Tables 9.10, 9.11). 
Urinary output of sodium-to-potassium in girls at outcome was significantly 
greater than baseline value (Table 9.11). Boys had significant increase in
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creatinine and a significant decrease in sodium-to-creatinine ratio over the 1 year 
period. Adjusted calcium and creatinine outputs were significantly greater in 
boys than girls at outcome (Table 9.11) reflecting differences between sexes at 
baseline. After adjusting for baseline value, age, pubertal status and supplement 
group there was no significant difference between boys and girls in change in 
urinary output of deoxypyridinoline (Table 9.11). The change in sodium-to- 
creatinine ratio over the 12 month period was significantly lower in boys than 
girls before and after adjusting for baseline value and other confounders (Tables 
9.10, 9.11). Boys had significantly greater increases in calcium-to-sodium ratio 
than girls before and after correcting for baseline value, age, pubertal status and 
supplement group (Table 9.10, 9.11) again, reflecting the baseline difference in 
urinary calcium between the sexes.
9.6.3 Differences between boys and girls at follow-up
There were significant increases in urinary outputs of calcium, creatinine, 
calcium-to-creatinine and calcium-to-sodium ratios and significant decreases in 
potassium, potassium-to-creatinine and sodium-to-creatinine ratios in boys and 
girls over the 24 month period (Tables 9.12, 9.13). A significant increase in 
phosphorus and deoxypyridinoline output and a significant reduction in 
deoxypyridinoline-to-creatinine ratio over the 2 year period were seen in the 
boys but not in girls. Similarly girls but not the boys had significant decrease in 
phosphorus-to-creatinine ratio and a significant increase in sodium-to-potassium 
ratio over the 24 month period (Table 9.13). Boys had significantly lower daily 
urinary output of sodium and potassium, sodium-to-creatinine ratio, potassium-to- 
creatinine ratio and deoxypyridinoline-to-creatinine ratio than girls before and
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after appropriate adjustment (Table 9.12, 9.13). The change in unadjusted 
calcium-to-sodium ratio was higher in boys compared with girls at follow-up 
(Table 9.13). After adjusting for baseline value and other confounders, the 
change in calcium-to-sodium ratio was significantly greater in boys than girls at 
follow-up (Table 9.13).
9.7 Effect of supplement on urine markers
9.7.1 Differences between supplemented and placebo groups at baseline
There were no significant differences between the supplemented and 
placebo group in daily output of minerals or deoxypyridinoline measured in urine 
at baseline (Table 9.9).
9.7.2 Differences between supplemented and placebo groups at outcome
After correcting for baseline and other confounders, change in 
deoxypyridinoline over the 12 month period was lower in the supplemented (- 
12%) than placebo group but the difference did not reach statistical significance 
(Table 9.14). At outcome, the supplemented group had significantly greater daily 
output of calcium than the placebo group before and after adjusting for baseline 
value, age, puberty and sex (+64.5 SE 13.0%, p<0.0001, Table 9.11, 9.14), but 
the creatinine output did not differ between the groups (-2.7 SE 4.8%, p = 0.58), 
resulting in a higher calcium-to-creatinine ratio in the supplemented group 
compared with placebo (Table 9.14). Daily outputs of phosphorus and 
phosphorus-to-creatinine ratio were significantly lower in the supplemented 
compared with placebo group before and after adjusting for, pubertal status, sex 
and age (-41.8 SE 8.3%, p<0.0001, Table 9.10, 9.14). The supplemented group 
had significantly greater calcium-to-sodium ratio than
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placebo group at outcome before and after adjustment for the initial value, 
puberty, sex and age, (Table 9.14).
Daily outputs of calcium, creatinine, calcium-to-creatinine and calcium-to- 
sodium ratio at outcome were significantly greater than at baseline in the 
supplemented and placebo groups. There was a significant increase in urinary 
output of sodium-to-potassium ratio and a significant decrease in 
deoxypyridinoline in the supplemented group over the 12 month period (Table
9.14). There was a decrease in daily outputs of potassium, potassium-to- 
creatinine and deoxypyridinoline-to-creatinine in both the supplemented and 
placebo group over the 12 month period (Table 9.14). There was a significant 
decrease in urinary output of phosphorus in the supplemented group, and a 
significant increase in daily output of phosphorus in the placebo group over the 1 
year period (Table 9.14). A significant decrease in urinary output of phosphorus- 
to-creatinine was seen in the supplemented group over the 1 year period (Table 
14). The placebo group had significant reduction in sodium-to-creatinine ratio 
over the 1 year period. There was no change in urinary sodium output in either 
the supplemented or placebo group, resulting in a significantly greater sodium- 
to-potassium ratio in the supplemented than placebo group at outcome (Table
9.14), There was no interaction between the supplement effect and age, sex or 
pubertal status, indicating that the effect of supplement was not affected by any of 
these variables.
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9.7.3 Differences between supplemented and placebo groups at follow-up
There were significant changes over the 24 month period in urinary output 
of calcium, creatinine, potassium, calcium-to-creatinine, sodium-to-creatinine, 
potassium-to-creatinine and calcium-to-sodium ratios in both the supplemented 
and placebo groups (Table 9.15). Concentrations of phosphorus and 
deoxypyridinoline in the placebo group at follow-up were significantly greater 
than baseline value. Only in the supplemented group did sodium-to-potassium 
ratio at follow-up was significantly greater than baseline value (Table 9.15). 
Changes over 24 months in urinary outputs of biochemical markers were not 
significantly different between the groups. There were no significant differences 
between the supplemented and placebo groups in the daily output of minerals in 
urine at follow-up before and after value at follow-up was adjusted for baseline 
and other confounders (Tables 9.13 and 9.15).
9.7.4 Differences between the supplemented and placebo groups in urinary 
markers by sex
Although statistical analysis did not reveal any interaction between sex 
and supplement, the effect of supplement on the concentration of some of the 
urinary markers were evaluated in boys and girls separately to examine whether 
there was any suggestion of a different response between the groups in boys 
and girls. Only the variables that were significantly affected by the calcium 
supplement when sexes were combined are presented here. Similar analyses of 
remaining analytes revealed no effect of supplement in either sex.
Plasma concentration of calcium, calcium-to-creatinine and calcium-to-
sodium ratios in boys at outcome were significantly greater than that at baseline.
Phosphorus and phosphorus-to-creatinine ratio in the supplemented group in
boys at outcome were significantly lower than that at baseline (Table 9.16). In
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contrast, phosphorus concentration in the placebo group in boys at outcome was 
significantly greater than baseline value (Table 9.16). In girls, urinary outputs of 
calcium, calcium-to-creatinine, calcium-to-sodium and sodium-to-potassium 
ratios at outcome were all significantly greater than that at baseline (Table 9.16). 
Outputs of phosphorus and phosphorus-to-creatinine ratio in the supplemented 
group were significantly lower at outcome than at baseline (Table 9.16). In 
contrast, phosphorus output in the placebo group in girls at outcome was not 
significantly greater than baseline value (Table 9.16). In both sexes, many of the 
changes in urinary markers over the 12 month period were significantly different 
between the supplemented and placebo groups after appropriate adjustment 
(Table 9.16). Conversely, after baseline adjustment, changes in phosphorus and 
phosphorus-to-creatinine in girls over 12 months were significantly lower in the 
supplemented compared with the placebo group (Table 9.16). The magnitude of 
the increases in calcium and calcium-to-creatinine ratio in the supplemented 
group over the 12 month period were similar in both sexes. In both sexes, other 
markers were not significantly different between the supplemented and placebo 
groups after approbate adjustment (data not shown).
There was no evidence that the effect of the supplement was different between 
boys and girls as indicated by a lack of sex x supplement interaction when sexes 
were combined (see section 9.7.2).
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Chapter 9 Biochemical markers of bone metabolism
Table 9.16 Changes in urinary outputs over 12 months of the supplemented and placebo
groups, by sexf
Supplement Placebo #A%difference at outcome
•a % N *A% N supplement vs placebo
Boys
mean SE significance
Caldum(mmol/dl) +121.3 ± 16.8a 39 +62.8 ± 17.6 b 40 +69.1 16.6 p<0.0001
Ca/Cr (mmo/mmol) +107.1 ±14.4* 39 +36.9 ±15.9* 40 +72.4 16.0 p<0.0001
Phosphorus (mmol/d) -30.6 ± 11.7d 39 +29.1 ± 13.5* 40 -51.0 13.2
!i
P/Cr (mmol/mmol) -44.7 ±8.51* 39 +3.3 ±9.98 40 -16.5 13.7 p =0.23 (ns)
Na/K (mmol/mmol) +25.3 ±12.9 39 +4.65 ± 14.4 40 +17.0 14.8 p = 0.25 (ns)
Ca/Na (mmol/mmol) +133.7 ±14.9® 39 +65.7 ±16.2® 40 +73.9 17.4 p<0.0001
Girls
Caldum(mmol/dl) +104.1 ±16.6* 40 +51.2119.2' 40 +60.5 20.6 p=0.004
Ca/Cr (mmo/mmol) +99.8 ±14.8* 40 +41.6 ±17.2 = 40 +62.1 17.8 p=0.0008
Phosphorus (mmol/d) -29.4 ± 11.7h 40 +5.4 ± 7.54 40 -33.1 10.5
8t
P/Cr (mmol/mmol) -33.8 ±.8.66° 40 -4.2 ± 6.35 40 -31.9 8.0 p = 0.0001
Na/K (mmol/mmol) +53.2 ±14.01 ' 40 +29.5112.1,l 40 +25.3 14.2 p=0.079 (ns)
Ca/Na (mol/mmol)
i___________________
+97.7 + 14.2° 40 +55.5 + 14.1® 40 +45.5 16.2 p = 0.006
- -------------- 1
f Mean ± SE. #A% = percentage difference at outcome, after correcting for baseline value, age and puberty. 
Data transformed to natural logarithms before analysis. Phoshorus and phosphorus-to-creatinine at outcome 
were adjusted for the initial value, age and puberty.. Differences between outcome and baseline were . . . .
significantly different from nought (paired t-test): *  p<0.0001, b p = 0.001, 0 p = 0.025, d p = 0.013, *  p = 0.037, 
f p = 0.011, 9 p = 0.021, hp = 0.016,1 p = 0.0005, J p = 0.020. Ca, calcium, Cr, creatinine, K, potassium, Na, 
sodium, N, number of subjects in each data set. ns, not significant
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Chapter 9 Biochemical markers of bone metabolism
9.8 Titratable acid output and urinary pH
9.8.1 Differences between boys and girls
Titratable acid output was significantly greater in boys than in girls at
baseline, outcome and follow-up (p = 0.002, p = 0.023, and p = 0.002 
respectively, Table 9.17). There was a decrease in titratable acid output over the 
12 month period. After correcting for baseline value, supplement group, age and 
puberty, boys had significantly lower decreases in titratable acid output than girls 
at outcome and follow-up (outcome, +26.5 SE 13%, p = 0.043; follow-up, +34.1 
SE 12.2%, p = 0.006, Tables 9.17, 9.20) reflecting the difference at baseline, and 
over 24 months there was general increase with values for boys greater than that 
for girls.
There was a significant difference in urinary pH between boys and girls at 
outcome and follow-up (Table 9.17) with lower values in boys than girls 
(outcome, p = 0.027; follow-up, p = 0.004, Table 9.17).
Table 9.20 Differences in titrable acid output between boys and girls after 12 months and
24 months of the studyt
Bovs Girls #A%difference at outcome
12 months •a%
(n = 80)
•a%
(n = 80)
Boys vs girls
mean SE significance
Titratable acid output 
(mmol//)
-22.4 ±10.03" -22.2 ±6.56" +26.5 13.0 0.043
Bovs Girls #A%difference at follow-up
24 months #A%
(n = 80)
*A%
(n = 80)
Boys vs girls
mean SE significance
Titratable acid output 
(mmol//)
+22.8 ± 9.84 b +12.7 ±10.15 " +34.1 12.2 0.006
f Mean ± SE. *A% = percentage difference at outcome and follow-up respectively, after correcting for 
baseline value, age, pubertal status and supplement group. Data transformed to natural logarithms before 
analysis. Differences between outcome and baseline, and between follow-up and baseline were significantly
different from nought: a p = 0.046 and b p = 0.006 respectively.
21 1
Chapter 9 Biochemical markers of bone metabolism
9.8.2 Differences between supplemented and placebo groups
There was a significant decrease in titratable acid output in both the 
supplemented and placebo groups over the 12 month period and a significant 
increase over the 24 months (Table 9.21). The magnitude of the decrease at 
outcome was greater in the supplemented than placebo group (Table 9.21).
After correcting for baseline value, age, pubertal status and sex, titratable acid 
output was significantly lower in the supplemented group compared with the 
placebo group at outcome ( -43.7 SE 12.1%, p = 0.0004, Table 9.21). There was 
no significant difference in titratable acid output between the supplemented and 
placebo groups either at baseline or follow-up (Table 9.18, 9.21). There was no
evidence of any interaction between supplement effect and sex.
When the effect of supplement on titratable acid output was examined in 
each sex separately, only in boys was the titratable acid output significantly 
different between the groups and was lower in the supplemented group 
compared with placebo group (Table 9.19). Otherwise, there were no significant 
differences between the supplemented and placebo groups in titratable acid
output or pH in either sex after correcting for baseline value.
Urinary pH was not different between the groups at baseline and was not 
affected by supplement at any study timepoint (Table 9.18).
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Table 9.21 Differences in titrable acid output between the supplemented and placebo 
groups after 12 months and 24 months of the studyt
Supplement Placebo #A%difference at outcome
12 months #A% •a % Supplement vs Placebo
(n = 80) (n = 80)
mean SE significance
Titratable acid output -42.6 ±10.33 8 -2.28 ±10.168 -43.7 12.1 0.0004
(mmol//)
Supplement Placebo #A%difference at follow-up
24 months #A% #A% Supplement vs Placebo
(n = 80) (n = 80)
mean SE significance
Titratable acid output +12.3 ±11.52" +22.0 ± 8.29 b +12.2 11.8 0.303
(mmol//)
f Mean ± SE. #A% = percentage difference at outcome and follow-up respectively, after correcting for 
baseline value, age, pubertal status. Data transformed to natural logarithms before analysis. Differences 
between outcome and baseline, and between follow-up and baseline were significantly different from nought:
8 p = 0.046 and b p = 0.006 respectively.
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Summary 
9.9 Biochemical markers
9.9.1 Differences between the supplemented and placebo groups in
biochemical markers
Plasma concentration of osteocalcin at outcome in the supplemented 
group was significantly lower than at baseline. In contrast, the osteocalcin 
concentration of the placebo group at outcome was not significantly different from 
that at baseline. There were significant increases in total and bone specific 
alkaline phosphatase over the 12 month period in the two groups. PTH was 
significantly increased in placebo group but not in the supplemented group over 
the 1 year period. There were significant increases in osteocalcin, total alkaline 
phosphatase, bone specific alkaline phosphatase and creatinine concentration 
in the supplemented and placebo groups over the 24 month period. PTH 
concentration in the placebo group remained significantly increased at follow-up 
compared with baseline value. Daily urinary outputs of calcium, creatinine, 
calcium-to-creatinine and calcium-to-sodium ratios were significantly increased 
and potassium, titratable acid and deoxypyridinoline ratio were significantly 
reduced in the supplemented and placebo groups over the 12 month period. 
There was a significant increase in urinary phosphorus, and a significant 
decrease in sodium-to-creatinine ratio in the placebo group over the 1 year 
period. Urinary phosphorus and deoxypyridinoline were reduced and sodium-to- 
potassium significantly increased in the supplemented group over the 12 month 
period. Both the supplemented and placebo groups had significant gains in daily 
outputs of calcium, creatinine, calcium-to-creatinine and calcium-to-sodium ratio 
and significant decreases in potassium, sodium-to-creatinine and potassium-to- 
creatinine ratios over the 2 year period. Urinary phosphorus and
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deoxypyridinoline outputs were significantly increased in the placebo group over 
the 24 month period.
This study indicated a significant effect of calcium supplementation on 
plasma osteocalcin concentration. There was a 22% reduction in osteocalcin 
concentration in the supplemented compared with placebo group at outcome. 
Plasma concentration of osteocalcin is a marker of bone formation and bone 
turnover.
Calcium supplementation had no significant effect on either total or bone- 
specific alkaline phosphatase since changes over the 12 month period were not 
significantly different between the two groups. Similarly changes in 
deoxypyridinoline, a bone resorption marker in urine were not significantly ; 
different between the supplemented and placebo groups at outcome although 
the magnitude was -12% suggestive of a trend.
The supplemented group had a significantly lower parathyroid hormone, 
titratable acid output and a significantly higher urinary output of calcium than the 
placebo group at outcome, after correcting for baseline value. These are effects 
that would be expected given the large increase in calcium and carbonate intake.
In addition, after adjusting for baseline value, the supplemented group had a 
significantly lower plasma phosphate and lower urinary output of phosphorus at 
outcome compared with placebo group.
At follow-up, the effect on plasma osteocalcin had disappeared but 
parathyroid hormone remained significantly reduced in the supplemented group 
compared with placebo group. There were no significant differences between
215
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the supplemented and placebo group in any of the other biochemical markers 
measured at follow-up.
9.9.2 Differences between boys and girls
Both boys and girls had significant decreases in plasma osteocalcin 
concentration over the 12 month period and significant increases in total alkaline 
phosphatase, bone specific alkaline phosphatase and creatinine over this time 
period. Only girls had significant increase in PTH over the 1 year period. Plasma 
osteocalcin, total alkaline phosphatase, bone specific alkaline phosphatase and 
creatinine concentration in boys and girls at follow-up were significantly greater 
than at baseline. Plasma concentration of PTH was significantly increased and 
albumin concentration significantly reduced in girls over the 24 month period. 
Daily urinary outputs of calcium, calcium-to-creatinine and calcium-to-sodium 
ratio were significantly greater and potassium, titratable acid, potassium-to- 
creatinine and deoxypyridinoline-to-creatinine ratio significantly lower in boys 
and girls at outcome compared with baseline value. Only in boys was creatinine 
output at outcome was significantly greater than at baseline. There were 
significant changes in urinary outputs of calcium, creatinine, potassium, calcium- 
to-creatinine, sodium-to-creatinine, potassium-to-creatinine ratio and titratable 
acid in boys and girls over the 2 year period. Outputs of urinary phosphorus and 
deoxypyridinoline at follow-up in boys were significantly greater than that at 
baseline.
Both plasma total and bone specific alkaline phosphatase concentration 
were significantly lower in boys than girls at baseline. Similarly, both total and 
bone-specific alkaline phosphatase were significantly lower in boys than girls at
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12 months and 24 months. Boys had significantly lower plasma concentration of 
osteocalcin than girls at outcome and follow-up after appropriate adjustment. 
After adjusting for the initial value, plasma concentration of total and bone- 
specific alkaline phosphatase were significantly lower in boys compared with 
girls at follow-up. Since alkaline phosphatase is a marker of bone formation, the 
result indicates that bone mineral accretion rate was greater in girls than boys 
throughout the 2 years.
After adjusting for baseline value, boys had significantly greater urinary 
output of calcium than girls at outcome but not at follow-up. Urinary output of 
potassium was significantly higher in boys than girls at outcome. Changes in 
urinary deoxypyridinoline were hot significantly different between boys and girls 
at either timepoint. Interaction term between supplement effect and sex was not 
significant and there was no evidence to suggest that the response to 
supplement was different between boys and girls. No interaction of supplement 
effect with age or pubertal status was found.
Table 9.22 Effect of supplement on biochemical markers in blood
Maker Baseline Outcome Follow-up
Osteocalcin 0 - 0
Total alkaline phosphatase 0 0 0
Bone-specific alkaline phosphatase 0 0 0
Parathyroid hormone 0 - -
Calcium 0 0 0
Ionised calcium 0 0 0
Phosphate 0 - 0
Albumin 0 0 0
Creatinine 0 0 0
Plus (+) = positive effect, minus (-) = negative effect, 0 = no effect.
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Table 9.23 Effect of supplement on biochemical markers in urine
Maker Baseline Outcome Follow-up
Calcium output 0 + 0
Calcium/creatinine output 0 + 0
Phosphorus output 0 - 0
Phosphorus/Creatinine output 0 - 0
Creatinine output 0 0 0
Sodium output 0 0 0
Sodium/creatinine output 0 0 0
Sodium/potassium output 0 + 0
Potassium output 0 0 0
Potassium/creatinine output 0 0 0
Deoxypyridinoline output 0 0 0
Deoxypyhdinoline/creatinine output 0 0 0
Calcium/Sodium output 0 + 0
Titratable acid output 0 - 0
pH 0 0 0
Plus (+) = positive effect, minus (-) = negative effect, 0 = no effect.
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This study was carried out in a rural area of The Gambia where the growth 
of children is poor, puberty is delayed and bone mineral is low compared with 
British and American children (Lo etal., 1990; Prentice et al., 1990). In addition, 
the calcium intake is low, averaging 200 - 400 mg Ca/d (Prentice & Paul, 1990, 
Prentice etal., 1993; Dibba etal., in press). This study was conducted in order to 
gain insight into the calcium requirements for growth and bone mineral accretion 
of children accustomed to a low calcium diet.
Until recently, there have been few direct studies of the benefits of an 
increase in calcium intakes during growth in countries where the habitual 
calcium intake is low. Early supplementation studies which used linear growth 
as the main outcome showed little effect of calcium (Pettifor et al., 1981; Luyken 
et al., 1967; Malan & Ockerse, 1941). An exception was two Indian studies in 
which significant differences in height and weight gain were reported between 
those supplemented with relatively low doses of calcium and control children 
(Aykroyd & Krishnan, 1938; Aykroyd & Krishnan, 1939). However, a number of 
recent, detailed calcium supplementation and balance studies have 
demonstrated that an increase in calcium intake is associated with an increase in 
bone mineral in children, even in those whose calcium intakes are close to 
current recommended levels (Johnston etal., 1992; Lloyd et al., 1993; Lee et al., 
1994; Matkovic et al., 1990). These data suggested that the dietary calcium 
requirement of children may be greater than previously thought.
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10.1 Calcium intake
Increasing awareness of the importance of a high calcium intake for the 
maintenance of bone health has stimulated recommendations in United States 
and elsewhere to increase calcium intake. Calcium intake varies greatly 
worldwide, ranging from 800 mg per day or more in developed countries to 200 
to 300 mg in some developing countries (FAO, 1991, Lee etal., 1994; Prentice et 
al., 1994). The differences are mainly due to variations in the intake of dairy 
products, which are sources of calcium. In countries where milk consumption is 
rare, notably Africa, calcium may be obtained from cereals and leaf sauces such 
as millets and baobab but the overall consumption of calcium from these sources 
is low.
The measured calcium intake of children who took part in this study was 
extremely low and averaged 338 mg/d. This intake is considerably below current 
recommendations for children (National Academy Science, 1989, National 
Academy Science, 1997; Department of Health, Committee on Medical Aspects 
of Food Policy (COMA), 1992). A very low calcium intake in rural areas of The 
Gambia has been recorded in previous studies in Keneba involving other age 
groups where calcium intakes averaged 300 - 400 mg/d (Prentice et al., 1990; 
Prentice et al., 1993; Prentice et al., 1994). A similarly low level of dietary 
calcium intake of 300 mg/d has been reported in 11 year old Chinese children 
(Lee etal., 1994).
The diet of rural Gambia is based on cereals, and the major sources of 
calcium are dark green leafy vegetables, rice, fish and groundnuts. Dried and 
fresh leaf sauces were shown to be the principal sources of calcium for the 
children in the study and contributed 29 percent of their mean calcium intake. In
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contrast, milk contributed only 6 percent. As in The Gambia, the diet of Chinese 
children is based on rice and the main sources of calcium are dark green leafy 
vegetables, beans, tofu, cereals and fish (Lee etal., 1997). Calcium intakes of 
the Chinese and Gambian children are well below the current recommendations 
by US-AI and UK-RNI of 1300 and 1000 mg/d calcium respectively (National 
Academy of Science, 1997, Department of Health, COMA, 1992). The possibility 
that low calcium intakes may affect growth and bone mineral development of 
rural Gambian children was suggested by a previous study that demonstrated 
that Gambian infants have low size-adjusted bone mineral mass and are short 
compared to British reference children of the same age (Prentice et al., 1990). 
The comparative study presented here demonstrated differences in bone mineral 
status between older Gambian children and British which could largely be 
accounted for by the smaller size of Gambian children but showed that there 
were still marked differentials in overall bone mineral content and in height at 8 - 
12 years of age.
The calcium and phosphorus intakes of the study children were not 
affected by season in contrast to the marked seasonal variation in the intakes of 
most of the other nutrients measured. The wet season, traditionally known as 
hungry season, is the time of the year when people of this community are 
involved in strenuous agricultural activities and food stuffs from previous years’ 
harvest are depleted. The lower energy and protein intakes of the children 
paralleled seasonal variations seen in adults in this community (Prentice et al., 
1981).
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The diet of rural Gambia is based on cereals and groundnuts which mean 
that calcium in the diet may be poorly absorbed due to phytate and oxalate 
content of the diet. Other components of the diet that are considered to affect 
bone accretion such as protein and sodium were also evaluated in this study.
Low intakes of protein are associated with low calcium absorption 
(Kerstetter etal., 1997), while very high intakes of animal protein are associated 
with higher rates of hip fracture (Abelow et al., 1992). High intakes of animal 
protein are thought to result in metabolic acidosis which leads to bone resorption 
independent of PTH and osteocalcin activation (Breslau ef a/., 1988, Abelow et 
al., 1992). However, the exact association between animal protein and bone 
health is unclear. Some (Breslau ef a/., 1988; Schuette et al., 1980; Allen, 1982) 
but not all (Spencer et al., 1978) human metabolic studies suggest diet 
containing high levels of animal protein can increase urinary calcium excretion 
and result in a negative calcium balance. The main sources of protein in the diet 
of rural Gambia are groundnuts while meat and fish protein are rarely consumed. 
However, the average protein intake of boys and girls was 58 and 53 g/d 
respectively, greater than the reference range of 41 - 42 g/d for a 11 - 15 year old 
in Britain (Committee on Medical Aspects of Food Policy (COMA), 1992). 
Therefore, the protein intake of the subjects in this study appeared adequate.
High sodium intakes are thought to increase the amount of calcium 
excreted in the urine and thereby increase the body's need for calcium (Massey 
& Whiting, 1996). This is due to the intimate association between calcium and 
sodium re-absorption in the proximal tubule and loop of Henle (Goulding & Lim, 
1983; Devine etal., 1995; Matkovic etal., 1995). The mean sodium intake of the
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subjects as indicated by their 24h urine excretion was high (97 mmol/d) 
compared with the British recommendation of 25 mmol/d for 11 - 14 year olds 
(Department of Health, Committee on Medical Aspects of Food Policy (COMA),
1992). This was a surprising finding given the influence that high sodium intake 
is thought to have on bone health.
Although the impact of low calcium intake on bone health of populations 
accustomed to low calcium intake is still an area of great controversy it could be 
argued that such low intakes by children in the developing countries could limit 
their skeletal development, reduce peak bone mass and influence osteoporotic 
risk in old age. The hypothesis is extremely difficult to prove since the diet of the 
world's poorer countries are marginal in other essential nutrients and not just 
calcium. Despite the lower calcium intake, there is no evidence that fractures 
due to low bone mineral is more common in developing than in industrialised 
countries, rather the opposite (Adebajo etal., 1991; Solomon, 1979). It has been 
suggested that this is due to adaptation, made possible by low protein intakes 
(Heaney, 1997, Food and Agricultural Organization, 1962). It is this paradox and 
the concept of adaptation that led to a recommendation by FAO/WHO Expert 
Committee in 1960 for a calcium allowance of 500 mg/d (Food and Agricultural 
Organization, 1962). However, bone mineral measurements in Keneba suggest 
that poor bone mineral status is common (Aspray et al., 1996) and lack of 
fractures may be related to number of factors which if changed (e.g., lifestyle) 
could lead to an emerging problem.
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Racial differences in calcium intakes are well documented. American 
Blacks consume only 70 to 80 percent as much calcium as Whites (Park etal., 
1997). The ethnic differences in calcium intake generally reflect low 
consumption of milk and milk products by black people. However some suggest 
that the low dairy consumption by blacks could be partially due to a higher 
prevalence of lactose intolerance among blacks (Federation of American 
Societies for Experimental Biology, 1995). The situation may be different in The 
Gambia, where lactose intolerance is rare. In The Gambia, the overwhelming 
reason for people not to consume milk and milk products is more to do with the 
small dairy industry and small amounts of milk available than not being able to 
tolerate milk.
10.2 Growth
The Z scores for weight-and height-for-age of Gambian children who took 
part in the study were >1 SD below the British reference population and Gambian 
children showed no improvement in growth relative to British children throughout 
the two year period. The results of this study support previous reports which 
indicated that Gambian children have poor growth and delayed puberty 
compared with age matched British and American children (Prentice et al., 1990; 
Lo et al., 1990). This study also supports many previous observations that 
Gambian children show little sign of catch up until adolescence once a growth 
deficit has occurred (Whitehead, 1979, Rowland etal., 1977).
Gambian children who took part in the study were shorter than their age 
and sex matched reference children in the United Kingdom (Prentice & Bates,
1993). Girls had a slightly greater fat mass than boys at study entry (P = 0.0001),
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and fat deposition as assessed by change in triceps skinfold thickness, 
measured over 12 months, was greater in girls than boys (triceps, girls : boys, 
+0.94 mm/year vs 0.39 mm/ year, p <0.0001).
Calcium supplementation had no effect on longitudinal growth of the study 
children. Neither their height Z scores nor the weight Z scores were altered over 
the 12 month period. Similar findings have been observed in other 
supplementation studies using calcium salts (Johnston et al., 1992; Lloyd et al., 
1996; Lee etal., 1994; Lloyd etal., 1993). The lack of an effect of supplement on 
skeletal growth of the rural Gambian children is consistent with a number of early 
calcium supplementation studies in children where calcium salts failed to have 
any effect on weight and height velocity of children from poor social backgrounds 
(Malan & Ockerse, 1941; Pettifor et al., 1981). However, the results of these 
studies contrast with those of supplementation studies using calcium phosphate 
extracted from milk (Bonjour et al., 1997) or milk (Cadogan et al., 1997) where 
increases in BMD in girls was accompanied by increased gains in body size and 
statural height. This suggests a possible beneficial effect of milk on longitudinal 
growth as opposed to calcium itself.
10.3 Pubertal status
Early puberty has been shown as a significant predictor of bone mass 
acquisition in several studies (Bonjour etal., 1991; Glastre etal., 1990; Lloyd et 
al., 1992; Turner etal., 1992; Lee etal., 1996). The onset of puberty in girls is 
usually earlier than in boys, and hormonal changes during early puberty bring 
about the differences in growth spurt and bone mineral development between 
boys and girls. The age-adjusted Z scores for the Gambian children were
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considerably below 0 and decreased with age suggestive of delayed puberty 
relative to British children. In this study, puberty was defined as Tanner stage 2 - 
5. The majority of the children were prepubertal at study entry and remained so 
throughout the study. In Britain, about fifty percent of 12 year old would be 
Tanner stage 2 or more. However, some of the older children had entered 
puberty before the study began (19%). The number of children who had entered 
puberty increased to 31% at outcome and 46% by the end of the 2 years. Again, 
puberty would be expected in almost all the 12 -1 4  year olds in Britain.
This study is in agreement with a previous report that puberty is delayed in 
rural Gambian children by about 1 - 2  years compared with age matched British 
and American children (Lo et a/., 1990). The same study demonstrated that 
Gambian females attained the same bone mineral content by age 19 years as 
British girls did at age 14. Unlike the previous study, this study showed that size 
adjusted bone mineral content of the Gambian children was similar to the age 
and sex-matched British children.
There was no influence of the calcium supplement on stage of puberty. 
Both the supplemented and placebo groups made similar progress through 
puberty. In addition, the response to the supplement was similar in prepubertal 
and those who were either pubertal or went into puberty during the study. This 
finding was similar to that found in some other calcium supplementation studies 
where the effect of calcium supplement on bone mineral status was similar in 
prepubertal and pubertal children (Nowson etal., 1997; Lloyd et al., 1995). In 
contrast, Johnston et al (1992). found no evidence of a supplement effect in twin
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pairs who were post-puberty (4 pairs) at the study entry, or who passed through 
puberty during the study (19 pairs).
Studies in Caucasian populations have demonstrated that bone mineral in 
the forearm is similar in prepubertal boys and girls, but increases rapidly with the 
onset of puberty. This pubertal increase is thought to start 2 years later in boys, 
at about age 13, and to last longer than girls, resulting in boys having a greater 
bone mineral mass by the end of puberty (Krabbe & Christenson, 1984; Peacock, 
1991). This study is in agreement with previous observations in that the British 
boys in the comparative group had greater bone mass at mid-shaft radius than 
girls at age >11 years (see section 8.2, Figure 8.2). The same pattern of skeletal
' : Â
growth was not found in Gambian children, in fact the opposite was true since
v
bone mineral mass at age >11 years was greater in girls than boys (see section 
8.2, Figure 8.2).
227
Chapter 10 Discussion
10.4.1 Effect of supplement on bone mineral status
Table 10.1 Effect of calcium supplement on bone mineral status
Baseline Outcome Follow-up
Mid-shaft radius BMC 0 Î T
Mid-shaft radius BW 0 ( I ) 0
Mid-shaft radius BMD 0 Î T
Mid-shaft size-adjusted BMC 0 T Î
Distal radius BMC 0 Î (T)
Distal radius BW 0 0 0
Distal radius BMD 0 T (T)
Distal size-adjusted BMC 0 T (T)
Î  = positive effect; zero (0) = no effect, (T) = positive effect but not significant, (1) = negative effect 
but not significant. Yearl = baseline; year2 = outcome; years = follow-up
Bone mineral status = BMC adjusted for BW, weight, height and baseline value.
The results of this study, summarised in Table 10.1, demonstrated that an 
increased calcium consumption over a 12 month period by Gambian children 
resulted in a greater bone mineral acquisition. The difference in bone mineral 
accretion between the supplemented and placebo groups at the end of the 
supplementation period was 3% at mid-shaft radius and 8% at distal radius. 
Boys and girls had similar gains in BMC at the mid-shaft and distal radius over 
the 12 month period and these were not different in children who entered puberty 
and those who were prepubertal. The effect of supplement was not affected by 
pubertal status and did not differ between boys and girls. The results of this study 
is in agreement with the hypothesis that calcium supplementation increases 
bone mineral accretion (Johnston etal., 1992; Lloyd etal., 1993; Lee et al., 1994, 
Lee etal., 1995; Nowson etal., 1997) which if sustained throughout the pubertal
growth period and early adulthood, could positively modify peak bone mass.
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Dairy supplementation of girls in early puberty has been shown to have a 
positive effect on bone mineral acquisition (Chan et al., 1995; Cadogan et al., 
1997). There is evidence to suggest that a high calcium intake, generally in the 
form of dairy products, in early life is positively associated with greater peak bone 
mineral mass in adult life (Chan, 1991; Fehily et al., 1992; Hu et al., 1993). 
Supplementation with dairy products has been shown to protect bone loss in 
premenopausal and postmenopausal women (Polley et al., 1987; Smith et al., 
1989; Elders etal., 1994; Dawson-Hughes etal., 1990; Prince etal., 1995).
Calcium supplementation of rural Gambian children appeared to have no 
effect on the size of the growing skeleton. Neither the width of bone at the 2 
measurement sites, nor statural height were altered. The increase was similar 
whether expressed as BMC, BMD or size-adjusted BMC suggesting that the 
amount of mineral within the bone envelope was increased rather than that the 
size of the bones had increased. Similar findings have been observed in other 
supplementation studies (Johnston et al., 1992; Lloyd et al., 1993; Lee et al., 
1994, Lee et al., 1995). However, the result is in contrast to studies using 
calcium extracted from milk or using milk where an increase in BMD in girls was 
accompanied by increased gains in body size and statural height (Bonjour et al., 
1997; Cadogan et al., 1997). This suggests that the effects of calcium 
supplements and milk on the skeleton may differ.
In this study, the magnitude of the supplement effect was similar to that 
reported in supplementation studies of children accustomed to a high calcium 
diet (Table 10.2). Supplementation study in Chinese school children with mean 
dietary calcium intake of 280 mg/d (7.0 mmol/d) ((Lee etal., 1994) who were
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supplemented with 300 mg/d (7.5 mmol/d) calcium produced a similar effect on 
bone mineral density to that reported in both this study and that of the American 
study (Johnston etal., 1992). This is an interesting finding, considering the large 
difference in habitual calcium intake and in supplemented dose between these 
studies. This suggests that the effect may not necessarily reflect correction of a 
calcium deficiency but may indicate an effect of calcium supplement on bone 
turnover. A reduction in bone turnover results in a decreased reversible calcium 
space, and this can lead to a temporary increase in BMC as measured by 
absorptiometry (Lee etal., 1994; Slemenda et a!., 1997; Prentice et al., 1997). 
This is supported by the marked decrease noted in plasma osteocalcin 
concentration in the supplemented group (22%). The same effect was noted in 
prepubertal twins (Johnston etal., 1992) but not in peri and postpubertal children 
(Slemenda et al, 1996). Reduced rates of skeletal remodelling in children have 
been associated with increased bone mineral density and high peak bone mass 
(Slemenda etal., 1997; Department of Health, Committee on Medical Aspects of 
Food Policy (COMA), Report of the Subgroup on Bone Health, 1998).
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Chapter 10 Discussion
10.5 Follow-up
Results from calcium supplementation studies in children are inconclusive 
with regard to maximising peak bone mass. A number of studies have shown an 
association between high calcium intake in early life and attainment of greater 
peak bone mass (Matkovic, 1996; Theintz et al., 1992; Sandler et al., 1985; 
Chan, 1991; Fehily etal., 1992; Anderson., 1996b) but others failed to show any 
effect of calcium intake during childhood on bone mineral mass attained in old 
age (Katzman et al., 1991, Carrie & Bonjour, 1995). For calcium 
supplementation to be beneficial, its effect on bone mineral accretion should be 
sustained after the cessation of supplement, effective in maximising peak bone 
mass, and should have long-term effect in preventing osteoporotic fracture from 
occurring in later life. So far there have been only three supplementation studies 
in children in which follow-up data were collected and all these studies have 
indicated that gains in bone mineral acquired as a result of calcium 
supplementation were not sustained after the withdrawal of calcium supplement 
(Lee etal., 1996; Lee etal., 1997; Slemenda etal., 1997). This suggests that the 
effect of calcium supplement on bone mass is a transient effect, which 
disappears following supplement withdrawal.
In this study however, differences in mean BMC and BMD between the 
supplemented and placebo groups were still visible at mid-shaft and distal radius 
12 months after the supplement withdrawal. At mid-shaft the magnitude was 
similar to that seen at outcome. At distal radius the magnitude of increase in 
BMC and BMD was reduced and was not statistically significant. Differential 
gains in BMC, BMD and size-adjusted BMC at mid-shaft by the supplemented
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group were +4.5 (SE = 1.7)%, p=0.007) and +5.0 (SE = 1.2)%, p<0.0001 ) and 
+5.0 (SE 1.1)%, p<0.0001) respectively. This suggests a possible long-term 
effect of calcium supplementation on bone mineralisation in this group of rural 
Gambian children accustomed to a low calcium intake. A similar observation has 
been reported in supplementation studies of girls using milk or milk extracts in 
which the effect of supplement on bone mineral accretion was sustained 1 year 
after supplement withdrawal (Bonjour et al., 1997; Cadogan et al., 1997).
The mean differences in BMC, BMD and size-adjusted BMC at distal 
radius between the supplemented and placebo groups were reduced during the 
12 month follow-up (BMC, +4.1 (SE = 3.0)%, p=0.177), BMD, +4.0 (SE = 2.5)%, 
p=0.112), size-adjusted BMC, +2.7 (SE = 2.4)%, p = 0.27) and were no longer 
statistically significant at the end of the follow-up. However, the magnitude of the 
differences between supplemented and placebo group in BMC and BMD at the 
distal site at follow-up was similar to that seen at mid-shaft radius. Measurement 
of bone mineral mass at the distal radius using single photon absorptiometry is 
difficult and has a large positioning error compared with mid-shaft radius. It is 
possible that measurement of distal site with a more sensitive instrument such as 
dual energy x-ray absorptiometry (DXA) may give a better measure of changes 
occurring in bone mineral at the distal radius than single photon absorptiometry. 
This possibility is currently being explored in a second follow-up in which bone 
mineral status is being assessed by single photon absorptiometry and dual 
energy x-ray absorptiometry (DXA) 2 years after withdrawal of supplement. It is 
equally plausible that the effect of supplement on bone mineral status at mid­
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shaft at follow-up could be explained by differences in bone turnover rate 
between different skeletal sites, and that bone turnover rate may be slower at 
sites with higher proportion of cortical bone such as the mid-shaft radius 
compared with trabecular bone sites, example, the distal radius. Reduced bone 
turnover in blacks compared with whites has been associated with increased 
bone mineral mass (Weinstein & Bell, 1988; Johnston et al., 1992), so the effect 
seen at the mid-shaft radius of rural black Gambian children at follow-up could 
also mean that it takes longer for bone turnover rate to get back to normal in 
black people once changes in bone remodelling have occurred.
Whether the transient effect of calcium supplementation on bone mineral 
accretion in children should be regarded a beneficial to bone health or be seen 
as a temporal change in a normal bone physiology that reverts to a normal 
steady state once the supplementation is stopped is not clear. Evidence from 
recent literature on the subject of bone remodelling transient suggests the latter 
(Heaney, 1994; Slemenda et al., 1997; Slemenda et al., 1996). A bone 
remodelling transient is described as an imbalance between the amount of bone 
being removed and the amount being added in favour of bone formation as a 
result of reduction in bone remodelling rate. The alteration in remodelling rate is 
thought to last for one remodelling cycle (Heaney, 1994) and does not affect the 
fine balance between bone formation and resorption in other remodelling sites. 
How much of the change in bone reported by calcium supplementation studies 
represents a remodelling transient or a change in modelling is not clear. It is not 
clear whether reduced rates of skeletal remodelling are beneficial during growth 
in children whose habitual calcium intake is low.
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10.6 Ultrasound
In this study, calcium supplementation had no effect on either broadband 
ultrasound attenuation (BUA) or velocity of sound (VOS) at the heel. Our result 
contrasts with a supplementation study in healthy adults using clodronate as an 
anti-resorptive therapy where a significant change in both the BUA and VOS 
were reported in the supplemented group compared with placebo group 
(Detakats etal., 1998). Whether calcium supplementation has a similar effect on 
ultrasound variables in normal adults is not clear. There have been no reported 
studies on the effect of calcium supplementation on ultrasound variables in 
children. In this study change in nBUA (mean% ±  SE) was significantly greater in 
girls than boys at outcome (+5.8 ±  2.2% vs -2.7 ± 2.0%, p = 0.0006) but there was 
no effect of the supplement on nBUA.
Amongst the girls, those who had received supplement had a significant 
reduction in nBUA compared with placebo at follow-up (-8.9 (SE 3.6)%, p = 
0.015). No difference between the supplemented and placebo group in boys 
was found at follow-up and there were no interactions between the supplement 
effect and sex indicating that the response to the supplement was not different in 
boys and girls.
The VOS measurements were negatively related to age in both sexes 
(p<0.0001 ). BUA was also found to be age dependent and increased with age. 
A recent Swedish study of children 1 1 - 1 6  years old found a similar increase of 
BUA with age (Sundberg etal., 1998).
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There was no direct relationship between VOS with either height or 
weight. After adjustment for age, weight and height were positively related to 
nBUA. However, when sexes were considered separately, nBUA was related to 
weight and height in girls but not in boys. Others found a similar relationship 
between adjusted BUA and weight but not height in girls (Lee & Stevenson, 
1993; Schott etal., 1993; Moris etal., 1995). These studies found no association 
between nBUA with either weight or height in boys.
It should be noted that most of the studies on the relationship of ultrasound 
parameters and bone status conducted so far were on adults and normal elderly 
and osteoporotic patients. Little is known about the accuracy of the technique in 
determining bone mineral and bone strength in children. Therefore more 
research is needed to determine the performance of ultrasound in measuring 
bone status at the heel in children. A similar observation was reported by Aloia 
and associates, where ultrasound of the calcaneus failed to predict bone mineral 
density in Black and White women (Aloia etal., 1998). In addition, measurement 
of young children with ultrasound is extremely difficult. This was the case in this 
study particularly with the younger children with small feet. It is equally possible 
that calcium supplementation had no effect on ultrasound variables.
In this study, BUA was correlated with BMC, BW and BMD at both the mid­
shaft and distal radius. An exception was at mid-shaft radius where the 
correlation between nBUA and BMD was not significant. The correlation 
between nBUA and BMD at distal radius was similar to that previously reported 
(Waud etal., 1992; Gluer & Genant, 1994; Graafmans et al., 1994; Salamone et 
al., 1994). However, lower correlations were reported in other recent reports
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(Massie etal., 1993; Van Daele etal., 1994; Young etal., 1993). VOS was not 
related to either BMD or BMC at any of the sites measured, a similar poor 
correlation of VOS with BMD was evident in a study by Brooke-Wavell et al 
(1995) but contrasted with some previous findings (Faulkner et al., 1994). The 
result of this study suggests that bone mineral content and bone mineral density 
could be predicted by ultrasound measurement. The other advantage of the use 
of quantitative ultrasound techniques (QUS) is that QUS is thought to allow 
assessment of bone microstructure which currently is unachievable by bone 
densitometry techniques (Gluer etal., 1994).
In addition to daily calibration of the instrument, the stability of the 
ultrasound was assessed by measuring range of phantoms supplied by the 
manufacturer and the coefficient of variation ranged from 0.4 -1.3% . The stability 
of the SPA was also assessed with phantoms provided by the manufacturer and 
the instrument was stable throughout the study period. The reproducibility of 
ultrasound measurements was assessed by repeated measurement of an adult's 
foot weekly for the 2 year period and the CV for BUA and VOS were 2.1% and 
0.7% respectively which was comparable with values reported in adults (Hans et 
al., 1993; Stewart etal., 1994; Truscott etal., 1992; Schott etal., 1993; Herd etal., 
1992; Herd etal., 1993).
10.7 Biochemistry
In this study, the increase in bone mineral in the calcium supplemented 
group was associated with a significant decrease in osteocalcin concentration 
compared with the placebo group. This suggests that the increase in bone
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mineral observed in the Gambian children consuming the 714 mg/d calcium 
supplement may have been associated with a decrease in bone formation, 
suggesting that the supplement may have acted by altering bone remodelling. 
There are only two supplementation studies of adolescence where osteocalcin 
concentration was evaluated (Johnston et al., 1992; Cadogan et al., 1997 ) and 
the results are conflicting. One study showed an effect of a calcium supplement 
on osteocalcin concentration in blood (Johnston et al., 1992) while the other 
failed to show any change in osteocalcin concentration following 
supplementation (Cadogan etal., 1997). This difference could be due to the fact 
that one study, like the Gambian study used a calcium salt as the supplement 
(Johnston et al., 1992) while the other supplementation was based on milk 
(Cadogan et al., 1997). This supports the possibility that calcium salts and milk 
may have different effects on the growing skeleton. In the Gambian study, the 
supplemented group had a significantly lower plasma parathyroid hormone 
concentration than the placebo group at outcome indicating that the sustained 
increase in calcium intake had had the expected effect on calcium homeostasis. 
A similar reduction in parathyroid hormone secretion has been documented in 
postmenopausal women supplemented with calcium (Heaney, 1994).
There was no influence of the calcium supplement on other biochemical 
markers of bone turnover. Neither bone-specific nor total alkaline phosphatase 
were significantly different between the supplemented and placebo group at 
outcome. The urinary output of deoxypyridinoline was slightly but not 
significantly lower in the calcium-supplement group (-11.7 (SE 9.7)%, p = 0.23). 
In this study, it is plausible that the calcium supplementation of Gambian children
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reduced bone turnover by reducing bone formation as reflected in the plasma 
osteocalcin concentration, resulting in reduced bone remodelling space. Urinary 
output of deoxypyridinoline has been regarded as the most specific marker of 
bone resorption in the urine. Deoxypyridinoline output did not differ significantly 
between the supplemented and placebo group at outcome although there was a 
trend towards lower excretion in the supplemented group. The lack of a 
statistically significant result could have been due to the fact that there was a 
large intra-individual variation in the urinary concentration of deoxypyridinoline in 
these children which could have made it difficult to detect subtle changes in bone 
metabolism.
Calcium supplementation was associated with decreased urinary titratable 
acid and phosphate outputs, a common effect of calcium carbonate loading 
(Adams etal., 1979; Prentice etal., 1995) and indicative of good compliance.
As expected, the supplemented group had a significantly greater urinary 
calcium output (+65% (SE 13.0), p<0.0001) than placebo group. The difference 
averaged 28 mg/d (0.7 mmol/d), equivalent to 3.9% of the ingested dose. The 
effect of the calcium supplement on urinary calcium output is similar to that 
reported in other studies in which the influence of dietary change or the ingestion 
of calcium salts on urinary calcium output was assessed (Reid et al, 1993; 
Dawson-Hughes et al., 1990; Need et al., 1991), but smaller than the 6.6% 
reported in previous calcium supplementation study of lactating Gambian women 
(Prentice etal., 1995). Conversely, phosphorus excretion was significantly lower 
in the supplemented group (-42% (SE 8.3), p<0.0001) compared with the 
placebo group at outcome. Similar results have been reported in a number of
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studies in adults where an increase in calcium intake resulted in elevated level of 
urinary calcium excretion (Prentice et al., 1995; Heaney, 1994). This study was 
not designed to measure calcium absorption so it is not known whether the 
amount of calcium absorbed differed between the supplemented and placebo 
group. However, judging by the higher urinary calcium output in the 
supplemented group compared with placebo group at outcome and the increase 
in bone mineral status, the net absorption appeared higher in those children who 
had supplement than the placebo group.
At follow-up, only the parathyroid hormone concentration remained 
significantly reduced in the supplemented group compared with placebo group. 
This finding is in line with the residual effect of the calcium supplement on bone 
mineral and may suggest a long-term response. There were however no 
significant differences observable between the supplemented and placebo group 
in any of the other biochemical markers measured at follow-up. Urinary output of 
calcium » and phosphorus were not significantly different between the 
supplemented and placebo groups at follow-up, and the deoxypyridinoline was 
similar in the two groups at follow-up.
10.8 Differences between boys and girls
Girls had a higher growth velocity than boys indicated by a significant gain 
in weight, height and triceps skinfold thickness in girls over the 12 month period 
compared with boys, and although not statistically significant weight and height 
gains were greater in girls than boys at follow-up. The incremental gains in bone 
variables over the 12 month period were not statistically different between boys 
and girls. However, there were trends towards a greater BMC and BMD at the
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distal radius in girls. The increases in both mid-shaft and distal radius BMC and 
BMD over the 2 year period were greater in girls than boys but only differences at 
mid-shaft radius BMC and BMD reached statistical significance. A similar sex 
difference has been reported by Lee and coworkers (Lee et al., 1996).
Bone formation markers were higher while bone resorption markers were 
somewhat lower in girls than boys. This is demonstrated by a significantly higher 
concentration of osteocalcin, total and bone-specific alkaline phosphatase and a 
slight reduction in deoxypyridinoline (ns) output in girls than boys. The higher 
plasma alkaline phosphatase concentration in girls compared with boys 
suggests that rural Gambian girls may be reaching their growth spurt earlier than 
boys, an assumption which is supported by a previous study in Keneba (Lo et al., 
1990). This study is consistent with the observation by Husain and associates 
who found no significant sex difference in urinary output of deoxypyridinoline in 4 
to 10 years old children (Husain etal., 1999). In contrast, Marowska et al found a 
greater urinary excretion of deoxypyridinoline in girls compared with boys 
(Marowska etal., 1996). Girls had a similar urinary sodium but a significantly 
lower calcium output than boys at outcome.
The concentration of both total and bone-specific alkaline phosphatase, 
osteocalcin and urinary output of potassium remained elevated while urinary 
output of titratable acid output was significantly lower in girls compared with boys 
at follow-up. There was no significant sex difference in urinary output of calcium 
at follow-up. In contrast, urinary output of sodium was significantly greater in girls 
than boys at follow-up while the opposite was true at outcome. Calcium-to- 
sodium ratio remained significantly elevated in boys compared with girls at
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follow-up, suggesting that the renal handling of calcium may be different between 
boys and girls in this study.
10.9 Suggestions for future research
The above discussion indicates that the long-term effects of high calcium 
intake on growth and bone mineral accretion rate of Gambian children 
accustomed to a low calcium diet would merit further investigation and to 
determine whether such effects are beneficial. In particular, a long-term 
controlled calcium supplementation studies in children, coupled with the studies 
of bone turnover and calcium retention are required to examine whether greater 
gains in bone mineral mass resulting from high calcium intake in childhood will 
persist through to peak bone mass, or whether the effect of high calcium intake 
on bone merely reflects temporary changes in bone turnover. In view of the 
conflicting reports on the effect of supplementation on longitudinal growth, the 
need for adequate and long-term supplementation of children will be even more 
important in evaluating the long term effect of high calcium on growth and peak 
bone mass.
This study is unique among all other calcium supplementation studies in a 
number of ways. In particular, calcium supplementation studies to date have 
failed to demonstrate a sustained effect of supplementation with a calcium salt on 
bone mineral status following supplement withdrawal. An other interesting 
finding in this study which deserves further investigation is the finding that 
parathyroid hormone concentration in the supplemented group was significantly 
lower than in the placebo group at outcome and remained so at follow-up. There 
is so far no explanation for the low parathyroid hormone concentration in children
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who were supplemented one year after withdrawing the supplement. A further 
study investigating calcium metabolism in this group of rural Gambian children is 
needed to address this issue. Furthermore, the significant reduction in 
osteocalcin concentration in the calcium supplemented group at outcome 
compared with placebo group and the subsequent return to a similar level to the 
control group after the supplement was withdrawn cannot be ignored. 
Understanding the bone metabolism fully may help us to understand better what 
is happening at cellular level, and more importantly it will help in our 
understanding about the mechanism involved in bone remodelling transient, 
which could help to establish whether reduced rate of skeletal remodelling are 
beneficial during growth. Finally, a full understanding of these key areas could 
provide a valuable information for nutrition advice and policy making in an area 
of the world such as The Gambia where improving child health and nutrition are 
of paramount importance.
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10.10 Summary
In conclusion, this study has demonstrated that calcium intake of rural 
Gambian children is very low and that the children’s growth is poor and puberty 
delayed if compared with international standards. Calcium supplementation of 
rural Gambian children on low calcium diet resulted in an increase in bone 
mineral status. The magnitude of change was similar to that in other 
supplementation studies of children on higher calcium intakes. If the gain in 
bone mineral accretion is sustained, it could result in an increase in peak bone 
mass and hence reduce the risk of osteoporotic fractures later in life. However, 
calcium supplementation did not have any effect on the size of the skeleton, body 
weight and height, and the increase in bone mineral acquisition of Gambian 
children was marked by a significant decrease in osteocalcin concentration. This 
raises the possibility that the calcium supplement may have acted by altering 
bone turnover rather than by promoting bone growth. The follow-up study 
demonstrated a significantly greater bone mineral status at the mid-shaft in those 
children who received the calcium supplement compared with the placebo 
group. Similar results were found at the distal radius bone mineral, where the 
supplemented children had greater BMC, BW and BMD than the placebo group, 
but differences between the two groups were not statistically significant. 
However, BMC and BMD at the distal radius remained higher in the 
supplemented than placebo group at follow-up. The result of the follow-up study 
suggested that rural Gambian children accustomed to a low calcium diet may 
benefit from a higher calcium intake by promoting skeletal mineralisation.
A further follow-up study is required to determine whether the effect of 
calcium supplement on bone mineral accretion is sustained over the long-term.
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Appendices
Appendix 1
To be read to each prospective participant and the parent/guardian in their own language.
Two copies of the form to be signed: one to be given to the parent/guardian, the other to be kept by MRC.
Calcium Requirements of Children in The Gambia
Purpose of the study
We are interested in finding out whether the growth and bone development of Gambian children can 
be improved by the sort of food they eat. This work will benefit children throughout The Gambia and in 
other places in the world where the diet is similar. We are asking your child to take part in a study in which 
he/she will be given tablets to eat for one year. Half of the boys and girls in the study will be given tablets 
which contain calcium, an ingredient of many of the foods you normally eat and which is needed by the body 
to make strong bones and teeth. The other children in the study will be given tablets which are very similar 
but which will provide no extra calcium. The tablets will be kept at the supplement centre in your village 
and we will ask your child to visit the centre once a day, five days a week, to eat the tablets. If your child 
cannot come to the centre on a particular day for any reason, a fieldworker will bring the tablets to your home 
or arrange for your child to eat them over the weekend. The effect of the calcium on your child's bones will 
be measured at the Keneba clinic before your child starts receiving the tablets, 12 months later when he/she 
stops taking the tablets and 12 months after that. At these visits we will make measurements of the bones in 
your child's arms and feet, measure his/her height, weight and size, and take a blood sample. During the 
same week, fieldworkers will visit your home on 2-3 days to make measurements of the child's food intake 
and to help him/her collect urine.
Your child's involvement in this study is entirely voluntary and if you, or your child, decide that 
he/she prefers not take part, it will not affect the medical treatment you, your child or your family receive 
from the MRC in any way. If you decide to allow your child to join the study, your child is free to leave the 
study at any time, or to withdraw from parts of it, without explanation.
Consent
This explanation of the study was given by 
Date
Name of participating child 
Clinic number of child
Name of parent/guardian
I agree to this child taking part in this study and confirm that the child has been fully informed about the 
study and is happy to participate. We understand that participation is voluntary, and will not affect the 
medical treatment received by the child or the family in any way.
Signature (or thumbprint) of parent/guardian
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Appendix 2
MRC Dunn Nutrition Unit 
Subject Characteristics
Child M/F Date
Study Study time point
Study Number
Subject's ID LLU-U
Subject’s name.............................................................
Procedure explained by ..........................................
Family History
1. Are you currently living with your bom father? (Y/N)
If not, who are you living with?................................
2. Are you currently living with your bom mother? (Y/N)
If not, who are you living with?
3. How many people are currently in your sinkiro?
4. How many other children are currently in your sinkiro?
5. How many bom brothers and sisters have you?
6. How many of them are currently in your sinkiro? | | |
7, How many bom elder brothers/sisters have you
283
Fracture and Medical History
1. Are you left or right handed? (L7R/A)
2. Have you had a serious medical problem in the last year?
3. Have you had a serious medical problem at a younger age?
4. Have you ever broken a bone? (Y/N)
Age Bone Side
5. Are you presently on medication from MRC? (Y/N)
Type Reason
6. Are you presently on any other medication? (Y/N)
Type Reason
Occupation
1. What is/was your bom father's occupation? (F/E/T/A)_____________________________ |__|
2. What is your bom mother's occupation? (F/H/E/T)________________________________ |__|
3. If approriate, what is/was your step-father's occupation? (F/E/T/A)__________________ |__|
4. If appropriate, what is/was your step-mother's occupation? (F/H/E/T) |__|
5. Is there a wage earner in the family other than parents or step-parents? (Y/N) |__|
If yes, how many? |_|
Key: A = Animal herdsman F = Farmer E = Employee T = teacher H = House-wife
285
Socio-Economic Status
1. How many tin houses are currently in the compound? |_|
2. How many thatch houses are currently in the compound? |_|
3. How many radio/bicycle/car/cassette player are currently in the family? j_|
4. Is the family regarded as poor, average or well-off for Keneba (P/A/W)_______________ |__|
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Appendix 3
Results of the characteristics questionnaire at baseline*
Questionnaire Subjects %
Wage earner in the family 71 44
Thatch house 50 31
Children from house wife mothers 152 95
Children from employed mothers 8 5
Children whose fathers were farmers 109 68
Children whose fathers were herdsmen 8 5
Employed fathers 43 27
Radio in the family 126 79
Cassette player 99 62
t160 subjects
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Appendix 4
Activity Questionnaires
M /F  Date
Study .......................................................................................  Study timepoint
Study number |__|__|__|__
Subject's ID |__|__|__
Subject's name .........................................................................................................................
Questions asked by ...........................................................................................................
Questions answered by Subject / Mother /  O ther.......................................................
Education
Are you currently attending school
Which school   English/Arc
How many years have you been attending school |__.
Which class are you currently in |__
Have you ever attended another school
Which school   English/Arc,
How many years |__:
Sport
Do you play any extra sport organized by the school (not PE)
If yes, what activity and how often .....................................................................................................
Do you play any sport not involving school
If yes, what activity and how often ....................................................................................................
Dally activities
Are you responsible for looking after any younger child
If yes, who and what age ................
If yes, how often and in which season................... ...........
Do you regularly pound
Do you regularly cook
Do you regularly fetch water from well
Do you regularly pump water from well
Are you responsible for looking after sheep/goats in the bush
Doyou drink goat or sheep milk
If yes, how much and how often .......................
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Appendix 5 
CALCIUM FOOD FREQUENCY
Study ........................................
Study number 
Subject's ID
Subject's name .......
M /F Date | | | | |
Study timepoint |__
1 1 1 1 1 
U-U-
Questions asked by 
Questions answered by Subject /  Mother /  O th er..........
How often does the subject eat the following foods?
A. FOODS AVAILABLE ALL YEAR Think about now and the preceding >
Fish - fresh or smoked, as a separate item
Fish - dry, fresh or smoked, as part of a recipe
Milk - fresh, sour or tinned as a drink Usual portion.......................................................
Milk - fresh, sour or tinned added to porridge/tea «
Kolanut (kuruo) Usual portion........................................................
B. FOODS AVAILABLE IN SEASON Think about the most recent season for this f
Baobab fruit - raw (sito) Usual portion.......................................................
Baobab fruit - as a drink or ice lolly (sita nono/iso)
Baobab fruit - added to porridge 
Kucha fruit - as a drink/ice lolly (wonjo/iso)
Kucha leaf - in sauces
Baobab leaf - added to sanyo/kinto during steaming
Leaves - in sauces (eg morongo, jambanduro, baobab but not kucha)
Locust bean - fermented (nete tuo)
Locust bean - prepared as a porridge
COMMENTS
Never = 0 Occasionally = 1 Once a week = 2 2-3 times a week -  3 Once a day = 4 Several times a day =
5
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Appendix 6
Genital (penis) development:
Stage 1 Pre- adolescent, testes, scrotum and penis are of the same size and proportion as
in early childhood
Stage 2 Enlargement of testes and scrotum. Skin of scrotum reddens and changes in
texture. Little or no enlargement of penis at this stage 
Stage 3 Enlargement of penis, which occurs at first mainly in length. Further growth of
testes and scrotum.
Stage 4 Increased size of penis with growth in breadth and development of glans. Testes
and scrotum larger: scrotal skin darkened.
stage 5 Genitalia adult in size and shape.
Pubic hair
Stage 1 Pre- adolescent, no pubic hair.
Stage 2 Sparse growth of long, slightly pigmented downy hair, straight or slightly curled, 2:
chiefly at the base of the penis.
Stage 3 Considerably darker, coarser and more curled. The hair spreads sparsely over the ^
junction of the penis.
Stage 4 Hair now adult in type, but area covered is still considerably smaller than in the adult, f
No spread to the medial surface of thighs.
Stage 5 Adult in quantity and type with distribution of-the horizontal pattern. Spread to
medial surface of thighs
Stage of Breast Development (B)
B1 Preadolescent, elevation of papilla only.
B2 Breast bud stage, elevation of breast and papilla as a small mound, and enlargement of
areolar diameter.
B3 Further enlargement of breast and areola, with no separation of their contour.
B4 Projection of areola and papilla to form a secondary mound above the level of the breast
B5 Mature stage, projection of papilla only, owing to recession of the areola to the general
contour of the breast.
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Appendix 7
Table 12.1 Calcium and phosphorus contents of typical Gambian foods.
Food name Ca mg/100g Phosphorus mg/100g
Staples
mani Fajiringo 6 34
Mani Nyankatango 11 69
Mani Mono 5 12
Mani Mono plus sour milk 10 35
Tiakere Churo 6 29
Sanyo Futo 57 162
Sanyo Nyelengo 31 95
Sanyo Mono 5 13
Findi Nyelengo 38 51
Findi Mono 6 13
Kinti Futo 56 219
Kinti Nyelengo 25 84
Kinti Mono 3 29
Tubanyo Futo 56 169
Tubanyo Nyelengo 30 88
Groundnuts
Tio 45 260
Sauces
Tia Durango 21 69
Jambo, plus tio 133 91
Kucha/Domoda 99 51
Bukolo 39 62
Leaves
Baobab leaves, fresh 319 89
Baobab leaves, dried 1750 193
Kucha leaves fresh 354 49
Morongo leaves, fresh 433 144
Jambanduro leaves, fresh 705 124
Vegetables
Locust bean seed 449 282
Locust bean pod power 127 160
Bitter Tomatoes 10 12
Okra 70 60
Fruits
Mango, unripe 10 13
Mangoes, ripe 10 13
Orange 30 18
Baobab, fruit 390 35
Fish
Chalo, boiled 90 217
large fresh water fish (Kujalo) 30 75
Furo/Furindingo, boiled 49 138
Chalo dried 395 728
Kujalo, dried 177 409
Furo/Furindingo, dried 4000 2700
Other foods
Meat, boiled 10 190
Milk, cow 128 93
Water 1 0
Salt, local 275 5
Mani, rice; Fajiringo, boiled; Mono, porridge; Sanyo, millet; Futo, steamed cereal with dried baobab; Nyelengo, 
boiled millet/sorghum; Findi, wild grass; Tubanyo, maize; tio, groundnuts. Source: McCrae & Paul, 1996
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